id	sid	tid	token	lemma	pos
gsrj-75	1	1	intradermal	intradermal	ADJ
gsrj-75	1	2	injection	injection	NOUN
gsrj-75	1	3	of	of	ADP
gsrj-75	1	4	bleomycin	bleomycin	PROPN
gsrj-75	1	5	shows	show	VERB
gsrj-75	1	6	preliminary	preliminary	ADJ
gsrj-75	1	7	evidence	evidence	NOUN
gsrj-75	1	8	of	of	ADP
gsrj-75	1	9	dermal	dermal	ADJ
gsrj-75	1	10	fibrosis	fibrosis	NOUN
gsrj-75	1	11	in	in	ADP
gsrj-75	1	12	a	a	DET
gsrj-75	1	13	mouse	mouse	NOUN
gsrj-75	1	14	model	model	NOUN
gsrj-75	1	15	!	!	PUNCT
gsrj-75	2	1	arun	arun	PROPN
gsrj-75	2	2	potluri	potluri	PROPN
gsrj-75	2	3	,	,	PUNCT
gsrj-75	2	4	cameron	cameron	PROPN
gsrj-75	2	5	s.	s.	PROPN
gsrj-75	2	6	d'orio	d'orio	PROPN
gsrj-75	2	7	,	,	PUNCT
gsrj-75	2	8	bs	bs	PROPN
gsrj-75	2	9	,	,	PUNCT
gsrj-75	2	10	lauren	lauren	PROPN
gsrj-75	2	11	t.	t.	PROPN
gsrj-75	2	12	mo"att	mo"att	PROPN
gsrj-75	2	13	,	,	PUNCT
gsrj-75	2	14	phd	phd	NOUN
gsrj-75	2	15	,	,	PUNCT
gsrj-75	2	16	je"rey	je"rey	PROPN
gsrj-75	2	17	w.	w.	PROPN
gsrj-75	2	18	shupp	shupp	PROPN
gsrj-75	2	19	,	,	PUNCT
gsrj-75	2	20	md	md	PROPN
gsrj-75	2	21	,	,	PUNCT
gsrj-75	2	22	bonnie	bonnie	PROPN
gsrj-75	2	23	c.	c.	PROPN
gsrj-75	2	24	carney	carney	PROPN
gsrj-75	2	25	,	,	PUNCT
gsrj-75	2	26	phd	phd	NOUN
gsrj-75	2	27	volume	volume	NOUN
gsrj-75	2	28	four	four	NUM
gsrj-75	2	29	edition	edition	NOUN
gsrj-75	2	30	one	one	NUM
gsrj-75	2	31	spring	spring	NOUN
gsrj-75	2	32	2024	2024	NUM
gsrj-75	2	33	georgetown	georgetown	PROPN
gsrj-75	2	34	scientific	scientific	PROPN
gsrj-75	2	35	research	research	NOUN
gsrj-75	2	36	journal	journal	PROPN
gsrj-75	2	37	20	20	NUM
gsrj-75	2	38	�	�	PROPN
gsrj-75	2	39	�	�	PROPN
gsrj-75	2	40	�	�	PROPN
gsrj-75	2	41	�	�	PROPN
gsrj-75	2	42	�	�	PROPN
gsrj-75	2	43	�	�	PROPN
gsrj-75	2	44	�	�	PROPN
gsrj-75	2	45	�	�	PROPN
gsrj-75	2	46	�	�	PROPN
gsrj-75	2	47	�	�	PROPN
gsrj-75	2	48	�	�	PROPN
gsrj-75	2	49	�	�	PROPN
gsrj-75	2	50	�	�	PROPN
gsrj-75	2	51	�	�	PROPN
gsrj-75	2	52	�	�	PROPN
gsrj-75	2	53	�	�	PROPN
gsrj-75	2	54	�	�	PROPN
gsrj-75	2	55	�	�	PROPN
gsrj-75	2	56	�	�	PROPN
gsrj-75	2	57	�	�	PROPN
gsrj-75	2	58	�	�	PROPN
gsrj-75	2	59	�	�	PROPN
gsrj-75	2	60	�	�	PROPN
gsrj-75	2	61	�	�	PROPN
gsrj-75	2	62	�	�	PROPN
gsrj-75	2	63	�	�	PROPN
gsrj-75	2	64	�	�	PROPN
gsrj-75	2	65	�	�	PROPN
gsrj-75	2	66	�	�	PROPN
gsrj-75	2	67	�	�	PROPN
gsrj-75	2	68	�	�	PROPN
gsrj-75	2	69	�	�	PROPN
gsrj-75	2	70	�	�	PROPN
gsrj-75	2	71	�	�	PROPN
gsrj-75	2	72	�	�	PROPN
gsrj-75	2	73	�	�	PROPN
gsrj-75	2	74	�	�	PROPN
gsrj-75	2	75	�	�	PROPN
gsrj-75	2	76	�	�	PROPN
gsrj-75	2	77	�	�	PROPN
gsrj-75	2	78	�	�	PROPN
gsrj-75	2	79	�	�	PROPN
gsrj-75	2	80	�	�	PROPN
gsrj-75	2	81	�	�	PROPN
gsrj-75	2	82	�	�	PROPN
gsrj-75	2	83	�	�	PROPN
gsrj-75	2	84	�	�	PROPN
gsrj-75	2	85	�	�	PROPN
gsrj-75	2	86	�	�	PROPN
gsrj-75	2	87	�	�	PROPN
gsrj-75	2	88	�	�	PROPN
gsrj-75	2	89	�	�	PROPN
gsrj-75	2	90	�	�	PROPN
gsrj-75	2	91	�	�	PROPN
gsrj-75	2	92	�	�	PROPN
gsrj-75	2	93	�	�	PROPN
gsrj-75	2	94	�	�	PROPN
gsrj-75	2	95	�	�	PROPN
gsrj-75	2	96	�	�	PROPN
gsrj-75	2	97	�	�	PROPN
gsrj-75	2	98	�	�	PROPN
gsrj-75	2	99	�	�	PROPN
gsrj-75	2	100	�	�	PROPN
gsrj-75	2	101	�	�	PROPN
gsrj-75	2	102	�	�	PROPN
gsrj-75	2	103	�	�	PROPN
gsrj-75	2	104	�	�	PROPN
gsrj-75	2	105	�	�	PROPN
gsrj-75	2	106	�	�	PROPN
gsrj-75	2	107	�	�	PROPN
gsrj-75	2	108	�	�	PROPN
gsrj-75	2	109	�	�	PROPN
gsrj-75	2	110	�	�	PROPN
gsrj-75	2	111	�	�	PROPN
gsrj-75	2	112	�	�	PROPN
gsrj-75	2	113	�	�	PROPN
gsrj-75	2	114	�	�	PROPN
gsrj-75	2	115	�	�	PROPN
gsrj-75	2	116	�	�	PROPN
gsrj-75	2	117	�	�	PROPN
gsrj-75	2	118	�	�	PROPN
gsrj-75	2	119	�	�	PROPN
gsrj-75	2	120	�	�	PROPN
gsrj-75	2	121	�	�	PROPN
gsrj-75	2	122	�	�	PROPN
gsrj-75	2	123	�	�	PROPN
gsrj-75	2	124	�	�	PROPN
gsrj-75	2	125	�	�	PROPN
gsrj-75	2	126	�	�	PROPN
gsrj-75	2	127	�	�	PROPN
gsrj-75	2	128	�	�	PROPN
gsrj-75	2	129	�	�	PROPN
gsrj-75	2	130	�	�	PROPN
gsrj-75	2	131	�	�	PROPN
gsrj-75	2	132	�	�	PROPN
gsrj-75	2	133	�	�	PROPN
gsrj-75	2	134	�	�	PROPN
gsrj-75	2	135	�	�	PROPN
gsrj-75	2	136	�	�	PROPN
gsrj-75	2	137	�	�	PROPN
gsrj-75	2	138	�	�	PROPN
gsrj-75	2	139	�	�	PROPN
gsrj-75	2	140	�	�	PROPN
gsrj-75	2	141	�	�	PROPN
gsrj-75	2	142	�	�	PROPN
gsrj-75	2	143	�	�	PROPN
gsrj-75	2	144	�	�	PROPN
gsrj-75	2	145	�	�	PROPN
gsrj-75	2	146	�	�	PROPN
gsrj-75	2	147	�	�	PROPN
gsrj-75	2	148	�	�	PROPN
gsrj-75	2	149	�	�	PROPN
gsrj-75	2	150	�	�	PROPN
gsrj-75	2	151	�	�	PROPN
gsrj-75	2	152	�	�	PROPN
gsrj-75	2	153	�	�	PROPN
gsrj-75	2	154	�	�	PROPN
gsrj-75	2	155	�	�	PROPN
gsrj-75	2	156	�	�	PROPN
gsrj-75	2	157	�	�	PROPN
gsrj-75	2	158	�	�	PROPN
gsrj-75	2	159	�	�	PROPN
gsrj-75	2	160	�	�	PROPN
gsrj-75	2	161	�	�	PROPN
gsrj-75	2	162	�	�	PROPN
gsrj-75	2	163	�	�	PROPN
gsrj-75	2	164	�	�	PROPN
gsrj-75	2	165	tthhaarruunn	tthhaarruunn	PROPN
gsrj-75	2	166	ppoottlluurrii11,,22	ppoottlluurrii11,,22	NOUN
gsrj-75	2	167	,	,	PUNCT
gsrj-75	2	168	,	,	PUNCT
gsrj-75	2	169	ccaammeerroonn	ccaammeerroonn	PROPN
gsrj-75	2	170	ss	ss	PROPN
gsrj-75	2	171	..	..	PROPN
gsrj-75	2	172	dd’’oorriioo	dd’’oorriioo	NOUN
gsrj-75	2	173	,	,	PUNCT
gsrj-75	2	174	,	,	PUNCT
gsrj-75	2	175	bbss22	bbss22	NOUN
gsrj-75	2	176	,	,	PUNCT
gsrj-75	2	177	,	,	PUNCT
gsrj-75	2	178	llaauurreenn	llaauurreenn	PROPN
gsrj-75	2	179	tt	tt	PROPN
gsrj-75	2	180	..	..	PROPN
gsrj-75	2	181	mmooffffaatttt	mmooffffaatttt	PROPN
gsrj-75	2	182	,	,	PUNCT
gsrj-75	2	183	,	,	PUNCT
gsrj-75	2	184	pphhdd22,,33	pphhdd22,,33	PROPN
gsrj-75	2	185	,	,	PUNCT
gsrj-75	2	186	,	,	PUNCT
gsrj-75	2	187	jjeeffffrreeyy	jjeeffffrreeyy	PROPN
gsrj-75	2	188	ww	ww	PROPN
gsrj-75	2	189	..	..	PROPN
gsrj-75	2	190	sshhuupppp	sshhuupppp	NOUN
gsrj-75	2	191	,	,	PUNCT
gsrj-75	2	192	,	,	PUNCT
gsrj-75	2	193	mmdd22,,33,,44,,55	mmdd22,,33,,44,,55	PROPN
gsrj-75	2	194	,	,	PUNCT
gsrj-75	2	195	,	,	PUNCT
gsrj-75	2	196	bboonnnniiee	bboonnnniiee	PROPN
gsrj-75	2	197	cc	cc	PROPN
gsrj-75	2	198	..	..	PROPN
gsrj-75	2	199	ccaarrnneeyy	ccaarrnneeyy	PROPN
gsrj-75	2	200	,	,	PUNCT
gsrj-75	2	201	,	,	PUNCT
gsrj-75	2	202	pphhdd22,,33	pphhdd22,,33	PROPN
gsrj-75	2	203	1	1	NUM
gsrj-75	2	204	department	department	NOUN
gsrj-75	2	205	of	of	ADP
gsrj-75	2	206	human	human	ADJ
gsrj-75	2	207	science	science	NOUN
gsrj-75	2	208	,	,	PUNCT
gsrj-75	2	209	school	school	NOUN
gsrj-75	2	210	of	of	ADP
gsrj-75	2	211	health	health	NOUN
gsrj-75	2	212	,	,	PUNCT
gsrj-75	2	213	georgetown	georgetown	PROPN
gsrj-75	2	214	university	university	PROPN
gsrj-75	2	215	,	,	PUNCT
gsrj-75	2	216	washington	washington	PROPN
gsrj-75	2	217	dc	dc	PROPN
gsrj-75	2	218	,	,	PUNCT
gsrj-75	2	219	usa	usa	PROPN
gsrj-75	2	220	2	2	NUM
gsrj-75	2	221	firefighters	firefighter	NOUN
gsrj-75	2	222	’	'	PUNCT
gsrj-75	2	223	burn	burn	VERB
gsrj-75	2	224	and	and	CCONJ
gsrj-75	2	225	surgical	surgical	ADJ
gsrj-75	2	226	research	research	NOUN
gsrj-75	2	227	laboratory	laboratory	NOUN
gsrj-75	2	228	,	,	PUNCT
gsrj-75	2	229	medstar	medstar	NOUN
gsrj-75	2	230	health	health	PROPN
gsrj-75	2	231	research	research	PROPN
gsrj-75	2	232	institute	institute	PROPN
gsrj-75	2	233	,	,	PUNCT
gsrj-75	2	234	washington	washington	PROPN
gsrj-75	2	235	dc	dc	PROPN
gsrj-75	2	236	,	,	PUNCT
gsrj-75	2	237	usa	usa	PROPN
gsrj-75	2	238	3	3	NUM
gsrj-75	2	239	departments	department	NOUN
gsrj-75	2	240	of	of	ADP
gsrj-75	2	241	surgery	surgery	NOUN
gsrj-75	2	242	and	and	CCONJ
gsrj-75	2	243	biochemistry	biochemistry	NOUN
gsrj-75	2	244	and	and	CCONJ
gsrj-75	2	245	molecular	molecular	ADJ
gsrj-75	2	246	&	&	CCONJ
gsrj-75	2	247	cellular	cellular	ADJ
gsrj-75	2	248	biology	biology	NOUN
gsrj-75	2	249	,	,	PUNCT
gsrj-75	2	250	georgetown	georgetown	PROPN
gsrj-75	2	251	university	university	PROPN
gsrj-75	2	252	school	school	NOUN
gsrj-75	2	253	of	of	ADP
gsrj-75	2	254	medicine	medicine	NOUN
gsrj-75	2	255	,	,	PUNCT
gsrj-75	2	256	washington	washington	PROPN
gsrj-75	2	257	dc	dc	PROPN
gsrj-75	2	258	,	,	PUNCT
gsrj-75	2	259	usa	usa	PROPN
gsrj-75	2	260	4	4	NUM
gsrj-75	2	261	department	department	NOUN
gsrj-75	2	262	of	of	ADP
gsrj-75	2	263	plastic	plastic	ADJ
gsrj-75	2	264	surgery	surgery	NOUN
gsrj-75	2	265	,	,	PUNCT
gsrj-75	2	266	georgetown	georgetown	PROPN
gsrj-75	2	267	university	university	PROPN
gsrj-75	2	268	school	school	NOUN
gsrj-75	2	269	of	of	ADP
gsrj-75	2	270	medicine	medicine	NOUN
gsrj-75	2	271	,	,	PUNCT
gsrj-75	2	272	washington	washington	PROPN
gsrj-75	2	273	dc	dc	PROPN
gsrj-75	2	274	,	,	PUNCT
gsrj-75	2	275	usa	usa	PROPN
gsrj-75	2	276	5	5	NUM
gsrj-75	2	277	department	department	NOUN
gsrj-75	2	278	of	of	ADP
gsrj-75	2	279	surgery	surgery	NOUN
gsrj-75	2	280	,	,	PUNCT
gsrj-75	2	281	the	the	DET
gsrj-75	2	282	burn	burn	NOUN
gsrj-75	2	283	center	center	NOUN
gsrj-75	2	284	,	,	PUNCT
gsrj-75	2	285	medstar	medstar	PROPN
gsrj-75	2	286	washington	washington	PROPN
gsrj-75	2	287	hospital	hospital	PROPN
gsrj-75	2	288	center	center	NOUN
gsrj-75	2	289	,	,	PUNCT
gsrj-75	2	290	washington	washington	PROPN
gsrj-75	2	291	dc	dc	PROPN
gsrj-75	2	292	,	,	PUNCT
gsrj-75	2	293	usa	usa	PROPN
gsrj-75	2	294	email	email	NOUN
gsrj-75	2	295	:	:	PUNCT
gsrj-75	2	296	tp600@georgetown.edu	tp600@georgetown.edu	X
gsrj-75	2	297	hhttttppss::////ddooii	hhttttppss::////ddooii	PROPN
gsrj-75	2	298	..	..	PROPN
gsrj-75	2	299	oorrgg//1100	oorrgg//1100	PROPN
gsrj-75	2	300	..	..	PROPN
gsrj-75	2	301	4488009911//ggssrr	4488009911//ggssrr	NUM
gsrj-75	2	302	..	..	PUNCT
gsrj-75	2	303	vv33ii22	vv33ii22	NOUN
gsrj-75	2	304	..	..	SYM
gsrj-75	2	305	7700	7700	NUM
gsrj-75	2	306	�	�	PROPN
gsrj-75	2	307	aabbssttrraacctt	aabbssttrraacctt	ADJ
gsrj-75	2	308	burn	burn	NOUN
gsrj-75	2	309	wounds	wound	NOUN
gsrj-75	2	310	can	can	AUX
gsrj-75	2	311	result	result	VERB
gsrj-75	2	312	in	in	ADP
gsrj-75	2	313	the	the	DET
gsrj-75	2	314	development	development	NOUN
gsrj-75	2	315	of	of	ADP
gsrj-75	2	316	hypertrophic	hypertrophic	ADJ
gsrj-75	2	317	scar	scar	NOUN
gsrj-75	2	318	(	(	PUNCT
gsrj-75	2	319	hts	hts	PROPN
gsrj-75	2	320	)	)	PUNCT
gsrj-75	2	321	.	.	PUNCT
gsrj-75	3	1	a	a	DET
gsrj-75	3	2	problematic	problematic	ADJ
gsrj-75	3	3	characteristic	characteristic	NOUN
gsrj-75	3	4	of	of	ADP
gsrj-75	3	5	hts	hts	PROPN
gsrj-75	3	6	is	be	AUX
gsrj-75	3	7	dyschromia	dyschromia	NOUN
gsrj-75	3	8	,	,	PUNCT
gsrj-75	3	9	which	which	PRON
gsrj-75	3	10	is	be	AUX
gsrj-75	3	11	often	often	ADV
gsrj-75	3	12	distressing	distressing	ADJ
gsrj-75	3	13	to	to	ADP
gsrj-75	3	14	patients	patient	NOUN
gsrj-75	3	15	and	and	CCONJ
gsrj-75	3	16	has	have	AUX
gsrj-75	3	17	been	be	AUX
gsrj-75	3	18	shown	show	VERB
gsrj-75	3	19	to	to	PART
gsrj-75	3	20	impact	impact	VERB
gsrj-75	3	21	quality	quality	NOUN
gsrj-75	3	22	of	of	ADP
gsrj-75	3	23	life	life	NOUN
gsrj-75	3	24	.	.	PUNCT
gsrj-75	4	1	there	there	PRON
gsrj-75	4	2	are	be	VERB
gsrj-75	4	3	currently	currently	ADV
gsrj-75	4	4	no	no	DET
gsrj-75	4	5	viable	viable	ADJ
gsrj-75	4	6	,	,	PUNCT
gsrj-75	4	7	non	non	ADJ
gsrj-75	4	8	-	-	ADJ
gsrj-75	4	9	surgical	surgical	ADJ
gsrj-75	4	10	treatment	treatment	NOUN
gsrj-75	4	11	methods	method	NOUN
gsrj-75	4	12	for	for	ADP
gsrj-75	4	13	dyschromia	dyschromia	NOUN
gsrj-75	4	14	,	,	PUNCT
gsrj-75	4	15	and	and	CCONJ
gsrj-75	4	16	the	the	DET
gsrj-75	4	17	mechanisms	mechanism	NOUN
gsrj-75	4	18	of	of	ADP
gsrj-75	4	19	its	its	PRON
gsrj-75	4	20	etiology	etiology	NOUN
gsrj-75	4	21	are	be	AUX
gsrj-75	4	22	not	not	PART
gsrj-75	4	23	well	well	ADV
gsrj-75	4	24	understood	understand	VERB
gsrj-75	4	25	.	.	PUNCT
gsrj-75	5	1	we	we	PRON
gsrj-75	5	2	aimed	aim	VERB
gsrj-75	5	3	to	to	PART
gsrj-75	5	4	test	test	VERB
gsrj-75	5	5	if	if	SCONJ
gsrj-75	5	6	the	the	DET
gsrj-75	5	7	fibrotic	fibrotic	ADJ
gsrj-75	5	8	microenvironment	microenvironment	NOUN
gsrj-75	5	9	of	of	ADP
gsrj-75	5	10	the	the	DET
gsrj-75	5	11	dermis	dermis	NOUN
gsrj-75	5	12	plays	play	VERB
gsrj-75	5	13	a	a	DET
gsrj-75	5	14	contributing	contribute	VERB
gsrj-75	5	15	role	role	NOUN
gsrj-75	5	16	in	in	ADP
gsrj-75	5	17	the	the	DET
gsrj-75	5	18	development	development	NOUN
gsrj-75	5	19	of	of	ADP
gsrj-75	5	20	epidermal	epidermal	ADJ
gsrj-75	5	21	dyschromia	dyschromia	NOUN
gsrj-75	5	22	.	.	PUNCT
gsrj-75	6	1	to	to	PART
gsrj-75	6	2	do	do	VERB
gsrj-75	6	3	this	this	PRON
gsrj-75	6	4	,	,	PUNCT
gsrj-75	6	5	we	we	PRON
gsrj-75	6	6	focused	focus	VERB
gsrj-75	6	7	on	on	ADP
gsrj-75	6	8	reproducing	reproduce	VERB
gsrj-75	6	9	a	a	DET
gsrj-75	6	10	previously	previously	ADV
gsrj-75	6	11	published	publish	VERB
gsrj-75	6	12	model	model	NOUN
gsrj-75	6	13	of	of	ADP
gsrj-75	6	14	bleomycin	bleomycin	PROPN
gsrj-75	6	15	-	-	PUNCT
gsrj-75	6	16	induced	induce	VERB
gsrj-75	6	17	dermal	dermal	ADJ
gsrj-75	6	18	fibrosis	fibrosis	NOUN
gsrj-75	6	19	to	to	PART
gsrj-75	6	20	add	add	VERB
gsrj-75	6	21	to	to	ADP
gsrj-75	6	22	the	the	DET
gsrj-75	6	23	replicability	replicability	NOUN
gsrj-75	6	24	of	of	ADP
gsrj-75	6	25	previous	previous	ADJ
gsrj-75	6	26	findings	finding	NOUN
gsrj-75	6	27	and	and	CCONJ
gsrj-75	6	28	establish	establish	VERB
gsrj-75	6	29	a	a	DET
gsrj-75	6	30	reliable	reliable	ADJ
gsrj-75	6	31	model	model	NOUN
gsrj-75	6	32	to	to	PART
gsrj-75	6	33	serve	serve	VERB
gsrj-75	6	34	as	as	ADP
gsrj-75	6	35	a	a	DET
gsrj-75	6	36	basis	basis	NOUN
gsrj-75	6	37	for	for	ADP
gsrj-75	6	38	understanding	understand	VERB
gsrj-75	6	39	post	post	ADJ
gsrj-75	6	40	-	-	ADJ
gsrj-75	6	41	burn	burn	ADJ
gsrj-75	6	42	dyschromia	dyschromia	NOUN
gsrj-75	6	43	development	development	NOUN
gsrj-75	6	44	.	.	PUNCT
gsrj-75	7	1	by	by	ADP
gsrj-75	7	2	treating	treat	VERB
gsrj-75	7	3	c57bl/6	c57bl/6	NOUN
gsrj-75	7	4	mice	mouse	NOUN
gsrj-75	7	5	with	with	ADP
gsrj-75	7	6	intradermal	intradermal	ADJ
gsrj-75	7	7	injections	injection	NOUN
gsrj-75	7	8	of	of	ADP
gsrj-75	7	9	three	three	NUM
gsrj-75	7	10	varying	vary	VERB
gsrj-75	7	11	doses	dose	NOUN
gsrj-75	7	12	of	of	ADP
gsrj-75	7	13	bleomycin	bleomycin	PROPN
gsrj-75	7	14	for	for	ADP
gsrj-75	7	15	two	two	NUM
gsrj-75	7	16	weeks	week	NOUN
gsrj-75	7	17	and	and	CCONJ
gsrj-75	7	18	conducting	conduct	VERB
gsrj-75	7	19	histological	histological	ADJ
gsrj-75	7	20	and	and	CCONJ
gsrj-75	7	21	molecular	molecular	ADJ
gsrj-75	7	22	analyses	analysis	NOUN
gsrj-75	7	23	of	of	ADP
gsrj-75	7	24	collected	collect	VERB
gsrj-75	7	25	data	datum	NOUN
gsrj-75	7	26	,	,	PUNCT
gsrj-75	7	27	we	we	PRON
gsrj-75	7	28	were	be	AUX
gsrj-75	7	29	able	able	ADJ
gsrj-75	7	30	to	to	PART
gsrj-75	7	31	assess	assess	VERB
gsrj-75	7	32	the	the	DET
gsrj-75	7	33	adequacy	adequacy	NOUN
gsrj-75	7	34	of	of	ADP
gsrj-75	7	35	dermal	dermal	ADJ
gsrj-75	7	36	fibrosis	fibrosis	NOUN
gsrj-75	7	37	development	development	NOUN
gsrj-75	7	38	.	.	PUNCT
gsrj-75	8	1	collected	collect	VERB
gsrj-75	8	2	data	datum	NOUN
gsrj-75	8	3	showed	show	VERB
gsrj-75	8	4	evidence	evidence	NOUN
gsrj-75	8	5	of	of	ADP
gsrj-75	8	6	hair	hair	NOUN
gsrj-75	8	7	follicle	follicle	NOUN
gsrj-75	8	8	obliteration	obliteration	NOUN
gsrj-75	8	9	,	,	PUNCT
gsrj-75	8	10	dermal	dermal	ADJ
gsrj-75	8	11	thickening	thickening	NOUN
gsrj-75	8	12	,	,	PUNCT
gsrj-75	8	13	and	and	CCONJ
gsrj-75	8	14	other	other	ADJ
gsrj-75	8	15	characteristics	characteristic	NOUN
gsrj-75	8	16	of	of	ADP
gsrj-75	8	17	fibrotic	fibrotic	ADJ
gsrj-75	8	18	architecture	architecture	NOUN
gsrj-75	8	19	within	within	ADP
gsrj-75	8	20	all	all	DET
gsrj-75	8	21	three	three	NUM
gsrj-75	8	22	bleomycin	bleomycin	NOUN
gsrj-75	8	23	-	-	PUNCT
gsrj-75	8	24	treated	treat	VERB
gsrj-75	8	25	groups	group	NOUN
gsrj-75	8	26	,	,	PUNCT
gsrj-75	8	27	bust	bust	VERB
gsrj-75	8	28	mostly	mostly	ADV
gsrj-75	8	29	profoundly	profoundly	ADV
gsrj-75	8	30	in	in	ADP
gsrj-75	8	31	the	the	DET
gsrj-75	8	32	high	high	ADJ
gsrj-75	8	33	-	-	PUNCT
gsrj-75	8	34	dose	dose	NOUN
gsrj-75	8	35	group	group	NOUN
gsrj-75	8	36	.	.	PUNCT
gsrj-75	9	1	however	however	ADV
gsrj-75	9	2	,	,	PUNCT
gsrj-75	9	3	qrt	qrt	ADJ
gsrj-75	9	4	-	-	PUNCT
gsrj-75	9	5	pcr	pcr	ADJ
gsrj-75	9	6	data	datum	NOUN
gsrj-75	9	7	did	do	AUX
gsrj-75	9	8	not	not	PART
gsrj-75	9	9	reveal	reveal	VERB
gsrj-75	9	10	any	any	DET
gsrj-75	9	11	significant	significant	ADJ
gsrj-75	9	12	trends	trend	NOUN
gsrj-75	9	13	in	in	ADP
gsrj-75	9	14	differential	differential	ADJ
gsrj-75	9	15	expression	expression	NOUN
gsrj-75	9	16	of	of	ADP
gsrj-75	9	17	genes	gene	NOUN
gsrj-75	9	18	of	of	ADP
gsrj-75	9	19	interest	interest	NOUN
gsrj-75	9	20	.	.	PUNCT
gsrj-75	10	1	in	in	ADP
gsrj-75	10	2	future	future	ADJ
gsrj-75	10	3	work	work	NOUN
gsrj-75	10	4	,	,	PUNCT
gsrj-75	10	5	additional	additional	ADJ
gsrj-75	10	6	qrt	qrt	ADJ
gsrj-75	10	7	-	-	PUNCT
gsrj-75	10	8	pcr	pcr	ADJ
gsrj-75	10	9	analysis	analysis	NOUN
gsrj-75	10	10	,	,	PUNCT
gsrj-75	10	11	immunofluorescence	immunofluorescence	NOUN
gsrj-75	10	12	visualization	visualization	NOUN
gsrj-75	10	13	,	,	PUNCT
gsrj-75	10	14	and	and	CCONJ
gsrj-75	10	15	other	other	ADJ
gsrj-75	10	16	molecular	molecular	ADJ
gsrj-75	10	17	assays	assay	NOUN
gsrj-75	10	18	should	should	AUX
gsrj-75	10	19	be	be	AUX
gsrj-75	10	20	conducted	conduct	VERB
gsrj-75	10	21	to	to	PART
gsrj-75	10	22	obtain	obtain	VERB
gsrj-75	10	23	further	far	ADV
gsrj-75	10	24	molecular	molecular	ADJ
gsrj-75	10	25	confirmation	confirmation	NOUN
gsrj-75	10	26	of	of	ADP
gsrj-75	10	27	bleomycin	bleomycin	PROPN
gsrj-75	10	28	-	-	PUNCT
gsrj-75	10	29	induced	induce	VERB
gsrj-75	10	30	dermal	dermal	NOUN
gsrj-75	10	31	fibrosis	fibrosis	NOUN
gsrj-75	10	32	before	before	SCONJ
gsrj-75	10	33	we	we	PRON
gsrj-75	10	34	can	can	AUX
gsrj-75	10	35	attempt	attempt	VERB
gsrj-75	10	36	to	to	PART
gsrj-75	10	37	understand	understand	VERB
gsrj-75	10	38	the	the	DET
gsrj-75	10	39	mechanistic	mechanistic	ADJ
gsrj-75	10	40	relationship	relationship	NOUN
gsrj-75	10	41	between	between	ADP
gsrj-75	10	42	dermal	dermal	ADJ
gsrj-75	10	43	fibrosis	fibrosis	NOUN
gsrj-75	10	44	and	and	CCONJ
gsrj-75	10	45	epidermal	epidermal	ADJ
gsrj-75	10	46	dyschromia	dyschromia	NOUN
gsrj-75	10	47	.	.	PUNCT
gsrj-75	11	1	keywords	keyword	NOUN
gsrj-75	11	2	:	:	PUNCT
gsrj-75	11	3	hypertrophic	hypertrophic	ADJ
gsrj-75	11	4	scar	scar	NOUN
gsrj-75	11	5	,	,	PUNCT
gsrj-75	11	6	dyschromia	dyschromia	NOUN
gsrj-75	11	7	,	,	PUNCT
gsrj-75	11	8	fibrosis	fibrosis	NOUN
gsrj-75	11	9	,	,	PUNCT
gsrj-75	11	10	bleomycin	bleomycin	PROPN
gsrj-75	11	11	11	11	NUM
gsrj-75	11	12	..	..	PUNCT
gsrj-75	11	13	iinnttrroodduuccttiioonn	iinnttrroodduuccttiioonn	PROPN
gsrj-75	11	14	recent	recent	ADJ
gsrj-75	11	15	advances	advance	NOUN
gsrj-75	11	16	in	in	ADP
gsrj-75	11	17	the	the	DET
gsrj-75	11	18	management	management	NOUN
gsrj-75	11	19	and	and	CCONJ
gsrj-75	11	20	treatment	treatment	NOUN
gsrj-75	11	21	of	of	ADP
gsrj-75	11	22	burn	burn	NOUN
gsrj-75	11	23	-	-	PUNCT
gsrj-75	11	24	related	relate	VERB
gsrj-75	11	25	injuries	injury	NOUN
gsrj-75	11	26	have	have	AUX
gsrj-75	11	27	led	lead	VERB
gsrj-75	11	28	to	to	ADP
gsrj-75	11	29	a	a	DET
gsrj-75	11	30	significant	significant	ADJ
gsrj-75	11	31	decrease	decrease	NOUN
gsrj-75	11	32	in	in	ADP
gsrj-75	11	33	mortality	mortality	NOUN
gsrj-75	11	34	rates	rate	NOUN
gsrj-75	11	35	,	,	PUNCT
gsrj-75	11	36	especially	especially	ADV
gsrj-75	11	37	for	for	ADP
gsrj-75	11	38	large	large	ADJ
gsrj-75	11	39	total	total	ADJ
gsrj-75	11	40	body	body	NOUN
gsrj-75	11	41	surface	surface	NOUN
gsrj-75	11	42	area	area	NOUN
gsrj-75	11	43	full	full	ADJ
gsrj-75	11	44	-	-	PUNCT
gsrj-75	11	45	thickness	thickness	NOUN
gsrj-75	11	46	burns.1	burns.1	NOUN
gsrj-75	11	47	with	with	ADP
gsrj-75	11	48	an	an	DET
gsrj-75	11	49	increasing	increase	VERB
gsrj-75	11	50	patient	patient	ADJ
gsrj-75	11	51	survival	survival	NOUN
gsrj-75	11	52	rate	rate	NOUN
gsrj-75	11	53	,	,	PUNCT
gsrj-75	11	54	attention	attention	NOUN
gsrj-75	11	55	is	be	AUX
gsrj-75	11	56	now	now	ADV
gsrj-75	11	57	being	be	AUX
gsrj-75	11	58	turned	turn	VERB
gsrj-75	11	59	to	to	ADP
gsrj-75	11	60	managing	manage	VERB
gsrj-75	11	61	the	the	DET
gsrj-75	11	62	after	after	NOUN
gsrj-75	11	63	-	-	PUNCT
gsrj-75	11	64	effects	effect	NOUN
gsrj-75	11	65	of	of	ADP
gsrj-75	11	66	burn	burn	NOUN
gsrj-75	11	67	injury	injury	NOUN
gsrj-75	11	68	.	.	PUNCT
gsrj-75	12	1	burn	burn	VERB
gsrj-75	12	2	wounds	wound	NOUN
gsrj-75	12	3	and	and	CCONJ
gsrj-75	12	4	other	other	ADJ
gsrj-75	12	5	cutaneous	cutaneous	ADJ
gsrj-75	12	6	trauma	trauma	NOUN
gsrj-75	12	7	can	can	AUX
gsrj-75	12	8	result	result	VERB
gsrj-75	12	9	in	in	ADP
gsrj-75	12	10	the	the	DET
gsrj-75	12	11	development	development	NOUN
gsrj-75	12	12	of	of	ADP
gsrj-75	12	13	hypertrophic	hypertrophic	ADJ
gsrj-75	12	14	scar	scar	NOUN
gsrj-75	12	15	(	(	PUNCT
gsrj-75	12	16	hts	hts	PROPN
gsrj-75	12	17	)	)	PUNCT
gsrj-75	12	18	,	,	PUNCT
gsrj-75	12	19	among	among	ADP
gsrj-75	12	20	other	other	ADJ
gsrj-75	12	21	physiological	physiological	ADJ
gsrj-75	12	22	complications	complication	NOUN
gsrj-75	12	23	such	such	ADJ
gsrj-75	12	24	as	as	ADP
gsrj-75	12	25	muscle	muscle	NOUN
gsrj-75	12	26	wasting	wasting	NOUN
gsrj-75	12	27	,	,	PUNCT
gsrj-75	12	28	contractures	contracture	NOUN
gsrj-75	12	29	,	,	PUNCT
gsrj-75	12	30	infection	infection	NOUN
gsrj-75	12	31	,	,	PUNCT
gsrj-75	12	32	and	and	CCONJ
gsrj-75	12	33	more.2	more.2	PROPN
gsrj-75	12	34	hts	hts	PROPN
gsrj-75	12	35	is	be	AUX
gsrj-75	12	36	typically	typically	ADV
gsrj-75	12	37	raised	raise	VERB
gsrj-75	12	38	,	,	PUNCT
gsrj-75	12	39	thick	thick	ADJ
gsrj-75	12	40	,	,	PUNCT
gsrj-75	12	41	non	non	ADJ
gsrj-75	12	42	-	-	ADJ
gsrj-75	12	43	pliable	pliable	ADJ
gsrj-75	12	44	,	,	PUNCT
gsrj-75	12	45	erythematous	erythematous	ADJ
gsrj-75	12	46	,	,	PUNCT
gsrj-75	12	47	pruritic	pruritic	ADJ
gsrj-75	12	48	,	,	PUNCT
gsrj-75	12	49	and	and	CCONJ
gsrj-75	12	50	painful.3	painful.3	NOUN
gsrj-75	12	51	irregular	irregular	ADJ
gsrj-75	12	52	inflammatory	inflammatory	ADJ
gsrj-75	12	53	processes	process	NOUN
gsrj-75	12	54	in	in	ADP
gsrj-75	12	55	the	the	DET
gsrj-75	12	56	dermis	dermis	NOUN
gsrj-75	12	57	contribute	contribute	VERB
gsrj-75	12	58	to	to	ADP
gsrj-75	12	59	21	21	NUM
gsrj-75	12	60	�	�	PROPN
gsrj-75	12	61	�	�	PROPN
gsrj-75	12	62	�	�	PROPN
gsrj-75	12	63	�	�	PROPN
gsrj-75	12	64	�	�	PROPN
gsrj-75	12	65	�	�	PROPN
gsrj-75	12	66	�	�	PROPN
gsrj-75	12	67	�	�	PROPN
gsrj-75	12	68	�	�	PROPN
gsrj-75	12	69	�	�	PROPN
gsrj-75	12	70	�	�	PROPN
gsrj-75	12	71	�	�	PROPN
gsrj-75	12	72	�	�	PROPN
gsrj-75	12	73	�	�	PROPN
gsrj-75	12	74	�	�	PROPN
gsrj-75	12	75	�	�	PROPN
gsrj-75	12	76	�	�	PROPN
gsrj-75	12	77	�	�	PROPN
gsrj-75	12	78	�	�	PROPN
gsrj-75	12	79	�	�	PROPN
gsrj-75	12	80	�	�	PROPN
gsrj-75	12	81	�	�	PROPN
gsrj-75	12	82	�	�	PROPN
gsrj-75	12	83	�	�	PROPN
gsrj-75	12	84	�	�	PROPN
gsrj-75	12	85	�	�	PROPN
gsrj-75	12	86	�	�	PROPN
gsrj-75	12	87	�	�	PROPN
gsrj-75	12	88	�	�	PROPN
gsrj-75	12	89	�	�	PROPN
gsrj-75	12	90	�	�	PROPN
gsrj-75	12	91	�	�	PROPN
gsrj-75	12	92	�	�	PROPN
gsrj-75	12	93	�	�	PROPN
gsrj-75	12	94	�	�	PROPN
gsrj-75	12	95	�	�	PROPN
gsrj-75	12	96	�	�	PROPN
gsrj-75	12	97	�	�	PROPN
gsrj-75	12	98	hts	hts	PROPN
gsrj-75	12	99	pathophysiology	pathophysiology	NOUN
gsrj-75	12	100	.	.	PUNCT
gsrj-75	13	1	hts	hts	PROPN
gsrj-75	13	2	forms	form	NOUN
gsrj-75	13	3	as	as	ADP
gsrj-75	13	4	a	a	DET
gsrj-75	13	5	result	result	NOUN
gsrj-75	13	6	of	of	ADP
gsrj-75	13	7	excess	excess	ADJ
gsrj-75	13	8	collagen	collagen	NOUN
gsrj-75	13	9	deposition	deposition	NOUN
gsrj-75	13	10	and	and	CCONJ
gsrj-75	13	11	abnormal	abnormal	ADJ
gsrj-75	13	12	fibroblast	fibroblast	ADJ
gsrj-75	13	13	proliferation	proliferation	NOUN
gsrj-75	13	14	.	.	PUNCT
gsrj-75	14	1	the	the	DET
gsrj-75	14	2	abnormal	abnormal	ADJ
gsrj-75	14	3	functioning	functioning	NOUN
gsrj-75	14	4	of	of	ADP
gsrj-75	14	5	these	these	DET
gsrj-75	14	6	fibroblasts	fibroblast	NOUN
gsrj-75	14	7	results	result	NOUN
gsrj-75	14	8	in	in	ADP
gsrj-75	14	9	excess	excess	ADJ
gsrj-75	14	10	amounts	amount	NOUN
gsrj-75	14	11	of	of	ADP
gsrj-75	14	12	extracellular	extracellular	ADJ
gsrj-75	14	13	matrix	matrix	NOUN
gsrj-75	14	14	components	component	NOUN
gsrj-75	14	15	that	that	PRON
gsrj-75	14	16	cause	cause	VERB
gsrj-75	14	17	elevated	elevated	ADJ
gsrj-75	14	18	and	and	CCONJ
gsrj-75	14	19	stiff	stiff	ADJ
gsrj-75	14	20	skin	skin	NOUN
gsrj-75	14	21	characteristic	characteristic	NOUN
gsrj-75	14	22	of	of	ADP
gsrj-75	14	23	hts.4	hts.4	PRON
gsrj-75	14	24	the	the	DET
gsrj-75	14	25	bulk	bulk	NOUN
gsrj-75	14	26	of	of	ADP
gsrj-75	14	27	hts	ht	NOUN
gsrj-75	14	28	tissue	tissue	NOUN
gsrj-75	14	29	is	be	AUX
gsrj-75	14	30	composed	compose	VERB
gsrj-75	14	31	of	of	ADP
gsrj-75	14	32	the	the	DET
gsrj-75	14	33	dermis	dermis	NOUN
gsrj-75	14	34	layer	layer	NOUN
gsrj-75	14	35	which	which	PRON
gsrj-75	14	36	is	be	AUX
gsrj-75	14	37	primarily	primarily	ADV
gsrj-75	14	38	made	make	VERB
gsrj-75	14	39	up	up	ADP
gsrj-75	14	40	of	of	ADP
gsrj-75	14	41	type	type	NOUN
gsrj-75	14	42	1	1	NUM
gsrj-75	14	43	collagen	collagen	NOUN
gsrj-75	14	44	,	,	PUNCT
gsrj-75	14	45	fibroblasts	fibroblast	NOUN
gsrj-75	14	46	,	,	PUNCT
gsrj-75	14	47	and	and	CCONJ
gsrj-75	14	48	endothelial	endothelial	NOUN
gsrj-75	14	49	cells.5	cells.5	PROPN
gsrj-75	14	50	a	a	DET
gsrj-75	14	51	number	number	NOUN
gsrj-75	14	52	of	of	ADP
gsrj-75	14	53	proteins	protein	NOUN
gsrj-75	14	54	,	,	PUNCT
gsrj-75	14	55	such	such	ADJ
gsrj-75	14	56	as	as	ADP
gsrj-75	14	57	collagen	collagen	NOUN
gsrj-75	14	58	1	1	NUM
gsrj-75	14	59	alpha	alpha	NOUN
gsrj-75	14	60	1	1	NUM
gsrj-75	14	61	(	(	PUNCT
gsrj-75	14	62	col1a1	col1a1	NOUN
gsrj-75	14	63	)	)	PUNCT
gsrj-75	14	64	,	,	PUNCT
gsrj-75	14	65	col1a3	col1a3	NOUN
gsrj-75	14	66	,	,	PUNCT
gsrj-75	14	67	transforming	transform	VERB
gsrj-75	14	68	growth	growth	NOUN
gsrj-75	14	69	factor	factor	NOUN
gsrj-75	14	70	beta-1	beta-1	NUM
gsrj-75	14	71	(	(	PUNCT
gsrj-75	14	72	tgfb1	tgfb1	NOUN
gsrj-75	14	73	)	)	PUNCT
gsrj-75	14	74	,	,	PUNCT
gsrj-75	14	75	and	and	CCONJ
gsrj-75	14	76	galectin-1	galectin-1	PROPN
gsrj-75	14	77	(	(	PUNCT
gsrj-75	14	78	lgals1	lgals1	PROPN
gsrj-75	14	79	)	)	PUNCT
gsrj-75	14	80	,	,	PUNCT
gsrj-75	14	81	have	have	AUX
gsrj-75	14	82	been	be	AUX
gsrj-75	14	83	shown	show	VERB
gsrj-75	14	84	to	to	PART
gsrj-75	14	85	be	be	AUX
gsrj-75	14	86	differentially	differentially	ADV
gsrj-75	14	87	overexpressed	overexpresse	VERB
gsrj-75	14	88	in	in	ADP
gsrj-75	14	89	fibrotic	fibrotic	ADJ
gsrj-75	14	90	skin	skin	NOUN
gsrj-75	14	91	characteristic	characteristic	NOUN
gsrj-75	14	92	of	of	ADP
gsrj-75	14	93	hts.6	hts.6	PROPN
gsrj-75	14	94	additionally	additionally	ADV
gsrj-75	14	95	,	,	PUNCT
gsrj-75	14	96	hts	hts	PROPN
gsrj-75	14	97	typically	typically	ADV
gsrj-75	14	98	has	have	AUX
gsrj-75	14	99	thickened	thicken	VERB
gsrj-75	14	100	dermis	dermis	NOUN
gsrj-75	14	101	and	and	CCONJ
gsrj-75	14	102	epidermis	epidermis	NOUN
gsrj-75	14	103	layers	layer	NOUN
gsrj-75	14	104	and	and	CCONJ
gsrj-75	14	105	a	a	DET
gsrj-75	14	106	change	change	NOUN
gsrj-75	14	107	in	in	ADP
gsrj-75	14	108	collagen	collagen	NOUN
gsrj-75	14	109	architecture	architecture	NOUN
gsrj-75	14	110	that	that	PRON
gsrj-75	14	111	causes	cause	VERB
gsrj-75	14	112	the	the	DET
gsrj-75	14	113	increased	increase	VERB
gsrj-75	14	114	skin	skin	NOUN
gsrj-75	14	115	stiffness	stiffness	NOUN
gsrj-75	14	116	.	.	PUNCT
gsrj-75	15	1	in	in	ADP
gsrj-75	15	2	addition	addition	NOUN
gsrj-75	15	3	to	to	ADP
gsrj-75	15	4	the	the	DET
gsrj-75	15	5	physical	physical	ADJ
gsrj-75	15	6	impacts	impact	NOUN
gsrj-75	15	7	of	of	ADP
gsrj-75	15	8	postburn	postburn	NOUN
gsrj-75	15	9	hts	hts	PROPN
gsrj-75	15	10	development	development	NOUN
gsrj-75	15	11	,	,	PUNCT
gsrj-75	15	12	patients	patient	NOUN
gsrj-75	15	13	with	with	ADP
gsrj-75	15	14	hts	hts	PROPN
gsrj-75	15	15	frequently	frequently	ADV
gsrj-75	15	16	suffer	suffer	VERB
gsrj-75	15	17	from	from	ADP
gsrj-75	15	18	the	the	DET
gsrj-75	15	19	psychosocial	psychosocial	ADJ
gsrj-75	15	20	impacts	impact	NOUN
gsrj-75	15	21	of	of	ADP
gsrj-75	15	22	altered	altered	ADJ
gsrj-75	15	23	appearance	appearance	NOUN
gsrj-75	15	24	and	and	CCONJ
gsrj-75	15	25	restricted	restricted	ADJ
gsrj-75	15	26	range	range	NOUN
gsrj-75	15	27	of	of	ADP
gsrj-75	15	28	motion	motion	NOUN
gsrj-75	15	29	that	that	PRON
gsrj-75	15	30	often	often	ADV
gsrj-75	15	31	results	result	VERB
gsrj-75	15	32	due	due	ADP
gsrj-75	15	33	to	to	ADP
gsrj-75	15	34	hts.7	hts.7	NOUN
gsrj-75	15	35	almost	almost	ADV
gsrj-75	15	36	all	all	PRON
gsrj-75	15	37	htss	htss	ADJ
gsrj-75	15	38	display	display	NOUN
gsrj-75	15	39	dyschromia	dyschromia	NOUN
gsrj-75	15	40	,	,	PUNCT
gsrj-75	15	41	which	which	PRON
gsrj-75	15	42	appears	appear	VERB
gsrj-75	15	43	as	as	ADP
gsrj-75	15	44	hypoor	hypoor	ADJ
gsrj-75	15	45	hyperpigmentation	hyperpigmentation	NOUN
gsrj-75	15	46	of	of	ADP
gsrj-75	15	47	the	the	DET
gsrj-75	15	48	skin	skin	NOUN
gsrj-75	15	49	.	.	PUNCT
gsrj-75	16	1	more	more	ADV
gsrj-75	16	2	severe	severe	ADJ
gsrj-75	16	3	scars	scar	NOUN
gsrj-75	16	4	with	with	ADP
gsrj-75	16	5	extreme	extreme	ADJ
gsrj-75	16	6	dermal	dermal	NOUN
gsrj-75	16	7	pathology	pathology	NOUN
gsrj-75	16	8	(	(	PUNCT
gsrj-75	16	9	increased	increase	VERB
gsrj-75	16	10	thickness	thickness	NOUN
gsrj-75	16	11	,	,	PUNCT
gsrj-75	16	12	hyper	hyper	NOUN
gsrj-75	16	13	-	-	ADJ
gsrj-75	16	14	vasculature	vasculature	ADJ
gsrj-75	16	15	,	,	PUNCT
gsrj-75	16	16	hyper	hyper	NOUN
gsrj-75	16	17	-	-	NOUN
gsrj-75	16	18	cellularity	cellularity	NOUN
gsrj-75	16	19	,	,	PUNCT
gsrj-75	16	20	non	non	ADJ
gsrj-75	16	21	-	-	NOUN
gsrj-75	16	22	pliability	pliability	ADJ
gsrj-75	16	23	,	,	PUNCT
gsrj-75	16	24	contracture	contracture	NOUN
gsrj-75	16	25	)	)	PUNCT
gsrj-75	16	26	often	often	ADV
gsrj-75	16	27	exhibit	exhibit	VERB
gsrj-75	16	28	the	the	DET
gsrj-75	16	29	most	most	ADV
gsrj-75	16	30	profound	profound	ADJ
gsrj-75	16	31	dyschromia	dyschromia	NOUN
gsrj-75	16	32	.	.	PUNCT
gsrj-75	17	1	dyschromic	dyschromic	PROPN
gsrj-75	17	2	hts	hts	PROPN
gsrj-75	17	3	,	,	PUNCT
gsrj-75	17	4	which	which	PRON
gsrj-75	17	5	develops	develop	VERB
gsrj-75	17	6	pervasively	pervasively	ADV
gsrj-75	17	7	amongst	amongst	ADP
gsrj-75	17	8	patients	patient	NOUN
gsrj-75	17	9	with	with	ADP
gsrj-75	17	10	skin	skin	NOUN
gsrj-75	17	11	of	of	ADP
gsrj-75	17	12	color	color	NOUN
gsrj-75	17	13	,	,	PUNCT
gsrj-75	17	14	is	be	AUX
gsrj-75	17	15	often	often	ADV
gsrj-75	17	16	distressing	distressing	ADJ
gsrj-75	17	17	to	to	ADP
gsrj-75	17	18	patients	patient	NOUN
gsrj-75	17	19	and	and	CCONJ
gsrj-75	17	20	has	have	AUX
gsrj-75	17	21	been	be	AUX
gsrj-75	17	22	shown	show	VERB
gsrj-75	17	23	to	to	PART
gsrj-75	17	24	impact	impact	VERB
gsrj-75	17	25	quality	quality	NOUN
gsrj-75	17	26	of	of	ADP
gsrj-75	17	27	life	life	NOUN
gsrj-75	17	28	metrics	metric	NOUN
gsrj-75	17	29	such	such	ADJ
gsrj-75	17	30	as	as	ADP
gsrj-75	17	31	stigmatization	stigmatization	NOUN
gsrj-75	17	32	,	,	PUNCT
gsrj-75	17	33	sexual	sexual	ADJ
gsrj-75	17	34	health	health	NOUN
gsrj-75	17	35	,	,	PUNCT
gsrj-75	17	36	and	and	CCONJ
gsrj-75	17	37	physiological	physiological	ADJ
gsrj-75	17	38	health.8	health.8	NOUN
gsrj-75	17	39	-	-	PUNCT
gsrj-75	17	40	12	12	NUM
gsrj-75	17	41	while	while	SCONJ
gsrj-75	17	42	some	some	DET
gsrj-75	17	43	therapies	therapy	NOUN
gsrj-75	17	44	have	have	AUX
gsrj-75	17	45	led	lead	VERB
gsrj-75	17	46	to	to	ADP
gsrj-75	17	47	modest	modest	ADJ
gsrj-75	17	48	improvements	improvement	NOUN
gsrj-75	17	49	in	in	ADP
gsrj-75	17	50	hts	hts	PROPN
gsrj-75	17	51	symptoms	symptom	NOUN
gsrj-75	17	52	for	for	ADP
gsrj-75	17	53	some	some	DET
gsrj-75	17	54	patients	patient	NOUN
gsrj-75	17	55	,	,	PUNCT
gsrj-75	17	56	hts	hts	PROPN
gsrj-75	17	57	and	and	CCONJ
gsrj-75	17	58	its	its	PRON
gsrj-75	17	59	psychosocial	psychosocial	ADJ
gsrj-75	17	60	impact	impact	NOUN
gsrj-75	17	61	continues	continue	VERB
gsrj-75	17	62	to	to	PART
gsrj-75	17	63	be	be	AUX
gsrj-75	17	64	challenging	challenge	VERB
gsrj-75	17	65	to	to	PART
gsrj-75	17	66	treat	treat	VERB
gsrj-75	17	67	.	.	PUNCT
gsrj-75	18	1	finding	find	VERB
gsrj-75	18	2	viable	viable	ADJ
gsrj-75	18	3	,	,	PUNCT
gsrj-75	18	4	non	non	ADJ
gsrj-75	18	5	-	-	ADJ
gsrj-75	18	6	surgical	surgical	ADJ
gsrj-75	18	7	treatment	treatment	NOUN
gsrj-75	18	8	methods	method	NOUN
gsrj-75	18	9	for	for	ADP
gsrj-75	18	10	dyschromia	dyschromia	NOUN
gsrj-75	18	11	could	could	AUX
gsrj-75	18	12	significantly	significantly	ADV
gsrj-75	18	13	improve	improve	VERB
gsrj-75	18	14	the	the	DET
gsrj-75	18	15	quality	quality	NOUN
gsrj-75	18	16	of	of	ADP
gsrj-75	18	17	life	life	NOUN
gsrj-75	18	18	for	for	ADP
gsrj-75	18	19	patients	patient	NOUN
gsrj-75	18	20	with	with	ADP
gsrj-75	18	21	hts	hts	PROPN
gsrj-75	18	22	.	.	PUNCT
gsrj-75	19	1	before	before	ADP
gsrj-75	19	2	testing	test	VERB
gsrj-75	19	3	treatment	treatment	NOUN
gsrj-75	19	4	methods	method	NOUN
gsrj-75	19	5	,	,	PUNCT
gsrj-75	19	6	however	however	ADV
gsrj-75	19	7	,	,	PUNCT
gsrj-75	19	8	the	the	DET
gsrj-75	19	9	mechanistic	mechanistic	ADJ
gsrj-75	19	10	processes	process	NOUN
gsrj-75	19	11	behind	behind	ADP
gsrj-75	19	12	dyschromia	dyschromia	NOUN
gsrj-75	19	13	must	must	AUX
gsrj-75	19	14	first	first	ADV
gsrj-75	19	15	be	be	AUX
gsrj-75	19	16	understood	understand	VERB
gsrj-75	19	17	.	.	PUNCT
gsrj-75	20	1	there	there	PRON
gsrj-75	20	2	is	be	VERB
gsrj-75	20	3	currently	currently	ADV
gsrj-75	20	4	a	a	DET
gsrj-75	20	5	large	large	ADJ
gsrj-75	20	6	gap	gap	NOUN
gsrj-75	20	7	in	in	ADP
gsrj-75	20	8	knowledge	knowledge	NOUN
gsrj-75	20	9	as	as	ADP
gsrj-75	20	10	to	to	ADP
gsrj-75	20	11	how	how	SCONJ
gsrj-75	20	12	post	post	ADJ
gsrj-75	20	13	-	-	ADJ
gsrj-75	20	14	burn	burn	ADJ
gsrj-75	20	15	dyschromia	dyschromia	NOUN
gsrj-75	20	16	actually	actually	ADV
gsrj-75	20	17	develops	develop	VERB
gsrj-75	20	18	,	,	PUNCT
gsrj-75	20	19	which	which	PRON
gsrj-75	20	20	is	be	AUX
gsrj-75	20	21	underscored	underscore	VERB
gsrj-75	20	22	by	by	ADP
gsrj-75	20	23	the	the	DET
gsrj-75	20	24	paucity	paucity	NOUN
gsrj-75	20	25	of	of	ADP
gsrj-75	20	26	literature	literature	NOUN
gsrj-75	20	27	surrounding	surround	VERB
gsrj-75	20	28	the	the	DET
gsrj-75	20	29	topic	topic	NOUN
gsrj-75	20	30	.	.	PUNCT
gsrj-75	21	1	one	one	NUM
gsrj-75	21	2	hypothesis	hypothesis	NOUN
gsrj-75	21	3	is	be	AUX
gsrj-75	21	4	that	that	SCONJ
gsrj-75	21	5	dyschromia	dyschromia	NOUN
gsrj-75	21	6	develops	develop	VERB
gsrj-75	21	7	due	due	ADJ
gsrj-75	21	8	to	to	ADP
gsrj-75	21	9	abnormalities	abnormality	NOUN
gsrj-75	21	10	in	in	ADP
gsrj-75	21	11	the	the	DET
gsrj-75	21	12	paracrine	paracrine	NOUN
gsrj-75	21	13	signaling	signal	VERB
gsrj-75	21	14	between	between	ADP
gsrj-75	21	15	melanocytes	melanocyte	NOUN
gsrj-75	21	16	and	and	CCONJ
gsrj-75	21	17	surrounding	surround	VERB
gsrj-75	21	18	cell	cell	NOUN
gsrj-75	21	19	types.13	types.13	NOUN
gsrj-75	21	20	in	in	ADP
gsrj-75	21	21	fibrotic	fibrotic	ADJ
gsrj-75	21	22	skin	skin	NOUN
gsrj-75	21	23	,	,	PUNCT
gsrj-75	21	24	fibroblasts	fibroblast	NOUN
gsrj-75	21	25	are	be	AUX
gsrj-75	21	26	in	in	ADP
gsrj-75	21	27	an	an	DET
gsrj-75	21	28	altered	altered	ADJ
gsrj-75	21	29	state	state	NOUN
gsrj-75	21	30	of	of	ADP
gsrj-75	21	31	inflammation	inflammation	NOUN
gsrj-75	21	32	that	that	PRON
gsrj-75	21	33	could	could	AUX
gsrj-75	21	34	influence	influence	VERB
gsrj-75	21	35	melanocyte	melanocyte	NOUN
gsrj-75	21	36	function	function	NOUN
gsrj-75	21	37	,	,	PUNCT
gsrj-75	21	38	which	which	PRON
gsrj-75	21	39	can	can	AUX
gsrj-75	21	40	be	be	AUX
gsrj-75	21	41	quantifiably	quantifiably	ADV
gsrj-75	21	42	assessed	assess	VERB
gsrj-75	21	43	by	by	ADP
gsrj-75	21	44	melanin	melanin	NOUN
gsrj-75	21	45	index.14	index.14	PROPN
gsrj-75	21	46	however	however	ADV
gsrj-75	21	47	,	,	PUNCT
gsrj-75	21	48	it	it	PRON
gsrj-75	21	49	is	be	AUX
gsrj-75	21	50	also	also	ADV
gsrj-75	21	51	possible	possible	ADJ
gsrj-75	21	52	that	that	SCONJ
gsrj-75	21	53	fibroblasts	fibroblast	NOUN
gsrj-75	21	54	do	do	AUX
gsrj-75	21	55	not	not	PART
gsrj-75	21	56	contribute	contribute	VERB
gsrj-75	21	57	to	to	ADP
gsrj-75	21	58	dyschromia	dyschromia	NOUN
gsrj-75	21	59	at	at	ADV
gsrj-75	21	60	all	all	ADV
gsrj-75	21	61	,	,	PUNCT
gsrj-75	21	62	and	and	CCONJ
gsrj-75	21	63	that	that	DET
gsrj-75	21	64	keratinocytes	keratinocyte	NOUN
gsrj-75	21	65	play	play	VERB
gsrj-75	21	66	a	a	DET
gsrj-75	21	67	more	more	ADV
gsrj-75	21	68	significant	significant	ADJ
gsrj-75	21	69	role	role	NOUN
gsrj-75	21	70	.	.	PUNCT
gsrj-75	22	1	understanding	understand	VERB
gsrj-75	22	2	the	the	DET
gsrj-75	22	3	cellular	cellular	ADJ
gsrj-75	22	4	abnormalities	abnormality	NOUN
gsrj-75	22	5	that	that	PRON
gsrj-75	22	6	cause	cause	VERB
gsrj-75	22	7	dyschromia	dyschromia	NOUN
gsrj-75	22	8	is	be	AUX
gsrj-75	22	9	a	a	DET
gsrj-75	22	10	crucial	crucial	ADJ
gsrj-75	22	11	first	first	ADJ
gsrj-75	22	12	step	step	NOUN
gsrj-75	22	13	in	in	ADP
gsrj-75	22	14	the	the	DET
gsrj-75	22	15	effort	effort	NOUN
gsrj-75	22	16	to	to	PART
gsrj-75	22	17	develop	develop	VERB
gsrj-75	22	18	treatments	treatment	NOUN
gsrj-75	22	19	for	for	ADP
gsrj-75	22	20	dyschromic	dyschromic	ADJ
gsrj-75	22	21	hts	ht	NOUN
gsrj-75	22	22	.	.	PUNCT
gsrj-75	23	1	thus	thus	ADV
gsrj-75	23	2	,	,	PUNCT
gsrj-75	23	3	a	a	DET
gsrj-75	23	4	reliable	reliable	ADJ
gsrj-75	23	5	and	and	CCONJ
gsrj-75	23	6	repeatable	repeatable	ADJ
gsrj-75	23	7	model	model	NOUN
gsrj-75	23	8	for	for	ADP
gsrj-75	23	9	hts	ht	NOUN
gsrj-75	23	10	must	must	AUX
gsrj-75	23	11	be	be	AUX
gsrj-75	23	12	established	establish	VERB
gsrj-75	23	13	by	by	ADP
gsrj-75	23	14	which	which	DET
gsrj-75	23	15	dyschromia	dyschromia	NOUN
gsrj-75	23	16	can	can	AUX
gsrj-75	23	17	be	be	AUX
gsrj-75	23	18	studied	study	VERB
gsrj-75	23	19	.	.	PUNCT
gsrj-75	24	1	not	not	PART
gsrj-75	24	2	only	only	ADV
gsrj-75	24	3	does	do	AUX
gsrj-75	24	4	skin	skin	NOUN
gsrj-75	24	5	fibrosis	fibrosis	NOUN
gsrj-75	24	6	develop	develop	VERB
gsrj-75	24	7	as	as	ADP
gsrj-75	24	8	a	a	DET
gsrj-75	24	9	result	result	NOUN
gsrj-75	24	10	of	of	ADP
gsrj-75	24	11	burn	burn	NOUN
gsrj-75	24	12	wounds	wound	NOUN
gsrj-75	24	13	(	(	PUNCT
gsrj-75	24	14	hts	ht	NOUN
gsrj-75	24	15	)	)	PUNCT
gsrj-75	24	16	,	,	PUNCT
gsrj-75	24	17	but	but	CCONJ
gsrj-75	24	18	it	it	PRON
gsrj-75	24	19	can	can	AUX
gsrj-75	24	20	also	also	ADV
gsrj-75	24	21	occur	occur	VERB
gsrj-75	24	22	due	due	ADP
gsrj-75	24	23	to	to	ADP
gsrj-75	24	24	various	various	ADJ
gsrj-75	24	25	disease	disease	NOUN
gsrj-75	24	26	processes	process	NOUN
gsrj-75	24	27	.	.	PUNCT
gsrj-75	25	1	a	a	DET
gsrj-75	25	2	common	common	ADJ
gsrj-75	25	3	disease	disease	NOUN
gsrj-75	25	4	that	that	PRON
gsrj-75	25	5	results	result	VERB
gsrj-75	25	6	in	in	ADP
gsrj-75	25	7	skin	skin	NOUN
gsrj-75	25	8	fibrosis	fibrosis	NOUN
gsrj-75	25	9	is	be	AUX
gsrj-75	25	10	systemic	systemic	ADJ
gsrj-75	25	11	sclerosis.15	sclerosis.15	NOUN
gsrj-75	25	12	patients	patient	NOUN
gsrj-75	25	13	with	with	ADP
gsrj-75	25	14	this	this	DET
gsrj-75	25	15	disease	disease	NOUN
gsrj-75	25	16	have	have	AUX
gsrj-75	25	17	thickened	thicken	VERB
gsrj-75	25	18	skin	skin	NOUN
gsrj-75	25	19	that	that	PRON
gsrj-75	25	20	looks	look	VERB
gsrj-75	25	21	similar	similar	ADJ
gsrj-75	25	22	to	to	PART
gsrj-75	25	23	burn	burn	VERB
gsrj-75	25	24	scars	scar	NOUN
gsrj-75	25	25	and	and	CCONJ
gsrj-75	25	26	often	often	ADV
gsrj-75	25	27	exhibits	exhibit	VERB
gsrj-75	25	28	dyschromia	dyschromia	NOUN
gsrj-75	25	29	classified	classify	VERB
gsrj-75	25	30	as	as	ADP
gsrj-75	25	31	“	"	PUNCT
gsrj-75	25	32	salt	salt	NOUN
gsrj-75	25	33	-	-	PUNCT
gsrj-75	25	34	and	and	CCONJ
gsrj-75	25	35	-	-	PUNCT
gsrj-75	25	36	pepper	pepper	NOUN
gsrj-75	25	37	”	"	PUNCT
gsrj-75	25	38	skin.16	skin.16	NOUN
gsrj-75	25	39	an	an	DET
gsrj-75	25	40	approach	approach	NOUN
gsrj-75	25	41	that	that	PRON
gsrj-75	25	42	has	have	AUX
gsrj-75	25	43	previously	previously	ADV
gsrj-75	25	44	been	be	AUX
gsrj-75	25	45	taken	take	VERB
gsrj-75	25	46	by	by	ADP
gsrj-75	25	47	other	other	ADJ
gsrj-75	25	48	researchers	researcher	NOUN
gsrj-75	25	49	is	be	AUX
gsrj-75	25	50	to	to	PART
gsrj-75	25	51	study	study	VERB
gsrj-75	25	52	non	non	ADJ
gsrj-75	25	53	-	-	ADJ
gsrj-75	25	54	hts	hts	ADJ
gsrj-75	25	55	dermal	dermal	NOUN
gsrj-75	25	56	fibrosis	fibrosis	NOUN
gsrj-75	25	57	by	by	ADP
gsrj-75	25	58	synthetically	synthetically	ADV
gsrj-75	25	59	inducing	induce	VERB
gsrj-75	25	60	fibrosis	fibrosis	NOUN
gsrj-75	25	61	with	with	ADP
gsrj-75	25	62	a	a	DET
gsrj-75	25	63	commonly	commonly	ADV
gsrj-75	25	64	used	use	VERB
gsrj-75	25	65	antineoplastic	antineoplastic	ADJ
gsrj-75	25	66	drug	drug	NOUN
gsrj-75	25	67	called	call	VERB
gsrj-75	25	68	bleomycin	bleomycin	PROPN
gsrj-75	25	69	.	.	PUNCT
gsrj-75	26	1	a	a	DET
gsrj-75	26	2	study	study	NOUN
gsrj-75	26	3	conducted	conduct	VERB
gsrj-75	26	4	by	by	ADP
gsrj-75	26	5	b!yszczuk	b!yszczuk	ADP
gsrj-75	26	6	et	et	PROPN
gsrj-75	26	7	al	al	PROPN
gsrj-75	26	8	.	.	PROPN
gsrj-75	26	9	showed	show	VERB
gsrj-75	26	10	the	the	DET
gsrj-75	26	11	efficacy	efficacy	NOUN
gsrj-75	26	12	of	of	ADP
gsrj-75	26	13	bleomycin	bleomycin	PROPN
gsrj-75	26	14	-	-	PUNCT
gsrj-75	26	15	induced	induce	VERB
gsrj-75	26	16	dermal	dermal	ADJ
gsrj-75	26	17	fibrosis	fibrosis	NOUN
gsrj-75	26	18	in	in	ADP
gsrj-75	26	19	a	a	DET
gsrj-75	26	20	mouse	mouse	NOUN
gsrj-75	26	21	model	model	NOUN
gsrj-75	26	22	through	through	ADP
gsrj-75	26	23	regular	regular	ADJ
gsrj-75	26	24	injections	injection	NOUN
gsrj-75	26	25	of	of	ADP
gsrj-75	26	26	bleomycin.14	bleomycin.14	NOUN
gsrj-75	26	27	this	this	DET
gsrj-75	26	28	study	study	NOUN
gsrj-75	26	29	aims	aim	VERB
gsrj-75	26	30	to	to	PART
gsrj-75	26	31	reproduce	reproduce	VERB
gsrj-75	26	32	this	this	DET
gsrj-75	26	33	published	publish	VERB
gsrj-75	26	34	model	model	NOUN
gsrj-75	26	35	of	of	ADP
gsrj-75	26	36	bleomycin	bleomycin	PROPN
gsrj-75	26	37	-	-	PUNCT
gsrj-75	26	38	induced	induce	VERB
gsrj-75	26	39	dermal	dermal	ADJ
gsrj-75	26	40	fibrosis	fibrosis	NOUN
gsrj-75	26	41	in	in	ADP
gsrj-75	26	42	an	an	DET
gsrj-75	26	43	effort	effort	NOUN
gsrj-75	26	44	to	to	PART
gsrj-75	26	45	establish	establish	VERB
gsrj-75	26	46	the	the	DET
gsrj-75	26	47	utility	utility	NOUN
gsrj-75	26	48	of	of	ADP
gsrj-75	26	49	this	this	DET
gsrj-75	26	50	model	model	NOUN
gsrj-75	26	51	for	for	ADP
gsrj-75	26	52	the	the	DET
gsrj-75	26	53	study	study	NOUN
gsrj-75	26	54	of	of	ADP
gsrj-75	26	55	hts	hts	PROPN
gsrj-75	26	56	dyschromia	dyschromia	PROPN
gsrj-75	26	57	.	.	PUNCT
gsrj-75	27	1	22	22	NUM
gsrj-75	27	2	..	..	PUNCT
gsrj-75	27	3	mmeetthhooddss	mmeetthhooddss	NOUN
gsrj-75	27	4	in	in	ADP
gsrj-75	27	5	this	this	DET
gsrj-75	27	6	study	study	NOUN
gsrj-75	27	7	,	,	PUNCT
gsrj-75	27	8	two	two	NUM
gsrj-75	27	9	groups	group	NOUN
gsrj-75	27	10	of	of	ADP
gsrj-75	27	11	mice	mouse	NOUN
gsrj-75	27	12	were	be	AUX
gsrj-75	27	13	tested	test	VERB
gsrj-75	27	14	.	.	PUNCT
gsrj-75	28	1	following	follow	VERB
gsrj-75	28	2	the	the	DET
gsrj-75	28	3	completion	completion	NOUN
gsrj-75	28	4	of	of	ADP
gsrj-75	28	5	group	group	NOUN
gsrj-75	28	6	1	1	NUM
gsrj-75	28	7	mice	mouse	NOUN
gsrj-75	28	8	,	,	PUNCT
gsrj-75	28	9	data	datum	NOUN
gsrj-75	28	10	was	be	AUX
gsrj-75	28	11	collected	collect	VERB
gsrj-75	28	12	and	and	CCONJ
gsrj-75	28	13	analyzed	analyze	VERB
gsrj-75	28	14	before	before	ADP
gsrj-75	28	15	starting	start	VERB
gsrj-75	28	16	the	the	DET
gsrj-75	28	17	next	next	ADJ
gsrj-75	28	18	group	group	NOUN
gsrj-75	28	19	.	.	PUNCT
gsrj-75	29	1	using	use	VERB
gsrj-75	29	2	lessons	lesson	NOUN
gsrj-75	29	3	learned	learn	VERB
gsrj-75	29	4	from	from	ADP
gsrj-75	29	5	the	the	DET
gsrj-75	29	6	group	group	NOUN
gsrj-75	29	7	1	1	NUM
gsrj-75	29	8	mice	mouse	NOUN
gsrj-75	29	9	,	,	PUNCT
gsrj-75	29	10	group	group	NOUN
gsrj-75	29	11	2	2	NUM
gsrj-75	29	12	mice	mouse	NOUN
gsrj-75	29	13	had	have	VERB
gsrj-75	29	14	a	a	DET
gsrj-75	29	15	refined	refined	ADJ
gsrj-75	29	16	experimental	experimental	ADJ
gsrj-75	29	17	procedure	procedure	NOUN
gsrj-75	29	18	in	in	ADP
gsrj-75	29	19	an	an	DET
gsrj-75	29	20	effort	effort	NOUN
gsrj-75	29	21	to	to	PART
gsrj-75	29	22	produce	produce	VERB
gsrj-75	29	23	more	more	ADJ
gsrj-75	29	24	conclusive	conclusive	ADJ
gsrj-75	29	25	results	result	NOUN
gsrj-75	29	26	.	.	PUNCT
gsrj-75	30	1	all	all	DET
gsrj-75	30	2	animal	animal	NOUN
gsrj-75	30	3	work	work	NOUN
gsrj-75	30	4	was	be	AUX
gsrj-75	30	5	approved	approve	VERB
gsrj-75	30	6	by	by	ADP
gsrj-75	30	7	the	the	DET
gsrj-75	30	8	medstar	medstar	PROPN
gsrj-75	30	9	health	health	PROPN
gsrj-75	30	10	research	research	PROPN
gsrj-75	30	11	institute	institute	PROPN
gsrj-75	30	12	’s	’s	PART
gsrj-75	30	13	institutional	institutional	PROPN
gsrj-75	30	14	animal	animal	NOUN
gsrj-75	30	15	care	care	NOUN
gsrj-75	30	16	and	and	CCONJ
gsrj-75	30	17	use	use	NOUN
gsrj-75	30	18	committee	committee	NOUN
gsrj-75	30	19	.	.	PUNCT
gsrj-75	31	1	facility	facility	NOUN
gsrj-75	31	2	standard	standard	ADJ
gsrj-75	31	3	operating	operating	NOUN
gsrj-75	31	4	procedures	procedure	NOUN
gsrj-75	31	5	under	under	ADP
gsrj-75	31	6	an	an	DET
gsrj-75	31	7	animal	animal	NOUN
gsrj-75	31	8	care	care	NOUN
gsrj-75	31	9	and	and	CCONJ
gsrj-75	31	10	use	use	VERB
gsrj-75	31	11	program	program	NOUN
gsrj-75	31	12	accredited	accredit	VERB
gsrj-75	31	13	by	by	ADP
gsrj-75	31	14	the	the	DET
gsrj-75	31	15	association	association	NOUN
gsrj-75	31	16	for	for	ADP
gsrj-75	31	17	assessment	assessment	NOUN
gsrj-75	31	18	and	and	CCONJ
gsrj-75	31	19	accreditation	accreditation	NOUN
gsrj-75	31	20	of	of	ADP
gsrj-75	31	21	laboratory	laboratory	NOUN
gsrj-75	31	22	animal	animal	NOUN
gsrj-75	31	23	care	care	NOUN
gsrj-75	31	24	international	international	PROPN
gsrj-75	31	25	were	be	AUX
gsrj-75	31	26	strictly	strictly	ADV
gsrj-75	31	27	followed	follow	VERB
gsrj-75	31	28	22	22	NUM
gsrj-75	31	29	�	�	PROPN
gsrj-75	31	30	�	�	PROPN
gsrj-75	31	31	�	�	PROPN
gsrj-75	31	32	�	�	PROPN
gsrj-75	31	33	�	�	PROPN
gsrj-75	31	34	�	�	PROPN
gsrj-75	31	35	�	�	PROPN
gsrj-75	31	36	�	�	PROPN
gsrj-75	31	37	�	�	PROPN
gsrj-75	31	38	�	�	PROPN
gsrj-75	31	39	�	�	PROPN
gsrj-75	31	40	�	�	PROPN
gsrj-75	31	41	�	�	PROPN
gsrj-75	31	42	�	�	PROPN
gsrj-75	31	43	�	�	PROPN
gsrj-75	31	44	�	�	PROPN
gsrj-75	31	45	�	�	PROPN
gsrj-75	31	46	�	�	PROPN
gsrj-75	31	47	�	�	PROPN
gsrj-75	31	48	�	�	PROPN
gsrj-75	31	49	�	�	PROPN
gsrj-75	31	50	�	�	PROPN
gsrj-75	31	51	�	�	PROPN
gsrj-75	31	52	�	�	PROPN
gsrj-75	31	53	�	�	PROPN
gsrj-75	31	54	�	�	PROPN
gsrj-75	31	55	�	�	PROPN
gsrj-75	31	56	�	�	PROPN
gsrj-75	31	57	�	�	PROPN
gsrj-75	31	58	�	�	PROPN
gsrj-75	31	59	�	�	PROPN
gsrj-75	31	60	�	�	PROPN
gsrj-75	31	61	�	�	PROPN
gsrj-75	31	62	�	�	PROPN
gsrj-75	31	63	�	�	PROPN
gsrj-75	31	64	�	�	PROPN
gsrj-75	31	65	�	�	PROPN
gsrj-75	31	66	�	�	PROPN
gsrj-75	31	67	for	for	ADP
gsrj-75	31	68	handling	handling	NOUN
gsrj-75	31	69	and	and	CCONJ
gsrj-75	31	70	care	care	NOUN
gsrj-75	31	71	of	of	ADP
gsrj-75	31	72	all	all	DET
gsrj-75	31	73	the	the	DET
gsrj-75	31	74	animals	animal	NOUN
gsrj-75	31	75	used	use	VERB
gsrj-75	31	76	in	in	ADP
gsrj-75	31	77	this	this	DET
gsrj-75	31	78	study	study	NOUN
gsrj-75	31	79	.	.	PUNCT
gsrj-75	32	1	22	22	NUM
gsrj-75	32	2	..	..	SYM
gsrj-75	32	3	11	11	NUM
gsrj-75	32	4	ggrroouupp	ggrroouupp	PROPN
gsrj-75	32	5	sseelleeccttiioonn	sseelleeccttiioonn	NOUN
gsrj-75	32	6	,	,	PUNCT
gsrj-75	32	7	,	,	PUNCT
gsrj-75	32	8	aanneesstthheessiiaa	aanneesstthheessiiaa	NOUN
gsrj-75	32	9	,	,	PUNCT
gsrj-75	32	10	,	,	PUNCT
gsrj-75	32	11	aanndd	aanndd	NOUN
gsrj-75	32	12	pprreettrreeaattmmeenntt	pprreettrreeaattmmeenntt	PROPN
gsrj-75	32	13	pprroocceedduurreess	pprroocceedduurreess	PROPN
gsrj-75	32	14	ffiigguurree	ffiigguurree	NOUN
gsrj-75	32	15	11	11	NUM
gsrj-75	32	16	..	..	PUNCT
gsrj-75	32	17	dorsal	dorsal	NOUN
gsrj-75	32	18	demarcation	demarcation	NOUN
gsrj-75	32	19	of	of	ADP
gsrj-75	32	20	the	the	DET
gsrj-75	32	21	injection	injection	NOUN
gsrj-75	32	22	site	site	NOUN
gsrj-75	32	23	.	.	PUNCT
gsrj-75	33	1	the	the	DET
gsrj-75	33	2	1	1	NUM
gsrj-75	33	3	cm	cm	NOUN
gsrj-75	33	4	x	x	SYM
gsrj-75	33	5	1	1	NUM
gsrj-75	33	6	cm	cm	NOUN
gsrj-75	33	7	demarcated	demarcate	VERB
gsrj-75	33	8	square	square	NOUN
gsrj-75	33	9	is	be	AUX
gsrj-75	33	10	where	where	SCONJ
gsrj-75	33	11	all	all	DET
gsrj-75	33	12	injections	injection	NOUN
gsrj-75	33	13	occurred	occur	VERB
gsrj-75	33	14	.	.	PUNCT
gsrj-75	34	1	this	this	DET
gsrj-75	34	2	square	square	NOUN
gsrj-75	34	3	was	be	AUX
gsrj-75	34	4	drawn	draw	VERB
gsrj-75	34	5	3	3	NUM
gsrj-75	34	6	cm	cm	NOUN
gsrj-75	34	7	below	below	ADP
gsrj-75	34	8	the	the	DET
gsrj-75	34	9	midline	midline	NOUN
gsrj-75	34	10	of	of	ADP
gsrj-75	34	11	the	the	DET
gsrj-75	34	12	ears	ear	NOUN
gsrj-75	34	13	on	on	ADP
gsrj-75	34	14	each	each	DET
gsrj-75	34	15	mouse	mouse	NOUN
gsrj-75	34	16	for	for	ADP
gsrj-75	34	17	standardization	standardization	NOUN
gsrj-75	34	18	.	.	PUNCT
gsrj-75	35	1	a	a	DET
gsrj-75	35	2	2	2	NUM
gsrj-75	35	3	cm	cm	NOUN
gsrj-75	35	4	x	x	SYM
gsrj-75	35	5	2	2	NUM
gsrj-75	35	6	cm	cm	NOUN
gsrj-75	35	7	square	square	NOUN
gsrj-75	35	8	was	be	AUX
gsrj-75	35	9	demarcated	demarcate	VERB
gsrj-75	35	10	as	as	ADP
gsrj-75	35	11	a	a	DET
gsrj-75	35	12	“	"	PUNCT
gsrj-75	35	13	buffer	buffer	NOUN
gsrj-75	35	14	zone	zone	NOUN
gsrj-75	35	15	”	"	PUNCT
gsrj-75	35	16	to	to	PART
gsrj-75	35	17	account	account	VERB
gsrj-75	35	18	for	for	ADP
gsrj-75	35	19	spreading	spread	VERB
gsrj-75	35	20	of	of	ADP
gsrj-75	35	21	bleomycin	bleomycin	NOUN
gsrj-75	35	22	or	or	CCONJ
gsrj-75	35	23	saline	saline	NOUN
gsrj-75	35	24	control	control	NOUN
gsrj-75	35	25	outside	outside	ADP
gsrj-75	35	26	of	of	ADP
gsrj-75	35	27	the	the	DET
gsrj-75	35	28	1	1	NUM
gsrj-75	35	29	cm	cm	NOUN
gsrj-75	35	30	x	x	SYM
gsrj-75	35	31	1	1	NUM
gsrj-75	35	32	cm	cm	NOUN
gsrj-75	35	33	injection	injection	NOUN
gsrj-75	35	34	square	square	NOUN
gsrj-75	35	35	.	.	PUNCT
gsrj-75	36	1	female	female	ADJ
gsrj-75	36	2	c57	c57	NOUN
gsrj-75	36	3	-	-	PUNCT
gsrj-75	36	4	bl/6	bl/6	NOUN
gsrj-75	36	5	mice	mouse	NOUN
gsrj-75	36	6	(	(	PUNCT
gsrj-75	36	7	22	22	NUM
gsrj-75	36	8	-	-	SYM
gsrj-75	36	9	45±6.59	45±6.59	NUM
gsrj-75	36	10	g	g	NOUN
gsrj-75	36	11	)	)	PUNCT
gsrj-75	36	12	were	be	AUX
gsrj-75	36	13	used	use	VERB
gsrj-75	36	14	in	in	ADP
gsrj-75	36	15	group	group	NOUN
gsrj-75	36	16	1	1	NUM
gsrj-75	36	17	(	(	PUNCT
gsrj-75	36	18	n=3	n=3	PUNCT
gsrj-75	36	19	in	in	ADP
gsrj-75	36	20	control	control	NOUN
gsrj-75	36	21	,	,	PUNCT
gsrj-75	36	22	high	high	ADJ
gsrj-75	36	23	-	-	PUNCT
gsrj-75	36	24	dose	dose	NOUN
gsrj-75	36	25	,	,	PUNCT
gsrj-75	36	26	middose	middose	ADJ
gsrj-75	36	27	,	,	PUNCT
gsrj-75	36	28	n=4	n=4	PROPN
gsrj-75	36	29	in	in	ADP
gsrj-75	36	30	low	low	ADJ
gsrj-75	36	31	-	-	PUNCT
gsrj-75	36	32	dose	dose	NOUN
gsrj-75	36	33	groups	group	NOUN
gsrj-75	36	34	)	)	PUNCT
gsrj-75	36	35	.	.	PUNCT
gsrj-75	37	1	in	in	ADP
gsrj-75	37	2	group	group	NOUN
gsrj-75	37	3	2	2	NUM
gsrj-75	37	4	,	,	PUNCT
gsrj-75	37	5	female	female	ADJ
gsrj-75	37	6	c57	c57	NOUN
gsrj-75	37	7	-	-	PUNCT
gsrj-75	37	8	bl/6	bl/6	NOUN
gsrj-75	37	9	mice	mouse	NOUN
gsrj-75	37	10	(	(	PUNCT
gsrj-75	37	11	19	19	NUM
gsrj-75	37	12	-	-	PUNCT
gsrj-75	37	13	23±1.11	23±1.11	NUM
gsrj-75	37	14	g	g	NOUN
gsrj-75	37	15	)	)	PUNCT
gsrj-75	37	16	were	be	AUX
gsrj-75	37	17	used	use	VERB
gsrj-75	37	18	(	(	PUNCT
gsrj-75	37	19	n=5	n=5	PROPN
gsrj-75	37	20	in	in	ADP
gsrj-75	37	21	control	control	NOUN
gsrj-75	37	22	,	,	PUNCT
gsrj-75	37	23	n=4	n=4	PROPN
gsrj-75	37	24	in	in	ADP
gsrj-75	37	25	high	high	ADJ
gsrj-75	37	26	-	-	PUNCT
gsrj-75	37	27	dose	dose	NOUN
gsrj-75	37	28	,	,	PUNCT
gsrj-75	37	29	mid	mid	PROPN
gsrj-75	37	30	-	-	ADJ
gsrj-75	37	31	dose	dose	ADJ
gsrj-75	37	32	,	,	PUNCT
gsrj-75	37	33	low	low	ADJ
gsrj-75	37	34	-	-	PUNCT
gsrj-75	37	35	dose	dose	NOUN
gsrj-75	37	36	groups	group	NOUN
gsrj-75	37	37	)	)	PUNCT
gsrj-75	37	38	.	.	PUNCT
gsrj-75	38	1	anesthesia	anesthesia	PROPN
gsrj-75	38	2	was	be	AUX
gsrj-75	38	3	induced	induce	VERB
gsrj-75	38	4	by	by	ADP
gsrj-75	38	5	placing	place	VERB
gsrj-75	38	6	the	the	DET
gsrj-75	38	7	mice	mouse	NOUN
gsrj-75	38	8	into	into	ADP
gsrj-75	38	9	a	a	DET
gsrj-75	38	10	box	box	NOUN
gsrj-75	38	11	with	with	ADP
gsrj-75	38	12	3	3	NUM
gsrj-75	38	13	-	-	SYM
gsrj-75	38	14	5	5	NUM
gsrj-75	38	15	%	%	NOUN
gsrj-75	38	16	isoflurane	isoflurane	NOUN
gsrj-75	38	17	.	.	PUNCT
gsrj-75	39	1	once	once	ADV
gsrj-75	39	2	a	a	DET
gsrj-75	39	3	plane	plane	NOUN
gsrj-75	39	4	of	of	ADP
gsrj-75	39	5	anesthesia	anesthesia	NOUN
gsrj-75	39	6	was	be	AUX
gsrj-75	39	7	established	establish	VERB
gsrj-75	39	8	by	by	ADP
gsrj-75	39	9	confirming	confirm	VERB
gsrj-75	39	10	absence	absence	NOUN
gsrj-75	39	11	of	of	ADP
gsrj-75	39	12	corneal	corneal	ADJ
gsrj-75	39	13	and	and	CCONJ
gsrj-75	39	14	pedal	pedal	ADJ
gsrj-75	39	15	reflexes	reflex	NOUN
gsrj-75	39	16	,	,	PUNCT
gsrj-75	39	17	anesthesia	anesthesia	PROPN
gsrj-75	39	18	was	be	AUX
gsrj-75	39	19	continued	continue	VERB
gsrj-75	39	20	via	via	ADP
gsrj-75	39	21	nose	nose	NOUN
gsrj-75	39	22	cone	cone	PROPN
gsrj-75	39	23	administration	administration	NOUN
gsrj-75	39	24	of	of	ADP
gsrj-75	39	25	14	14	NUM
gsrj-75	39	26	%	%	NOUN
gsrj-75	39	27	isoflurane	isoflurane	NOUN
gsrj-75	39	28	.	.	PUNCT
gsrj-75	40	1	ophthalmic	ophthalmic	ADJ
gsrj-75	40	2	ointment	ointment	NOUN
gsrj-75	40	3	was	be	AUX
gsrj-75	40	4	used	use	VERB
gsrj-75	40	5	in	in	ADP
gsrj-75	40	6	cases	case	NOUN
gsrj-75	40	7	of	of	ADP
gsrj-75	40	8	prolonged	prolonged	ADJ
gsrj-75	40	9	anesthesia	anesthesia	NOUN
gsrj-75	40	10	.	.	PUNCT
gsrj-75	41	1	thermoregulation	thermoregulation	NOUN
gsrj-75	41	2	was	be	AUX
gsrj-75	41	3	achieved	achieve	VERB
gsrj-75	41	4	with	with	ADP
gsrj-75	41	5	a	a	DET
gsrj-75	41	6	warming	warming	NOUN
gsrj-75	41	7	blanket	blanket	NOUN
gsrj-75	41	8	during	during	ADP
gsrj-75	41	9	anesthesia	anesthesia	PROPN
gsrj-75	41	10	procedures	procedure	NOUN
gsrj-75	41	11	.	.	PUNCT
gsrj-75	42	1	during	during	ADP
gsrj-75	42	2	the	the	DET
gsrj-75	42	3	pre	pre	ADJ
gsrj-75	42	4	-	-	ADJ
gsrj-75	42	5	injury	injury	ADJ
gsrj-75	42	6	timepoint	timepoint	NOUN
gsrj-75	42	7	,	,	PUNCT
gsrj-75	42	8	the	the	DET
gsrj-75	42	9	dorsum	dorsum	NOUN
gsrj-75	42	10	of	of	ADP
gsrj-75	42	11	the	the	DET
gsrj-75	42	12	mouse	mouse	NOUN
gsrj-75	42	13	was	be	AUX
gsrj-75	42	14	shaved	shave	VERB
gsrj-75	42	15	using	use	VERB
gsrj-75	42	16	standard	standard	ADJ
gsrj-75	42	17	veterinary	veterinary	ADJ
gsrj-75	42	18	clippers	clipper	NOUN
gsrj-75	42	19	and	and	CCONJ
gsrj-75	42	20	depilated	depilate	VERB
gsrj-75	42	21	using	use	VERB
gsrj-75	42	22	a	a	DET
gsrj-75	42	23	commercial	commercial	ADJ
gsrj-75	42	24	agent	agent	NOUN
gsrj-75	42	25	for	for	ADP
gsrj-75	42	26	90	90	NUM
gsrj-75	42	27	seconds	second	NOUN
gsrj-75	42	28	with	with	ADP
gsrj-75	42	29	massage	massage	NOUN
gsrj-75	42	30	of	of	ADP
gsrj-75	42	31	the	the	DET
gsrj-75	42	32	agent	agent	NOUN
gsrj-75	42	33	into	into	ADP
gsrj-75	42	34	the	the	DET
gsrj-75	42	35	skin	skin	NOUN
gsrj-75	42	36	with	with	ADP
gsrj-75	42	37	a	a	DET
gsrj-75	42	38	cotton	cotton	NOUN
gsrj-75	42	39	swab	swab	NOUN
gsrj-75	42	40	(	(	PUNCT
gsrj-75	42	41	nair	nair	NOUN
gsrj-75	42	42	,	,	PUNCT
gsrj-75	42	43	church	church	PROPN
gsrj-75	42	44	&	&	CCONJ
gsrj-75	42	45	dwight	dwight	PROPN
gsrj-75	42	46	co.	co.	PROPN
gsrj-75	42	47	,	,	PUNCT
gsrj-75	42	48	ewing	ewing	PROPN
gsrj-75	42	49	,	,	PUNCT
gsrj-75	42	50	nj	nj	PROPN
gsrj-75	42	51	)	)	PUNCT
gsrj-75	42	52	.	.	PUNCT
gsrj-75	43	1	in	in	ADP
gsrj-75	43	2	group	group	NOUN
gsrj-75	43	3	1	1	NUM
gsrj-75	43	4	mice	mouse	NOUN
gsrj-75	43	5	,	,	PUNCT
gsrj-75	43	6	a	a	DET
gsrj-75	43	7	1	1	NUM
gsrj-75	43	8	cm	cm	NOUN
gsrj-75	43	9	x	x	SYM
gsrj-75	43	10	1	1	NUM
gsrj-75	43	11	cm	cm	NOUN
gsrj-75	43	12	square	square	NOUN
gsrj-75	43	13	was	be	AUX
gsrj-75	43	14	demarcated	demarcate	VERB
gsrj-75	43	15	3	3	NUM
gsrj-75	43	16	cm	cm	NOUN
gsrj-75	43	17	below	below	ADP
gsrj-75	43	18	the	the	DET
gsrj-75	43	19	midline	midline	NOUN
gsrj-75	43	20	of	of	ADP
gsrj-75	43	21	the	the	DET
gsrj-75	43	22	ears	ear	NOUN
gsrj-75	43	23	using	use	VERB
gsrj-75	43	24	a	a	DET
gsrj-75	43	25	surgical	surgical	ADJ
gsrj-75	43	26	marker	marker	NOUN
gsrj-75	43	27	(	(	PUNCT
gsrj-75	43	28	figure	figure	NOUN
gsrj-75	43	29	1	1	NUM
gsrj-75	43	30	)	)	PUNCT
gsrj-75	43	31	.	.	PUNCT
gsrj-75	44	1	in	in	ADP
gsrj-75	44	2	group	group	NOUN
gsrj-75	44	3	2	2	NUM
gsrj-75	44	4	mice	mouse	NOUN
gsrj-75	44	5	,	,	PUNCT
gsrj-75	44	6	a	a	DET
gsrj-75	44	7	2	2	NUM
gsrj-75	44	8	cm	cm	NOUN
gsrj-75	44	9	x	x	SYM
gsrj-75	44	10	2	2	NUM
gsrj-75	44	11	cm	cm	NOUN
gsrj-75	44	12	square	square	NOUN
gsrj-75	44	13	was	be	AUX
gsrj-75	44	14	demarcated	demarcate	VERB
gsrj-75	44	15	around	around	ADP
gsrj-75	44	16	the	the	DET
gsrj-75	44	17	1	1	NUM
gsrj-75	44	18	cm	cm	NOUN
gsrj-75	44	19	x	x	SYM
gsrj-75	44	20	1	1	NUM
gsrj-75	44	21	cm	cm	NOUN
gsrj-75	44	22	square	square	NOUN
gsrj-75	44	23	(	(	PUNCT
gsrj-75	44	24	figure	figure	NOUN
gsrj-75	44	25	1	1	NUM
gsrj-75	44	26	)	)	PUNCT
gsrj-75	44	27	.	.	PUNCT
gsrj-75	45	1	in	in	ADP
gsrj-75	45	2	addition	addition	NOUN
gsrj-75	45	3	to	to	PART
gsrj-75	45	4	baseline	baseline	VERB
gsrj-75	45	5	weights	weight	NOUN
gsrj-75	45	6	,	,	PUNCT
gsrj-75	45	7	non	non	ADJ
gsrj-75	45	8	-	-	ADJ
gsrj-75	45	9	invasive	invasive	ADJ
gsrj-75	45	10	skin	skin	NOUN
gsrj-75	45	11	probe	probe	NOUN
gsrj-75	45	12	measurements	measurement	NOUN
gsrj-75	45	13	(	(	PUNCT
gsrj-75	45	14	elasticity	elasticity	NOUN
gsrj-75	45	15	,	,	PUNCT
gsrj-75	45	16	trans	tran	NOUN
gsrj-75	45	17	-	-	ADJ
gsrj-75	45	18	epidermal	epidermal	ADJ
gsrj-75	45	19	water	water	NOUN
gsrj-75	45	20	loss	loss	NOUN
gsrj-75	45	21	,	,	PUNCT
gsrj-75	45	22	erythema	erythema	ADV
gsrj-75	45	23	,	,	PUNCT
gsrj-75	45	24	melanin	melanin	NOUN
gsrj-75	45	25	)	)	PUNCT
gsrj-75	45	26	(	(	PUNCT
gsrj-75	45	27	delfin	delfin	NOUN
gsrj-75	45	28	technologies	technology	NOUN
gsrj-75	45	29	,	,	PUNCT
gsrj-75	45	30	kuopio	kuopio	PROPN
gsrj-75	45	31	,	,	PUNCT
gsrj-75	45	32	finland	finland	PROPN
gsrj-75	45	33	)	)	PUNCT
gsrj-75	45	34	were	be	AUX
gsrj-75	45	35	also	also	ADV
gsrj-75	45	36	taken	take	VERB
gsrj-75	45	37	within	within	ADP
gsrj-75	45	38	the	the	DET
gsrj-75	45	39	demarcated	demarcate	VERB
gsrj-75	45	40	area	area	NOUN
gsrj-75	45	41	.	.	PUNCT
gsrj-75	46	1	mice	mouse	NOUN
gsrj-75	46	2	were	be	AUX
gsrj-75	46	3	placed	place	VERB
gsrj-75	46	4	on	on	ADP
gsrj-75	46	5	their	their	PRON
gsrj-75	46	6	sides	side	NOUN
gsrj-75	46	7	with	with	ADP
gsrj-75	46	8	their	their	PRON
gsrj-75	46	9	hind	hind	NOUN
gsrj-75	46	10	legs	leg	NOUN
gsrj-75	46	11	facing	face	VERB
gsrj-75	46	12	the	the	DET
gsrj-75	46	13	same	same	ADJ
gsrj-75	46	14	direction	direction	NOUN
gsrj-75	46	15	during	during	ADP
gsrj-75	46	16	probe	probe	NOUN
gsrj-75	46	17	measurements	measurement	NOUN
gsrj-75	46	18	to	to	PART
gsrj-75	46	19	reduce	reduce	VERB
gsrj-75	46	20	the	the	DET
gsrj-75	46	21	pressure	pressure	NOUN
gsrj-75	46	22	of	of	ADP
gsrj-75	46	23	the	the	DET
gsrj-75	46	24	probe	probe	NOUN
gsrj-75	46	25	on	on	ADP
gsrj-75	46	26	the	the	DET
gsrj-75	46	27	spine	spine	NOUN
gsrj-75	46	28	.	.	PUNCT
gsrj-75	47	1	22	22	NUM
gsrj-75	47	2	..	..	SYM
gsrj-75	47	3	22	22	NUM
gsrj-75	47	4	bblleeoommyycciinn	bblleeoommyycciinn	NOUN
gsrj-75	47	5	iinnjjeeccttiioonn	iinnjjeeccttiioonn	PROPN
gsrj-75	47	6	aanndd	aanndd	NOUN
gsrj-75	47	7	mmoonniittoorriinngg	mmoonniittoorriinngg	PROPN
gsrj-75	47	8	lyophilized	lyophilize	VERB
gsrj-75	47	9	bleomycin	bleomycin	PROPN
gsrj-75	47	10	sulphate	sulphate	NOUN
gsrj-75	47	11	(	(	PUNCT
gsrj-75	47	12	sigmaaldrich	sigmaaldrich	PROPN
gsrj-75	47	13	,	,	PUNCT
gsrj-75	47	14	st	st	PROPN
gsrj-75	47	15	.	.	PROPN
gsrj-75	47	16	louis	louis	PROPN
gsrj-75	47	17	,	,	PUNCT
gsrj-75	47	18	mo	mo	PROPN
gsrj-75	47	19	)	)	PUNCT
gsrj-75	47	20	was	be	AUX
gsrj-75	47	21	dissolved	dissolve	VERB
gsrj-75	47	22	in	in	ADP
gsrj-75	47	23	normal	normal	ADJ
gsrj-75	47	24	saline	saline	NOUN
gsrj-75	47	25	.	.	PUNCT
gsrj-75	48	1	100	100	NUM
gsrj-75	48	2	µl	µl	NOUN
gsrj-75	48	3	of	of	ADP
gsrj-75	48	4	bleomycin	bleomycin	NOUN
gsrj-75	48	5	or	or	CCONJ
gsrj-75	48	6	saline	saline	NOUN
gsrj-75	48	7	control	control	NOUN
gsrj-75	48	8	was	be	AUX
gsrj-75	48	9	injected	inject	VERB
gsrj-75	48	10	on	on	ADP
gsrj-75	48	11	days	day	NOUN
gsrj-75	48	12	1	1	NUM
gsrj-75	48	13	,	,	PUNCT
gsrj-75	48	14	2	2	NUM
gsrj-75	48	15	,	,	PUNCT
gsrj-75	48	16	4	4	NUM
gsrj-75	48	17	,	,	PUNCT
gsrj-75	48	18	5	5	NUM
gsrj-75	48	19	,	,	PUNCT
gsrj-75	48	20	8	8	NUM
gsrj-75	48	21	,	,	PUNCT
gsrj-75	48	22	9	9	NUM
gsrj-75	48	23	,	,	PUNCT
gsrj-75	48	24	11	11	NUM
gsrj-75	48	25	,	,	PUNCT
gsrj-75	48	26	and	and	CCONJ
gsrj-75	48	27	12	12	NUM
gsrj-75	48	28	for	for	ADP
gsrj-75	48	29	group	group	NOUN
gsrj-75	48	30	1	1	NUM
gsrj-75	48	31	,	,	PUNCT
gsrj-75	48	32	and	and	CCONJ
gsrj-75	48	33	days	day	NOUN
gsrj-75	48	34	1	1	NUM
gsrj-75	48	35	,	,	PUNCT
gsrj-75	48	36	2	2	NUM
gsrj-75	48	37	,	,	PUNCT
gsrj-75	48	38	5	5	NUM
gsrj-75	48	39	,	,	PUNCT
gsrj-75	48	40	6	6	NUM
gsrj-75	48	41	,	,	PUNCT
gsrj-75	48	42	8	8	NUM
gsrj-75	48	43	,	,	PUNCT
gsrj-75	48	44	9	9	NUM
gsrj-75	48	45	,	,	PUNCT
gsrj-75	48	46	12	12	NUM
gsrj-75	48	47	,	,	PUNCT
gsrj-75	48	48	and	and	CCONJ
gsrj-75	48	49	13	13	NUM
gsrj-75	48	50	for	for	ADP
gsrj-75	48	51	group	group	NOUN
gsrj-75	48	52	2	2	NUM
gsrj-75	48	53	.	.	PUNCT
gsrj-75	48	54	injections	injection	NOUN
gsrj-75	48	55	were	be	AUX
gsrj-75	48	56	administered	administer	VERB
gsrj-75	48	57	intradermally	intradermally	ADV
gsrj-75	48	58	into	into	ADP
gsrj-75	48	59	the	the	DET
gsrj-75	48	60	1	1	NUM
gsrj-75	48	61	cm	cm	NOUN
gsrj-75	48	62	x	x	SYM
gsrj-75	48	63	1	1	NUM
gsrj-75	48	64	cm	cm	NOUN
gsrj-75	48	65	square	square	NOUN
gsrj-75	48	66	at	at	ADP
gsrj-75	48	67	different	different	ADJ
gsrj-75	48	68	positions	position	NOUN
gsrj-75	48	69	on	on	ADP
gsrj-75	48	70	different	different	ADJ
gsrj-75	48	71	days	day	NOUN
gsrj-75	48	72	(	(	PUNCT
gsrj-75	48	73	figure	figure	NOUN
gsrj-75	48	74	2	2	NUM
gsrj-75	48	75	)	)	PUNCT
gsrj-75	48	76	.	.	PUNCT
gsrj-75	49	1	on	on	ADP
gsrj-75	49	2	day	day	NOUN
gsrj-75	49	3	1	1	NUM
gsrj-75	49	4	,	,	PUNCT
gsrj-75	49	5	injections	injection	NOUN
gsrj-75	49	6	were	be	AUX
gsrj-75	49	7	performed	perform	VERB
gsrj-75	49	8	at	at	ADP
gsrj-75	49	9	position	position	NOUN
gsrj-75	49	10	1	1	NUM
gsrj-75	49	11	,	,	PUNCT
gsrj-75	49	12	on	on	ADP
gsrj-75	49	13	day	day	NOUN
gsrj-75	49	14	2	2	NUM
gsrj-75	49	15	at	at	ADP
gsrj-75	49	16	position	position	NOUN
gsrj-75	49	17	2	2	NUM
gsrj-75	49	18	,	,	PUNCT
gsrj-75	49	19	continuing	continue	VERB
gsrj-75	49	20	in	in	ADP
gsrj-75	49	21	this	this	DET
gsrj-75	49	22	fashion	fashion	NOUN
gsrj-75	49	23	throughout	throughout	ADP
gsrj-75	49	24	the	the	DET
gsrj-75	49	25	time	time	NOUN
gsrj-75	49	26	course	course	NOUN
gsrj-75	49	27	.	.	PUNCT
gsrj-75	50	1	after	after	ADP
gsrj-75	50	2	position	position	NOUN
gsrj-75	50	3	5	5	NUM
gsrj-75	50	4	,	,	PUNCT
gsrj-75	50	5	injections	injection	NOUN
gsrj-75	50	6	were	be	AUX
gsrj-75	50	7	further	far	ADV
gsrj-75	50	8	continued	continue	VERB
gsrj-75	50	9	cyclically	cyclically	ADV
gsrj-75	50	10	starting	start	VERB
gsrj-75	50	11	again	again	ADV
gsrj-75	50	12	at	at	ADP
gsrj-75	50	13	position	position	NOUN
gsrj-75	50	14	1	1	NUM
gsrj-75	50	15	.	.	PUNCT
gsrj-75	51	1	this	this	DET
gsrj-75	51	2	injection	injection	NOUN
gsrj-75	51	3	pattern	pattern	NOUN
gsrj-75	51	4	,	,	PUNCT
gsrj-75	51	5	which	which	PRON
gsrj-75	51	6	was	be	AUX
gsrj-75	51	7	based	base	VERB
gsrj-75	51	8	off	off	ADP
gsrj-75	51	9	of	of	ADP
gsrj-75	51	10	previously	previously	ADV
gsrj-75	51	11	published	publish	VERB
gsrj-75	51	12	literature	literature	NOUN
gsrj-75	51	13	,	,	PUNCT
gsrj-75	51	14	ensured	ensure	VERB
gsrj-75	51	15	that	that	SCONJ
gsrj-75	51	16	the	the	DET
gsrj-75	51	17	bleomycin	bleomycin	PROPN
gsrj-75	51	18	was	be	AUX
gsrj-75	51	19	distributed	distribute	VERB
gsrj-75	51	20	equally	equally	ADV
gsrj-75	51	21	across	across	ADP
gsrj-75	51	22	the	the	DET
gsrj-75	51	23	entire	entire	ADJ
gsrj-75	51	24	demarcated	demarcate	VERB
gsrj-75	51	25	treatment	treatment	NOUN
gsrj-75	51	26	zone.14	zone.14	NOUN
gsrj-75	51	27	three	three	NUM
gsrj-75	51	28	different	different	ADJ
gsrj-75	51	29	dosages	dosage	NOUN
gsrj-75	51	30	of	of	ADP
gsrj-75	51	31	bleomycin	bleomycin	PROPN
gsrj-75	51	32	were	be	AUX
gsrj-75	51	33	tested	test	VERB
gsrj-75	51	34	in	in	ADP
gsrj-75	51	35	each	each	DET
gsrj-75	51	36	group	group	NOUN
gsrj-75	51	37	.	.	PUNCT
gsrj-75	52	1	in	in	ADP
gsrj-75	52	2	group	group	NOUN
gsrj-75	52	3	1	1	NUM
gsrj-75	52	4	mice	mouse	NOUN
gsrj-75	52	5	,	,	PUNCT
gsrj-75	52	6	low	low	ADJ
gsrj-75	52	7	-	-	PUNCT
gsrj-75	52	8	dose	dose	NOUN
gsrj-75	52	9	(	(	PUNCT
gsrj-75	52	10	0.5	0.5	NUM
gsrj-75	52	11	u	u	NOUN
gsrj-75	52	12	/	/	SYM
gsrj-75	52	13	ml	ml	NOUN
gsrj-75	52	14	)	)	PUNCT
gsrj-75	52	15	,	,	PUNCT
gsrj-75	52	16	mid	mid	PROPN
gsrj-75	52	17	-	-	ADJ
gsrj-75	52	18	dose	dose	ADJ
gsrj-75	52	19	(	(	PUNCT
gsrj-75	52	20	1.0	1.0	NUM
gsrj-75	52	21	u	u	NOUN
gsrj-75	52	22	/	/	SYM
gsrj-75	52	23	ml	ml	NOUN
gsrj-75	52	24	)	)	PUNCT
gsrj-75	52	25	,	,	PUNCT
gsrj-75	52	26	and	and	CCONJ
gsrj-75	52	27	high	high	ADV
gsrj-75	52	28	-	-	PUNCT
gsrj-75	52	29	dose	dose	NOUN
gsrj-75	52	30	(	(	PUNCT
gsrj-75	52	31	5	5	NUM
gsrj-75	52	32	u	u	NOUN
gsrj-75	52	33	/	/	SYM
gsrj-75	52	34	ml	ml	NOUN
gsrj-75	52	35	)	)	PUNCT
gsrj-75	52	36	bleomycin	bleomycin	PROPN
gsrj-75	52	37	was	be	AUX
gsrj-75	52	38	used	use	VERB
gsrj-75	52	39	.	.	PUNCT
gsrj-75	53	1	in	in	ADP
gsrj-75	53	2	group	group	NOUN
gsrj-75	53	3	2	2	NUM
gsrj-75	53	4	,	,	PUNCT
gsrj-75	53	5	the	the	DET
gsrj-75	53	6	high	high	ADJ
gsrj-75	53	7	-	-	PUNCT
gsrj-75	53	8	dose	dose	NOUN
gsrj-75	53	9	concentration	concentration	NOUN
gsrj-75	53	10	was	be	AUX
gsrj-75	53	11	adjusted	adjust	VERB
gsrj-75	53	12	to	to	ADP
gsrj-75	53	13	2.5	2.5	NUM
gsrj-75	53	14	u	u	NOUN
gsrj-75	53	15	/	/	SYM
gsrj-75	53	16	ml	ml	NOUN
gsrj-75	53	17	.	.	PUNCT
gsrj-75	54	1	after	after	ADP
gsrj-75	54	2	injection	injection	NOUN
gsrj-75	54	3	,	,	PUNCT
gsrj-75	54	4	mice	mouse	NOUN
gsrj-75	54	5	were	be	AUX
gsrj-75	54	6	removed	remove	VERB
gsrj-75	54	7	from	from	ADP
gsrj-75	54	8	anesthesia	anesthesia	NOUN
gsrj-75	54	9	and	and	CCONJ
gsrj-75	54	10	monitored	monitor	VERB
gsrj-75	54	11	until	until	ADP
gsrj-75	54	12	ambulatory	ambulatory	ADJ
gsrj-75	54	13	.	.	PUNCT
gsrj-75	55	1	noninvasive	noninvasive	ADJ
gsrj-75	55	2	skin	skin	NOUN
gsrj-75	55	3	probe	probe	NOUN
gsrj-75	55	4	measurements	measurement	NOUN
gsrj-75	55	5	of	of	ADP
gsrj-75	55	6	the	the	DET
gsrj-75	55	7	treated	treat	VERB
gsrj-75	55	8	zone	zone	NOUN
gsrj-75	55	9	and	and	CCONJ
gsrj-75	55	10	normal	normal	ADJ
gsrj-75	55	11	skin	skin	NOUN
gsrj-75	55	12	were	be	AUX
gsrj-75	55	13	taken	take	VERB
gsrj-75	55	14	periodically	periodically	ADV
gsrj-75	55	15	throughout	throughout	ADP
gsrj-75	55	16	the	the	DET
gsrj-75	55	17	study	study	NOUN
gsrj-75	55	18	and	and	CCONJ
gsrj-75	55	19	were	be	AUX
gsrj-75	55	20	collected	collect	VERB
gsrj-75	55	21	in	in	ADP
gsrj-75	55	22	triplicate	triplicate	NOUN
gsrj-75	55	23	for	for	ADP
gsrj-75	55	24	each	each	DET
gsrj-75	55	25	probe	probe	NOUN
gsrj-75	55	26	.	.	PUNCT
gsrj-75	56	1	animal	animal	NOUN
gsrj-75	56	2	checks	check	NOUN
gsrj-75	56	3	were	be	AUX
gsrj-75	56	4	conducted	conduct	VERB
gsrj-75	56	5	twice	twice	DET
gsrj-75	56	6	a	a	DET
gsrj-75	56	7	day	day	NOUN
gsrj-75	56	8	at	at	ADP
gsrj-75	56	9	minimum	minimum	NOUN
gsrj-75	56	10	and	and	CCONJ
gsrj-75	56	11	mice	mouse	NOUN
gsrj-75	56	12	weights	weight	NOUN
gsrj-75	56	13	were	be	AUX
gsrj-75	56	14	obtained	obtain	VERB
gsrj-75	56	15	each	each	DET
gsrj-75	56	16	day	day	NOUN
gsrj-75	56	17	.	.	PUNCT
gsrj-75	57	1	mice	mouse	NOUN
gsrj-75	57	2	with	with	ADP
gsrj-75	57	3	weight	weight	NOUN
gsrj-75	57	4	loss	loss	NOUN
gsrj-75	57	5	of	of	ADP
gsrj-75	57	6	5	5	NUM
gsrj-75	57	7	%	%	NOUN
gsrj-75	57	8	compared	compare	VERB
gsrj-75	57	9	to	to	ADP
gsrj-75	57	10	their	their	PRON
gsrj-75	57	11	initial	initial	ADJ
gsrj-75	57	12	weight	weight	NOUN
gsrj-75	57	13	or	or	CCONJ
gsrj-75	57	14	with	with	ADP
gsrj-75	57	15	obvious	obvious	ADJ
gsrj-75	57	16	signs	sign	NOUN
gsrj-75	57	17	of	of	ADP
gsrj-75	57	18	distress	distress	NOUN
gsrj-75	57	19	were	be	AUX
gsrj-75	57	20	given	give	VERB
gsrj-75	57	21	a	a	DET
gsrj-75	57	22	1	1	NUM
gsrj-75	57	23	ml	ml	NOUN
gsrj-75	57	24	intraperitoneal	intraperitoneal	ADJ
gsrj-75	57	25	injection	injection	NOUN
gsrj-75	57	26	of	of	ADP
gsrj-75	57	27	lactated	lactated	ADJ
gsrj-75	57	28	ringers	ringer	NOUN
gsrj-75	57	29	daily	daily	ADV
gsrj-75	57	30	in	in	ADP
gsrj-75	57	31	addition	addition	NOUN
gsrj-75	57	32	to	to	ADP
gsrj-75	57	33	dietgel	dietgel	NOUN
gsrj-75	57	34	dietary	dietary	ADJ
gsrj-75	57	35	supplements	supplement	NOUN
gsrj-75	57	36	(	(	PUNCT
gsrj-75	57	37	clearh2o	clearh2o	NOUN
gsrj-75	57	38	,	,	PUNCT
gsrj-75	57	39	westbrook	westbrook	PROPN
gsrj-75	57	40	,	,	PUNCT
gsrj-75	57	41	me	i	PRON
gsrj-75	57	42	)	)	PUNCT
gsrj-75	57	43	.	.	PUNCT
gsrj-75	58	1	in	in	ADP
gsrj-75	58	2	group	group	NOUN
gsrj-75	58	3	2	2	NUM
gsrj-75	58	4	mice	mouse	NOUN
gsrj-75	58	5	,	,	PUNCT
gsrj-75	58	6	all	all	DET
gsrj-75	58	7	mice	mouse	NOUN
gsrj-75	58	8	were	be	AUX
gsrj-75	58	9	given	give	VERB
gsrj-75	58	10	dietgels	dietgel	NOUN
gsrj-75	58	11	on	on	ADP
gsrj-75	58	12	day	day	NOUN
gsrj-75	58	13	1	1	NUM
gsrj-75	58	14	23	23	NUM
gsrj-75	58	15	�	�	PROPN
gsrj-75	58	16	�	�	PROPN
gsrj-75	58	17	�	�	PROPN
gsrj-75	58	18	�	�	PROPN
gsrj-75	58	19	�	�	PROPN
gsrj-75	58	20	�	�	PROPN
gsrj-75	58	21	�	�	PROPN
gsrj-75	58	22	�	�	PROPN
gsrj-75	58	23	�	�	PROPN
gsrj-75	58	24	�	�	PROPN
gsrj-75	58	25	�	�	PROPN
gsrj-75	58	26	�	�	PROPN
gsrj-75	58	27	�	�	PROPN
gsrj-75	58	28	�	�	PROPN
gsrj-75	58	29	�	�	PROPN
gsrj-75	58	30	�	�	PROPN
gsrj-75	58	31	�	�	PROPN
gsrj-75	58	32	�	�	PROPN
gsrj-75	58	33	�	�	PROPN
gsrj-75	58	34	�	�	PROPN
gsrj-75	58	35	�	�	PROPN
gsrj-75	58	36	�	�	PROPN
gsrj-75	58	37	�	�	PROPN
gsrj-75	58	38	�	�	PROPN
gsrj-75	58	39	�	�	PROPN
gsrj-75	58	40	�	�	PROPN
gsrj-75	58	41	�	�	PROPN
gsrj-75	58	42	�	�	PROPN
gsrj-75	58	43	�	�	PROPN
gsrj-75	58	44	�	�	PROPN
gsrj-75	58	45	�	�	PROPN
gsrj-75	58	46	�	�	PROPN
gsrj-75	58	47	�	�	PROPN
gsrj-75	58	48	�	�	PROPN
gsrj-75	58	49	�	�	PROPN
gsrj-75	58	50	�	�	PROPN
gsrj-75	58	51	�	�	PROPN
gsrj-75	58	52	�	�	PROPN
gsrj-75	58	53	prophylactically	prophylactically	ADV
gsrj-75	58	54	.	.	PUNCT
gsrj-75	59	1	the	the	DET
gsrj-75	59	2	mice	mouse	NOUN
gsrj-75	59	3	were	be	AUX
gsrj-75	59	4	never	never	ADV
gsrj-75	59	5	subjected	subject	VERB
gsrj-75	59	6	to	to	ADP
gsrj-75	59	7	more	more	ADJ
gsrj-75	59	8	than	than	ADP
gsrj-75	59	9	two	two	NUM
gsrj-75	59	10	days	day	NOUN
gsrj-75	59	11	of	of	ADP
gsrj-75	59	12	back	back	NOUN
gsrj-75	59	13	-	-	PUNCT
gsrj-75	59	14	to	to	ADP
gsrj-75	59	15	-	-	PUNCT
gsrj-75	59	16	back	back	NOUN
gsrj-75	59	17	isoflurane	isoflurane	ADJ
gsrj-75	59	18	anesthesia	anesthesia	ADV
gsrj-75	59	19	to	to	PART
gsrj-75	59	20	prevent	prevent	VERB
gsrj-75	59	21	a	a	DET
gsrj-75	59	22	negative	negative	ADJ
gsrj-75	59	23	reaction	reaction	NOUN
gsrj-75	59	24	to	to	PART
gsrj-75	59	25	cumulative	cumulative	VERB
gsrj-75	59	26	anesthesia	anesthesia	NOUN
gsrj-75	59	27	.	.	PUNCT
gsrj-75	60	1	22	22	NUM
gsrj-75	60	2	..	..	SYM
gsrj-75	60	3	33	33	NUM
gsrj-75	60	4	tteerrmmiinnaall	tteerrmmiinnaall	NOUN
gsrj-75	60	5	ttiimmeeppooiinntt	ttiimmeeppooiinntt	NOUN
gsrj-75	60	6	on	on	ADP
gsrj-75	60	7	day	day	NOUN
gsrj-75	60	8	15	15	NUM
gsrj-75	60	9	,	,	PUNCT
gsrj-75	60	10	all	all	DET
gsrj-75	60	11	mice	mouse	NOUN
gsrj-75	60	12	were	be	AUX
gsrj-75	60	13	placed	place	VERB
gsrj-75	60	14	under	under	ADP
gsrj-75	60	15	anesthesia	anesthesia	NOUN
gsrj-75	60	16	and	and	CCONJ
gsrj-75	60	17	euthanized	euthanize	VERB
gsrj-75	60	18	via	via	ADP
gsrj-75	60	19	exsanguination	exsanguination	NOUN
gsrj-75	60	20	and	and	CCONJ
gsrj-75	60	21	cervical	cervical	ADJ
gsrj-75	60	22	dislocation	dislocation	NOUN
gsrj-75	60	23	.	.	PUNCT
gsrj-75	61	1	terminal	terminal	ADJ
gsrj-75	61	2	weights	weight	NOUN
gsrj-75	61	3	and	and	CCONJ
gsrj-75	61	4	noninvasive	noninvasive	ADJ
gsrj-75	61	5	probe	probe	NOUN
gsrj-75	61	6	measurements	measurement	NOUN
gsrj-75	61	7	were	be	AUX
gsrj-75	61	8	obtained	obtain	VERB
gsrj-75	61	9	prior	prior	ADV
gsrj-75	61	10	to	to	ADP
gsrj-75	61	11	euthanasia	euthanasia	PROPN
gsrj-75	61	12	.	.	PUNCT
gsrj-75	62	1	treated	treat	VERB
gsrj-75	62	2	zone	zone	NOUN
gsrj-75	62	3	skin	skin	NOUN
gsrj-75	62	4	and	and	CCONJ
gsrj-75	62	5	normal	normal	ADJ
gsrj-75	62	6	skin	skin	NOUN
gsrj-75	62	7	were	be	AUX
gsrj-75	62	8	collected	collect	VERB
gsrj-75	62	9	and	and	CCONJ
gsrj-75	62	10	preserved	preserve	VERB
gsrj-75	62	11	in	in	ADP
gsrj-75	62	12	allprotect	allprotect	ADJ
gsrj-75	62	13	tissue	tissue	NOUN
gsrj-75	62	14	reagent	reagent	NOUN
gsrj-75	62	15	(	(	PUNCT
gsrj-75	62	16	qiagen	qiagen	NOUN
gsrj-75	62	17	,	,	PUNCT
gsrj-75	62	18	germantown	germantown	PROPN
gsrj-75	62	19	,	,	PUNCT
gsrj-75	62	20	md	md	PROPN
gsrj-75	62	21	)	)	PUNCT
gsrj-75	62	22	and	and	CCONJ
gsrj-75	62	23	10	10	NUM
gsrj-75	62	24	%	%	NOUN
gsrj-75	62	25	neutral	neutral	ADJ
gsrj-75	62	26	buffered	buffer	VERB
gsrj-75	62	27	formalin	formalin	NOUN
gsrj-75	62	28	(	(	PUNCT
gsrj-75	62	29	nbf	nbf	NOUN
gsrj-75	62	30	)	)	PUNCT
gsrj-75	62	31	.	.	PUNCT
gsrj-75	63	1	blood	blood	NOUN
gsrj-75	63	2	was	be	AUX
gsrj-75	63	3	collected	collect	VERB
gsrj-75	63	4	and	and	CCONJ
gsrj-75	63	5	placed	place	VERB
gsrj-75	63	6	in	in	ADP
gsrj-75	63	7	rnaprotect	rnaprotect	ADJ
gsrj-75	63	8	tubes	tube	NOUN
gsrj-75	63	9	(	(	PUNCT
gsrj-75	63	10	qiagen	qiagen	PROPN
gsrj-75	63	11	,	,	PUNCT
gsrj-75	63	12	germantown	germantown	PROPN
gsrj-75	63	13	,	,	PUNCT
gsrj-75	63	14	md	md	PROPN
gsrj-75	63	15	)	)	PUNCT
gsrj-75	63	16	and	and	CCONJ
gsrj-75	63	17	k2edta	k2edta	PROPN
gsrj-75	63	18	tubes	tube	NOUN
gsrj-75	63	19	,	,	PUNCT
gsrj-75	63	20	and	and	CCONJ
gsrj-75	63	21	was	be	AUX
gsrj-75	63	22	spun	spin	VERB
gsrj-75	63	23	down	down	ADP
gsrj-75	63	24	to	to	PART
gsrj-75	63	25	isolate	isolate	VERB
gsrj-75	63	26	plasma	plasma	NOUN
gsrj-75	63	27	.	.	PUNCT
gsrj-75	64	1	lungs	lung	NOUN
gsrj-75	64	2	were	be	AUX
gsrj-75	64	3	dissected	dissect	VERB
gsrj-75	64	4	and	and	CCONJ
gsrj-75	64	5	preserved	preserve	VERB
gsrj-75	64	6	in	in	ADP
gsrj-75	64	7	allprotect	allprotect	ADJ
gsrj-75	64	8	tissue	tissue	NOUN
gsrj-75	64	9	reagent	reagent	NOUN
gsrj-75	64	10	(	(	PUNCT
gsrj-75	64	11	qiagen	qiagen	NOUN
gsrj-75	64	12	,	,	PUNCT
gsrj-75	64	13	germantown	germantown	PROPN
gsrj-75	64	14	,	,	PUNCT
gsrj-75	64	15	md	md	PROPN
gsrj-75	64	16	)	)	PUNCT
gsrj-75	64	17	and	and	CCONJ
gsrj-75	64	18	nbf	nbf	PROPN
gsrj-75	64	19	.	.	PROPN
gsrj-75	64	20	ffiigguurree	ffiigguurree	PROPN
gsrj-75	64	21	22	22	NUM
gsrj-75	64	22	..	..	PUNCT
gsrj-75	64	23	injection	injection	NOUN
gsrj-75	64	24	pattern	pattern	NOUN
gsrj-75	64	25	for	for	ADP
gsrj-75	64	26	intradermal	intradermal	ADJ
gsrj-75	64	27	injection	injection	NOUN
gsrj-75	64	28	of	of	ADP
gsrj-75	64	29	bleomycin	bleomycin	NOUN
gsrj-75	64	30	or	or	CCONJ
gsrj-75	64	31	saline	saline	ADJ
gsrj-75	64	32	control	control	NOUN
gsrj-75	64	33	.	.	PUNCT
gsrj-75	65	1	injections	injection	NOUN
gsrj-75	65	2	were	be	AUX
gsrj-75	65	3	administered	administer	VERB
gsrj-75	65	4	from	from	ADP
gsrj-75	65	5	positions	position	NOUN
gsrj-75	65	6	1	1	NUM
gsrj-75	65	7	to	to	PART
gsrj-75	65	8	5	5	NUM
gsrj-75	65	9	throughout	throughout	ADP
gsrj-75	65	10	the	the	DET
gsrj-75	65	11	time	time	NOUN
gsrj-75	65	12	course	course	NOUN
gsrj-75	65	13	.	.	PUNCT
gsrj-75	66	1	after	after	ADP
gsrj-75	66	2	position	position	NOUN
gsrj-75	66	3	5	5	NUM
gsrj-75	66	4	,	,	PUNCT
gsrj-75	66	5	injections	injection	NOUN
gsrj-75	66	6	were	be	AUX
gsrj-75	66	7	further	far	ADV
gsrj-75	66	8	continued	continue	VERB
gsrj-75	66	9	cyclically	cyclically	ADV
gsrj-75	66	10	starting	start	VERB
gsrj-75	66	11	again	again	ADV
gsrj-75	66	12	at	at	ADP
gsrj-75	66	13	position	position	NOUN
gsrj-75	66	14	1	1	NUM
gsrj-75	66	15	.	.	X
gsrj-75	66	16	2.4	2.4	NUM
gsrj-75	66	17	hhiissttoollooggiiccaall	hhiissttoollooggiiccaall	NOUN
gsrj-75	66	18	aannaallyyssiiss	aannaallyyssiiss	NOUN
gsrj-75	66	19	formalin	formalin	NOUN
gsrj-75	66	20	-	-	PUNCT
gsrj-75	66	21	fixed	fix	VERB
gsrj-75	66	22	skin	skin	NOUN
gsrj-75	66	23	and	and	CCONJ
gsrj-75	66	24	lung	lung	NOUN
gsrj-75	66	25	samples	sample	NOUN
gsrj-75	66	26	collected	collect	VERB
gsrj-75	66	27	at	at	ADP
gsrj-75	66	28	the	the	DET
gsrj-75	66	29	terminal	terminal	ADJ
gsrj-75	66	30	timepoint	timepoint	NOUN
gsrj-75	66	31	were	be	AUX
gsrj-75	66	32	paraffin	paraffin	NOUN
gsrj-75	66	33	embedded	embed	VERB
gsrj-75	66	34	,	,	PUNCT
gsrj-75	66	35	sectioned	section	VERB
gsrj-75	66	36	at	at	ADP
gsrj-75	66	37	4	4	NUM
gsrj-75	66	38	µm	µm	ADP
gsrj-75	66	39	thickness	thickness	NOUN
gsrj-75	66	40	onto	onto	ADP
gsrj-75	66	41	slides	slide	NOUN
gsrj-75	66	42	,	,	PUNCT
gsrj-75	66	43	and	and	CCONJ
gsrj-75	66	44	stained	stain	VERB
gsrj-75	66	45	with	with	ADP
gsrj-75	66	46	hematoxylin	hematoxylin	NOUN
gsrj-75	66	47	and	and	CCONJ
gsrj-75	66	48	eosin	eosin	PROPN
gsrj-75	66	49	(	(	PUNCT
gsrj-75	66	50	h&e	h&e	PROPN
gsrj-75	66	51	)	)	PUNCT
gsrj-75	66	52	as	as	SCONJ
gsrj-75	66	53	previously	previously	ADV
gsrj-75	66	54	described.17	described.17	ADJ
gsrj-75	66	55	tile	tile	NOUN
gsrj-75	66	56	images	image	NOUN
gsrj-75	66	57	were	be	AUX
gsrj-75	66	58	taken	take	VERB
gsrj-75	66	59	at	at	ADP
gsrj-75	66	60	10x	10x	NOUN
gsrj-75	66	61	magnification	magnification	NOUN
gsrj-75	66	62	to	to	PART
gsrj-75	66	63	assess	assess	VERB
gsrj-75	66	64	dermal	dermal	ADJ
gsrj-75	66	65	architecture	architecture	NOUN
gsrj-75	66	66	,	,	PUNCT
gsrj-75	66	67	dermal	dermal	ADJ
gsrj-75	66	68	cellularity	cellularity	NOUN
gsrj-75	66	69	,	,	PUNCT
gsrj-75	66	70	and	and	CCONJ
gsrj-75	66	71	dermal	dermal	ADJ
gsrj-75	66	72	and	and	CCONJ
gsrj-75	66	73	epidermal	epidermal	ADJ
gsrj-75	66	74	thickness	thickness	NOUN
gsrj-75	66	75	using	use	VERB
gsrj-75	66	76	an	an	DET
gsrj-75	66	77	axio	axio	NOUN
gsrj-75	66	78	imager	imager	NOUN
gsrj-75	66	79	m2	m2	PROPN
gsrj-75	66	80	microscope	microscope	NOUN
gsrj-75	66	81	with	with	ADP
gsrj-75	66	82	motorized	motorize	VERB
gsrj-75	66	83	stage	stage	NOUN
gsrj-75	66	84	(	(	PUNCT
gsrj-75	66	85	carl	carl	PROPN
gsrj-75	66	86	zeiss	zeiss	PROPN
gsrj-75	66	87	inc	inc	PROPN
gsrj-75	66	88	.	.	PROPN
gsrj-75	66	89	,	,	PUNCT
gsrj-75	66	90	oberkochen	oberkochen	PROPN
gsrj-75	66	91	,	,	PUNCT
gsrj-75	66	92	germany	germany	PROPN
gsrj-75	66	93	)	)	PUNCT
gsrj-75	66	94	and	and	CCONJ
gsrj-75	66	95	an	an	DET
gsrj-75	66	96	axiocam	axiocam	NOUN
gsrj-75	66	97	208	208	NUM
gsrj-75	66	98	color	color	NOUN
gsrj-75	66	99	camera	camera	NOUN
gsrj-75	66	100	.	.	PUNCT
gsrj-75	67	1	zen	zen	PROPN
gsrj-75	67	2	blue	blue	ADJ
gsrj-75	67	3	software	software	NOUN
gsrj-75	67	4	was	be	AUX
gsrj-75	67	5	used	use	VERB
gsrj-75	67	6	to	to	PART
gsrj-75	67	7	export	export	VERB
gsrj-75	67	8	images	image	NOUN
gsrj-75	67	9	(	(	PUNCT
gsrj-75	67	10	carl	carl	PROPN
gsrj-75	67	11	zeiss	zeiss	PROPN
gsrj-75	67	12	inc	inc	PROPN
gsrj-75	67	13	.	.	PROPN
gsrj-75	67	14	,	,	PUNCT
gsrj-75	67	15	oberkochen	oberkochen	PROPN
gsrj-75	67	16	,	,	PUNCT
gsrj-75	67	17	germany	germany	PROPN
gsrj-75	67	18	)	)	PUNCT
gsrj-75	67	19	.	.	PUNCT
gsrj-75	68	1	imagej	imagej	ADJ
gsrj-75	68	2	software	software	NOUN
gsrj-75	68	3	was	be	AUX
gsrj-75	68	4	used	use	VERB
gsrj-75	68	5	to	to	PART
gsrj-75	68	6	quantify	quantify	VERB
gsrj-75	68	7	dermal	dermal	NOUN
gsrj-75	68	8	and	and	CCONJ
gsrj-75	68	9	epidermal	epidermal	ADJ
gsrj-75	68	10	thickness	thickness	NOUN
gsrj-75	68	11	and	and	CCONJ
gsrj-75	68	12	10	10	NUM
gsrj-75	68	13	replicates	replicate	NOUN
gsrj-75	68	14	were	be	AUX
gsrj-75	68	15	taken	take	VERB
gsrj-75	68	16	at	at	ADP
gsrj-75	68	17	different	different	ADJ
gsrj-75	68	18	positions	position	NOUN
gsrj-75	68	19	across	across	ADP
gsrj-75	68	20	the	the	DET
gsrj-75	68	21	biopsy	biopsy	NOUN
gsrj-75	68	22	for	for	ADP
gsrj-75	68	23	each	each	DET
gsrj-75	68	24	sample	sample	NOUN
gsrj-75	68	25	.	.	PUNCT
gsrj-75	69	1	22	22	NUM
gsrj-75	69	2	..	..	SYM
gsrj-75	69	3	55	55	NUM
gsrj-75	69	4	ccoonnffiirrmmaattoorryy	ccoonnffiirrmmaattoorryy	NOUN
gsrj-75	69	5	qqrrtt	qqrrtt	NOUN
gsrj-75	69	6	--	--	PUNCT
gsrj-75	69	7	ppccrr	ppccrr	NOUN
gsrj-75	69	8	aannaallyyssiiss	aannaallyyssiiss	PROPN
gsrj-75	69	9	rna	rna	PROPN
gsrj-75	69	10	from	from	ADP
gsrj-75	69	11	collected	collect	VERB
gsrj-75	69	12	skin	skin	NOUN
gsrj-75	69	13	biopsies	biopsy	NOUN
gsrj-75	69	14	was	be	AUX
gsrj-75	69	15	isolated	isolate	VERB
gsrj-75	69	16	and	and	CCONJ
gsrj-75	69	17	purified	purify	VERB
gsrj-75	69	18	for	for	ADP
gsrj-75	69	19	molecular	molecular	ADJ
gsrj-75	69	20	assays	assay	NOUN
gsrj-75	69	21	using	use	VERB
gsrj-75	69	22	an	an	DET
gsrj-75	69	23	automated	automate	VERB
gsrj-75	69	24	protocol	protocol	NOUN
gsrj-75	69	25	for	for	ADP
gsrj-75	69	26	the	the	DET
gsrj-75	69	27	rneasy	rneasy	NOUN
gsrj-75	69	28	fibrous	fibrous	ADJ
gsrj-75	69	29	tissue	tissue	NOUN
gsrj-75	69	30	mini	mini	NOUN
gsrj-75	69	31	kit	kit	NOUN
gsrj-75	69	32	(	(	PUNCT
gsrj-75	69	33	qiagen	qiagen	PROPN
gsrj-75	69	34	,	,	PUNCT
gsrj-75	69	35	germantown	germantown	PROPN
gsrj-75	69	36	,	,	PUNCT
gsrj-75	69	37	md	md	PROPN
gsrj-75	69	38	)	)	PUNCT
gsrj-75	69	39	with	with	ADP
gsrj-75	69	40	the	the	DET
gsrj-75	69	41	qiacube	qiacube	NOUN
gsrj-75	69	42	.	.	PUNCT
gsrj-75	70	1	rna	rna	NOUN
gsrj-75	70	2	quality	quality	NOUN
gsrj-75	70	3	and	and	CCONJ
gsrj-75	70	4	quantity	quantity	NOUN
gsrj-75	70	5	determined	determine	VERB
gsrj-75	70	6	by	by	ADP
gsrj-75	70	7	spectro	spectro	NOUN
gsrj-75	70	8	-	-	PUNCT
gsrj-75	70	9	photometry	photometry	NOUN
gsrj-75	70	10	(	(	PUNCT
gsrj-75	70	11	nandrop2000	nandrop2000	PROPN
gsrj-75	70	12	,	,	PUNCT
gsrj-75	70	13	thermofisher	thermofisher	PROPN
gsrj-75	70	14	,	,	PUNCT
gsrj-75	70	15	waltham	waltham	PROPN
gsrj-75	70	16	,	,	PUNCT
gsrj-75	70	17	ma	ma	PROPN
gsrj-75	70	18	)	)	PUNCT
gsrj-75	70	19	and	and	CCONJ
gsrj-75	70	20	all	all	DET
gsrj-75	70	21	samples	sample	NOUN
gsrj-75	70	22	were	be	AUX
gsrj-75	70	23	diluted	dilute	VERB
gsrj-75	70	24	to	to	ADP
gsrj-75	70	25	1	1	NUM
gsrj-75	70	26	ng	ng	PROPN
gsrj-75	70	27	/	/	SYM
gsrj-75	70	28	ul	ul	PROPN
gsrj-75	70	29	prior	prior	ADV
gsrj-75	70	30	to	to	ADP
gsrj-75	70	31	running	run	VERB
gsrj-75	70	32	.	.	PUNCT
gsrj-75	71	1	confirmatory	confirmatory	NOUN
gsrj-75	71	2	qrt	qrt	NOUN
gsrj-75	71	3	-	-	PUNCT
gsrj-75	71	4	pcr	pcr	PROPN
gsrj-75	71	5	was	be	AUX
gsrj-75	71	6	conducted	conduct	VERB
gsrj-75	71	7	using	use	VERB
gsrj-75	71	8	a	a	DET
gsrj-75	71	9	one	one	NUM
gsrj-75	71	10	-	-	PUNCT
gsrj-75	71	11	step	step	NOUN
gsrj-75	71	12	reverse	reverse	NOUN
gsrj-75	71	13	transcription	transcription	NOUN
gsrj-75	71	14	and	and	CCONJ
gsrj-75	71	15	sybr	sybr	PROPN
gsrj-75	71	16	green	green	PROPN
gsrj-75	71	17	kit	kit	NOUN
gsrj-75	71	18	(	(	PUNCT
gsrj-75	71	19	biorad	biorad	PROPN
gsrj-75	71	20	laboratories	laboratories	PROPN
gsrj-75	71	21	inc	inc	PROPN
gsrj-75	71	22	.	.	PROPN
gsrj-75	71	23	,	,	PUNCT
gsrj-75	71	24	hercules	hercules	PROPN
gsrj-75	71	25	,	,	PUNCT
gsrj-75	71	26	ca	ca	NOUN
gsrj-75	71	27	)	)	PUNCT
gsrj-75	71	28	to	to	PART
gsrj-75	71	29	measure	measure	VERB
gsrj-75	71	30	differential	differential	ADJ
gsrj-75	71	31	expression	expression	NOUN
gsrj-75	71	32	of	of	ADP
gsrj-75	71	33	col1a1	col1a1	NOUN
gsrj-75	71	34	,	,	PUNCT
gsrj-75	71	35	col1a3	col1a3	NOUN
gsrj-75	71	36	,	,	PUNCT
gsrj-75	71	37	tgfb1	tgfb1	NOUN
gsrj-75	71	38	,	,	PUNCT
gsrj-75	71	39	and	and	CCONJ
gsrj-75	71	40	lgals1	lgals1	VERB
gsrj-75	71	41	as	as	ADP
gsrj-75	71	42	previously	previously	ADV
gsrj-75	71	43	described.17	described.17	ADJ
gsrj-75	71	44	glyceraldehyde	glyceraldehyde	NOUN
gsrj-75	71	45	3	3	NUM
gsrj-75	71	46	-	-	PUNCT
gsrj-75	71	47	phosphate	phosphate	NOUN
gsrj-75	71	48	dehydrogenase	dehydrogenase	NOUN
gsrj-75	71	49	(	(	PUNCT
gsrj-75	71	50	gapdh	gapdh	NOUN
gsrj-75	71	51	)	)	PUNCT
gsrj-75	71	52	and	and	CCONJ
gsrj-75	71	53	ribosomal	ribosomal	NOUN
gsrj-75	71	54	protein	protein	NOUN
gsrj-75	71	55	l13a	l13a	NOUN
gsrj-75	71	56	(	(	PUNCT
gsrj-75	71	57	rpl13a	rpl13a	X
gsrj-75	71	58	)	)	PUNCT
gsrj-75	71	59	were	be	AUX
gsrj-75	71	60	used	use	VERB
gsrj-75	71	61	as	as	ADP
gsrj-75	71	62	housekeeping	housekeeping	NOUN
gsrj-75	71	63	genes	gene	NOUN
gsrj-75	71	64	.	.	PUNCT
gsrj-75	72	1	fold	fold	PROPN
gsrj-75	72	2	changed	change	VERB
gsrj-75	72	3	was	be	AUX
gsrj-75	72	4	assessed	assess	VERB
gsrj-75	72	5	using	use	VERB
gsrj-75	72	6	!	!	PUNCT
gsrj-75	72	7	!	!	PUNCT
gsrj-75	73	1	ct	ct	NUM
gsrj-75	73	2	analysis	analysis	NOUN
gsrj-75	73	3	.	.	PUNCT
gsrj-75	74	1	22	22	NUM
gsrj-75	74	2	..	..	SYM
gsrj-75	74	3	66	66	NUM
gsrj-75	74	4	ssttaattiissttiiccss	ssttaattiissttiiccss	NOUN
gsrj-75	74	5	for	for	ADP
gsrj-75	74	6	non	non	ADJ
gsrj-75	74	7	-	-	ADJ
gsrj-75	74	8	invasive	invasive	ADJ
gsrj-75	74	9	probe	probe	NOUN
gsrj-75	74	10	measurements	measurement	NOUN
gsrj-75	74	11	and	and	CCONJ
gsrj-75	74	12	pcr	pcr	PROPN
gsrj-75	74	13	data	datum	NOUN
gsrj-75	74	14	,	,	PUNCT
gsrj-75	74	15	a	a	DET
gsrj-75	74	16	two	two	NUM
gsrj-75	74	17	-	-	PUNCT
gsrj-75	74	18	way	way	NOUN
gsrj-75	74	19	anova	anova	X
gsrj-75	74	20	with	with	ADP
gsrj-75	74	21	multiple	multiple	ADJ
gsrj-75	74	22	comparisons	comparison	NOUN
gsrj-75	74	23	was	be	AUX
gsrj-75	74	24	run	run	VERB
gsrj-75	74	25	to	to	PART
gsrj-75	74	26	compare	compare	VERB
gsrj-75	74	27	differences	difference	NOUN
gsrj-75	74	28	across	across	ADP
gsrj-75	74	29	treatment	treatment	NOUN
gsrj-75	74	30	groups	group	NOUN
gsrj-75	74	31	and	and	CCONJ
gsrj-75	74	32	time	time	NOUN
gsrj-75	74	33	points	point	NOUN
gsrj-75	74	34	.	.	PUNCT
gsrj-75	75	1	data	datum	NOUN
gsrj-75	75	2	was	be	AUX
gsrj-75	75	3	also	also	ADV
gsrj-75	75	4	analyzed	analyze	VERB
gsrj-75	75	5	as	as	ADP
gsrj-75	75	6	fold	fold	ADJ
gsrj-75	75	7	change	change	NOUN
gsrj-75	75	8	at	at	ADP
gsrj-75	75	9	various	various	ADJ
gsrj-75	75	10	time	time	NOUN
gsrj-75	75	11	points	point	NOUN
gsrj-75	75	12	to	to	PART
gsrj-75	75	13	compare	compare	VERB
gsrj-75	75	14	treatment	treatment	NOUN
gsrj-75	75	15	to	to	PART
gsrj-75	75	16	control	control	VERB
gsrj-75	75	17	at	at	ADP
gsrj-75	75	18	similar	similar	ADJ
gsrj-75	75	19	time	time	NOUN
gsrj-75	75	20	points	point	NOUN
gsrj-75	75	21	,	,	PUNCT
gsrj-75	75	22	or	or	CCONJ
gsrj-75	75	23	as	as	ADP
gsrj-75	75	24	fold	fold	ADJ
gsrj-75	75	25	change	change	NOUN
gsrj-75	75	26	over	over	ADP
gsrj-75	75	27	time	time	NOUN
gsrj-75	75	28	compared	compare	VERB
gsrj-75	75	29	to	to	ADP
gsrj-75	75	30	the	the	DET
gsrj-75	75	31	day	day	NOUN
gsrj-75	75	32	of	of	ADP
gsrj-75	75	33	treatment	treatment	NOUN
gsrj-75	75	34	initiation	initiation	NOUN
gsrj-75	75	35	.	.	PUNCT
gsrj-75	76	1	for	for	ADP
gsrj-75	76	2	all	all	DET
gsrj-75	76	3	analyses	analysis	NOUN
gsrj-75	76	4	,	,	PUNCT
gsrj-75	76	5	p<0.05	p<0.05	NOUN
gsrj-75	76	6	was	be	AUX
gsrj-75	76	7	considered	consider	VERB
gsrj-75	76	8	statistically	statistically	ADV
gsrj-75	76	9	significant	significant	ADJ
gsrj-75	76	10	.	.	PUNCT
gsrj-75	77	1	for	for	ADP
gsrj-75	77	2	qrtpcr	qrtpcr	ADJ
gsrj-75	77	3	,	,	PUNCT
gsrj-75	77	4	fold	fold	VERB
gsrj-75	77	5	change	change	NOUN
gsrj-75	77	6	>	>	X
gsrj-75	77	7	or	or	CCONJ
gsrj-75	77	8	<	<	X
gsrj-75	77	9	2	2	NUM
gsrj-75	77	10	was	be	AUX
gsrj-75	77	11	established	establish	VERB
gsrj-75	77	12	as	as	ADP
gsrj-75	77	13	the	the	DET
gsrj-75	77	14	significance	significance	NOUN
gsrj-75	77	15	threshold	threshold	NOUN
gsrj-75	77	16	.	.	PUNCT
gsrj-75	78	1	outliers	outlier	NOUN
gsrj-75	78	2	were	be	AUX
gsrj-75	78	3	excluded	exclude	VERB
gsrj-75	78	4	using	use	VERB
gsrj-75	78	5	grubb	grubb	PROPN
gsrj-75	78	6	’s	’s	PART
gsrj-75	78	7	outlier	outlier	ADJ
gsrj-75	78	8	test	test	NOUN
gsrj-75	78	9	.	.	PUNCT
gsrj-75	79	1	graphpad	graphpad	NOUN
gsrj-75	79	2	prism	prism	NOUN
gsrj-75	79	3	10	10	NUM
gsrj-75	79	4	was	be	AUX
gsrj-75	79	5	used	use	VERB
gsrj-75	79	6	for	for	ADP
gsrj-75	79	7	data	data	NOUN
gsrj-75	79	8	visualization	visualization	NOUN
gsrj-75	79	9	.	.	PUNCT
gsrj-75	80	1	33	33	NUM
gsrj-75	80	2	..	..	PUNCT
gsrj-75	80	3	rreessuullttss	rreessuullttss	VERB
gsrj-75	80	4	33	33	NUM
gsrj-75	80	5	..	..	SYM
gsrj-75	80	6	11	11	NUM
gsrj-75	80	7	bblleeoommyycciinn	bblleeoommyycciinn	NOUN
gsrj-75	80	8	ttrreeaattmmeenntt	ttrreeaattmmeenntt	PROPN
gsrj-75	80	9	rreessuulltteedd	rreessuulltteedd	PROPN
gsrj-75	80	10	iinn	iinn	PROPN
gsrj-75	80	11	ddeeccrreeaasseedd	ddeeccrreeaasseedd	PROPN
gsrj-75	80	12	sskkiinn	sskkiinn	PROPN
gsrj-75	80	13	eellaassttiicciittyy	eellaassttiicciittyy	VERB
gsrj-75	80	14	the	the	DET
gsrj-75	80	15	high	high	ADV
gsrj-75	80	16	-	-	PUNCT
gsrj-75	80	17	dose	dose	NOUN
gsrj-75	80	18	bleomycin	bleomycin	PROPN
gsrj-75	80	19	group	group	NOUN
gsrj-75	80	20	showed	show	VERB
gsrj-75	80	21	a	a	DET
gsrj-75	80	22	significant	significant	ADJ
gsrj-75	80	23	decrease	decrease	NOUN
gsrj-75	80	24	in	in	ADP
gsrj-75	80	25	skin	skin	NOUN
gsrj-75	80	26	elasticity	elasticity	NOUN
gsrj-75	80	27	at	at	ADP
gsrj-75	80	28	the	the	DET
gsrj-75	80	29	24	24	NUM
gsrj-75	80	30	�	�	PROPN
gsrj-75	80	31	�	�	PROPN
gsrj-75	80	32	�	�	PROPN
gsrj-75	80	33	�	�	PROPN
gsrj-75	80	34	�	�	PROPN
gsrj-75	80	35	�	�	PROPN
gsrj-75	80	36	�	�	PROPN
gsrj-75	80	37	�	�	PROPN
gsrj-75	80	38	�	�	PROPN
gsrj-75	80	39	�	�	PROPN
gsrj-75	80	40	�	�	PROPN
gsrj-75	80	41	�	�	PROPN
gsrj-75	80	42	�	�	PROPN
gsrj-75	80	43	�	�	PROPN
gsrj-75	80	44	�	�	PROPN
gsrj-75	80	45	�	�	PROPN
gsrj-75	80	46	�	�	PROPN
gsrj-75	80	47	�	�	PROPN
gsrj-75	80	48	�	�	PROPN
gsrj-75	80	49	�	�	PROPN
gsrj-75	80	50	�	�	PROPN
gsrj-75	80	51	�	�	PROPN
gsrj-75	80	52	�	�	PROPN
gsrj-75	80	53	�	�	PROPN
gsrj-75	80	54	�	�	PROPN
gsrj-75	80	55	�	�	PROPN
gsrj-75	80	56	�	�	PROPN
gsrj-75	80	57	�	�	PROPN
gsrj-75	80	58	�	�	PROPN
gsrj-75	80	59	�	�	PROPN
gsrj-75	80	60	�	�	PROPN
gsrj-75	80	61	�	�	PROPN
gsrj-75	80	62	�	�	PROPN
gsrj-75	80	63	�	�	PROPN
gsrj-75	80	64	�	�	PROPN
gsrj-75	80	65	�	�	PROPN
gsrj-75	80	66	�	�	PROPN
gsrj-75	80	67	�	�	PROPN
gsrj-75	80	68	terminal	terminal	PROPN
gsrj-75	80	69	timepoint	timepoint	NOUN
gsrj-75	80	70	(	(	PUNCT
gsrj-75	80	71	day	day	NOUN
gsrj-75	80	72	15	15	NUM
gsrj-75	80	73	)	)	PUNCT
gsrj-75	80	74	compared	compare	VERB
gsrj-75	80	75	to	to	ADP
gsrj-75	80	76	baseline	baseline	VERB
gsrj-75	80	77	measurements	measurement	NOUN
gsrj-75	80	78	(	(	PUNCT
gsrj-75	80	79	day	day	NOUN
gsrj-75	80	80	1	1	NUM
gsrj-75	80	81	-	-	SYM
gsrj-75	80	82	4	4	NUM
gsrj-75	80	83	)	)	PUNCT
gsrj-75	80	84	,	,	PUNCT
gsrj-75	80	85	indicating	indicate	VERB
gsrj-75	80	86	decreased	decrease	VERB
gsrj-75	80	87	skin	skin	NOUN
gsrj-75	80	88	pliability	pliability	NOUN
gsrj-75	80	89	(	(	PUNCT
gsrj-75	80	90	58±22.9	58±22.9	PROPN
gsrj-75	80	91	vs	vs	ADP
gsrj-75	80	92	135.8±57.9	135.8±57.9	NUM
gsrj-75	80	93	n	n	CCONJ
gsrj-75	80	94	/	/	SYM
gsrj-75	80	95	m	m	NOUN
gsrj-75	80	96	)	)	PUNCT
gsrj-75	80	97	(	(	PUNCT
gsrj-75	80	98	figure	figure	NOUN
gsrj-75	80	99	3a	3a	NUM
gsrj-75	80	100	)	)	PUNCT
gsrj-75	80	101	.	.	PUNCT
gsrj-75	81	1	the	the	DET
gsrj-75	81	2	low	low	ADV
gsrj-75	81	3	-	-	PUNCT
gsrj-75	81	4	dose	dose	NOUN
gsrj-75	81	5	group	group	NOUN
gsrj-75	81	6	showed	show	VERB
gsrj-75	81	7	a	a	DET
gsrj-75	81	8	similar	similar	ADJ
gsrj-75	81	9	decrease	decrease	NOUN
gsrj-75	81	10	in	in	ADP
gsrj-75	81	11	skin	skin	NOUN
gsrj-75	81	12	elasticity	elasticity	NOUN
gsrj-75	81	13	over	over	ADP
gsrj-75	81	14	time	time	NOUN
gsrj-75	81	15	(	(	PUNCT
gsrj-75	81	16	50.1±17.9	50.1±17.9	NUM
gsrj-75	81	17	vs	vs	ADP
gsrj-75	81	18	91.1±34.1	91.1±34.1	NUM
gsrj-75	81	19	n	n	CCONJ
gsrj-75	81	20	/	/	SYM
gsrj-75	81	21	m	m	NOUN
gsrj-75	81	22	)	)	PUNCT
gsrj-75	81	23	.	.	PUNCT
gsrj-75	82	1	however	however	ADV
gsrj-75	82	2	,	,	PUNCT
gsrj-75	82	3	there	there	PRON
gsrj-75	82	4	was	be	VERB
gsrj-75	82	5	no	no	DET
gsrj-75	82	6	significant	significant	ADJ
gsrj-75	82	7	difference	difference	NOUN
gsrj-75	82	8	in	in	ADP
gsrj-75	82	9	skin	skin	NOUN
gsrj-75	82	10	elasticity	elasticity	NOUN
gsrj-75	82	11	over	over	ADP
gsrj-75	82	12	time	time	NOUN
gsrj-75	82	13	in	in	ADP
gsrj-75	82	14	the	the	DET
gsrj-75	82	15	mid	mid	NOUN
gsrj-75	82	16	-	-	ADJ
gsrj-75	82	17	dose	dose	ADJ
gsrj-75	82	18	and	and	CCONJ
gsrj-75	82	19	control	control	NOUN
gsrj-75	82	20	groups	group	NOUN
gsrj-75	82	21	.	.	PUNCT
gsrj-75	83	1	33	33	NUM
gsrj-75	83	2	..	..	SYM
gsrj-75	83	3	22	22	NUM
gsrj-75	83	4	mmeellaanniinn	mmeellaanniinn	PROPN
gsrj-75	83	5	iinnddeexx	iinnddeexx	PROPN
gsrj-75	83	6	iinnccrreeaasseedd	iinnccrreeaasseedd	PROPN
gsrj-75	83	7	tthhrroouugghhoouutt	tthhrroouugghhoouutt	PROPN
gsrj-75	83	8	tthhee	tthhee	PROPN
gsrj-75	83	9	dduurraattiioonn	dduurraattiioonn	PROPN
gsrj-75	83	10	ooff	ooff	PROPN
gsrj-75	83	11	tthhee	tthhee	PROPN
gsrj-75	83	12	ssttuuddyy	ssttuuddyy	PROPN
gsrj-75	83	13	iinn	iinn	PROPN
gsrj-75	83	14	aallll	aallll	PROPN
gsrj-75	83	15	ggrroouuppss	ggrroouuppss	PROPN
gsrj-75	83	16	non	non	ADJ
gsrj-75	83	17	-	-	ADJ
gsrj-75	83	18	invasive	invasive	ADJ
gsrj-75	83	19	probe	probe	NOUN
gsrj-75	83	20	data	datum	NOUN
gsrj-75	83	21	showed	show	VERB
gsrj-75	83	22	a	a	DET
gsrj-75	83	23	4	4	NUM
gsrj-75	83	24	-	-	ADJ
gsrj-75	83	25	fold	fold	ADJ
gsrj-75	83	26	increase	increase	NOUN
gsrj-75	83	27	in	in	ADP
gsrj-75	83	28	melanin	melanin	NOUN
gsrj-75	83	29	at	at	ADP
gsrj-75	83	30	the	the	DET
gsrj-75	83	31	terminal	terminal	ADJ
gsrj-75	83	32	timepoint	timepoint	NOUN
gsrj-75	83	33	(	(	PUNCT
gsrj-75	83	34	day	day	NOUN
gsrj-75	83	35	15	15	NUM
gsrj-75	83	36	)	)	PUNCT
gsrj-75	83	37	compared	compare	VERB
gsrj-75	83	38	to	to	ADP
gsrj-75	83	39	baseline	baseline	VERB
gsrj-75	83	40	measurements	measurement	NOUN
gsrj-75	83	41	(	(	PUNCT
gsrj-75	83	42	day	day	NOUN
gsrj-75	83	43	1	1	NUM
gsrj-75	83	44	-	-	SYM
gsrj-75	83	45	4	4	NUM
gsrj-75	83	46	)	)	PUNCT
gsrj-75	83	47	for	for	ADP
gsrj-75	83	48	the	the	DET
gsrj-75	83	49	control	control	NOUN
gsrj-75	83	50	group	group	NOUN
gsrj-75	83	51	(	(	PUNCT
gsrj-75	83	52	628.7±42.4	628.7±42.4	NUM
gsrj-75	83	53	vs	vs	ADV
gsrj-75	83	54	882.9±81.8	882.9±81.8	ADJ
gsrj-75	83	55	)	)	PUNCT
gsrj-75	83	56	(	(	PUNCT
gsrj-75	83	57	figure	figure	NOUN
gsrj-75	83	58	3b	3b	NUM
gsrj-75	83	59	)	)	PUNCT
gsrj-75	83	60	.	.	PUNCT
gsrj-75	84	1	similar	similar	ADJ
gsrj-75	84	2	trends	trend	NOUN
gsrj-75	84	3	were	be	AUX
gsrj-75	84	4	present	present	ADJ
gsrj-75	84	5	for	for	ADP
gsrj-75	84	6	the	the	DET
gsrj-75	84	7	low	low	ADJ
gsrj-75	84	8	-	-	PUNCT
gsrj-75	84	9	dose	dose	NOUN
gsrj-75	84	10	group	group	NOUN
gsrj-75	84	11	(	(	PUNCT
gsrj-75	84	12	648.4±60.6	648.4±60.6	NOUN
gsrj-75	84	13	vs	vs	ADP
gsrj-75	84	14	850.2±56.5	850.2±56.5	NUM
gsrj-75	84	15	)	)	PUNCT
gsrj-75	84	16	and	and	CCONJ
gsrj-75	84	17	mid	mid	ADJ
gsrj-75	84	18	-	-	ADJ
gsrj-75	84	19	dose	dose	ADJ
gsrj-75	84	20	group	group	NOUN
gsrj-75	84	21	(	(	PUNCT
gsrj-75	84	22	658.2±116.5	658.2±116.5	NOUN
gsrj-75	84	23	vs	vs	ADP
gsrj-75	84	24	867.2±52.6	867.2±52.6	PROPN
gsrj-75	84	25	)	)	PUNCT
gsrj-75	84	26	.	.	PUNCT
gsrj-75	85	1	the	the	DET
gsrj-75	85	2	high	high	ADJ
gsrj-75	85	3	-	-	PUNCT
gsrj-75	85	4	dose	dose	NOUN
gsrj-75	85	5	group	group	NOUN
gsrj-75	85	6	did	do	AUX
gsrj-75	85	7	not	not	PART
gsrj-75	85	8	show	show	VERB
gsrj-75	85	9	any	any	DET
gsrj-75	85	10	significant	significant	ADJ
gsrj-75	85	11	difference	difference	NOUN
gsrj-75	85	12	in	in	ADP
gsrj-75	85	13	melanin	melanin	NOUN
gsrj-75	85	14	index	index	NOUN
gsrj-75	85	15	(	(	PUNCT
gsrj-75	85	16	746.6±132	746.6±132	NUM
gsrj-75	85	17	vs	vs	ADP
gsrj-75	85	18	806.9±108.7	806.9±108.7	NOUN
gsrj-75	85	19	)	)	PUNCT
gsrj-75	85	20	.	.	PUNCT
gsrj-75	86	1	�	�	PROPN
gsrj-75	86	2	ffiigguurree	ffiigguurree	PROPN
gsrj-75	86	3	33	33	NUM
gsrj-75	86	4	..	..	PUNCT
gsrj-75	86	5	elasticity	elasticity	NOUN
gsrj-75	86	6	and	and	CCONJ
gsrj-75	86	7	melanin	melanin	NOUN
gsrj-75	86	8	measurements	measurement	NOUN
gsrj-75	86	9	using	use	VERB
gsrj-75	86	10	non	non	ADJ
gsrj-75	86	11	-	-	ADJ
gsrj-75	86	12	invasive	invasive	ADJ
gsrj-75	86	13	skin	skin	NOUN
gsrj-75	86	14	probes	probe	NOUN
gsrj-75	86	15	.	.	PUNCT
gsrj-75	87	1	(	(	PUNCT
gsrj-75	87	2	a	a	X
gsrj-75	87	3	)	)	PUNCT
gsrj-75	87	4	in	in	ADP
gsrj-75	87	5	the	the	DET
gsrj-75	87	6	lowdose	lowdose	ADJ
gsrj-75	87	7	and	and	CCONJ
gsrj-75	87	8	high	high	ADJ
gsrj-75	87	9	-	-	PUNCT
gsrj-75	87	10	dose	dose	NOUN
gsrj-75	87	11	groups	group	NOUN
gsrj-75	87	12	,	,	PUNCT
gsrj-75	87	13	there	there	PRON
gsrj-75	87	14	was	be	VERB
gsrj-75	87	15	a	a	DET
gsrj-75	87	16	significant	significant	ADJ
gsrj-75	87	17	increase	increase	NOUN
gsrj-75	87	18	in	in	ADP
gsrj-75	87	19	stiffness	stiffness	NOUN
gsrj-75	87	20	between	between	ADP
gsrj-75	87	21	days	day	NOUN
gsrj-75	87	22	1	1	NUM
gsrj-75	87	23	-	-	SYM
gsrj-75	87	24	4	4	NUM
gsrj-75	87	25	and	and	CCONJ
gsrj-75	87	26	day	day	NOUN
gsrj-75	87	27	15	15	NUM
gsrj-75	87	28	(	(	PUNCT
gsrj-75	87	29	p	p	X
gsrj-75	87	30	<	<	X
gsrj-75	87	31	0.05	0.05	NUM
gsrj-75	87	32	)	)	PUNCT
gsrj-75	87	33	.	.	PUNCT
gsrj-75	88	1	(	(	PUNCT
gsrj-75	88	2	b	b	X
gsrj-75	88	3	)	)	PUNCT
gsrj-75	88	4	control	control	NOUN
gsrj-75	88	5	,	,	PUNCT
gsrj-75	88	6	low	low	ADJ
gsrj-75	88	7	-	-	PUNCT
gsrj-75	88	8	dose	dose	NOUN
gsrj-75	88	9	,	,	PUNCT
gsrj-75	88	10	and	and	CCONJ
gsrj-75	88	11	mid	mid	ADJ
gsrj-75	88	12	-	-	ADJ
gsrj-75	88	13	dose	dose	ADJ
gsrj-75	88	14	groups	group	NOUN
gsrj-75	88	15	showed	show	VERB
gsrj-75	88	16	significant	significant	ADJ
gsrj-75	88	17	increase	increase	NOUN
gsrj-75	88	18	in	in	ADP
gsrj-75	88	19	melanin	melanin	NOUN
gsrj-75	88	20	index	index	NOUN
gsrj-75	88	21	between	between	ADP
gsrj-75	88	22	days	day	NOUN
gsrj-75	88	23	1	1	NUM
gsrj-75	88	24	-	-	SYM
gsrj-75	88	25	4	4	NUM
gsrj-75	88	26	and	and	CCONJ
gsrj-75	88	27	day	day	NOUN
gsrj-75	88	28	15	15	NUM
gsrj-75	88	29	.	.	PUNCT
gsrj-75	89	1	values	value	NOUN
gsrj-75	89	2	presented	present	VERB
gsrj-75	89	3	as	as	ADP
gsrj-75	89	4	mean	mean	PROPN
gsrj-75	89	5	±	±	NUM
gsrj-75	89	6	sem	sem	NOUN
gsrj-75	89	7	.	.	PUNCT
gsrj-75	90	1	33	33	NUM
gsrj-75	90	2	..	..	SYM
gsrj-75	90	3	33	33	NUM
gsrj-75	90	4	hhiissttoollooggiiccaall	hhiissttoollooggiiccaall	NOUN
gsrj-75	90	5	aannaallyyssiiss	aannaallyyssiiss	PROPN
gsrj-75	90	6	sshhoowweedd	sshhoowweedd	PROPN
gsrj-75	90	7	cchhaannggeess	cchhaannggeess	PROPN
gsrj-75	90	8	ttoo	ttoo	PROPN
gsrj-75	90	9	ddeerrmmaall	ddeerrmmaall	NOUN
gsrj-75	90	10	aarrcchhiitteeccttuurree	aarrcchhiitteeccttuurree	VERB
gsrj-75	90	11	analysis	analysis	NOUN
gsrj-75	90	12	of	of	ADP
gsrj-75	90	13	h&e	h&e	NOUN
gsrj-75	90	14	-	-	PUNCT
gsrj-75	90	15	stained	stain	VERB
gsrj-75	90	16	biopsies	biopsy	NOUN
gsrj-75	90	17	of	of	ADP
gsrj-75	90	18	the	the	DET
gsrj-75	90	19	normal	normal	ADJ
gsrj-75	90	20	and	and	CCONJ
gsrj-75	90	21	treated	treat	VERB
gsrj-75	90	22	zone	zone	NOUN
gsrj-75	90	23	in	in	ADP
gsrj-75	90	24	high	high	ADJ
gsrj-75	90	25	-	-	PUNCT
gsrj-75	90	26	dose	dose	NOUN
gsrj-75	90	27	mice	mouse	NOUN
gsrj-75	90	28	showed	show	VERB
gsrj-75	90	29	areas	area	NOUN
gsrj-75	90	30	of	of	ADP
gsrj-75	90	31	dermal	dermal	NOUN
gsrj-75	90	32	and	and	CCONJ
gsrj-75	90	33	epidermal	epidermal	ADJ
gsrj-75	90	34	thickening	thickening	NOUN
gsrj-75	90	35	,	,	PUNCT
gsrj-75	90	36	hair	hair	NOUN
gsrj-75	90	37	follicle	follicle	NOUN
gsrj-75	90	38	obliteration	obliteration	NOUN
gsrj-75	90	39	,	,	PUNCT
gsrj-75	90	40	and	and	CCONJ
gsrj-75	90	41	evidence	evidence	NOUN
gsrj-75	90	42	of	of	ADP
gsrj-75	90	43	fibrotic	fibrotic	ADJ
gsrj-75	90	44	architecture	architecture	NOUN
gsrj-75	90	45	(	(	PUNCT
gsrj-75	90	46	figure	figure	NOUN
gsrj-75	90	47	4a	4a	NUM
gsrj-75	90	48	)	)	PUNCT
gsrj-75	90	49	.	.	PUNCT
gsrj-75	91	1	midand	midand	NOUN
gsrj-75	91	2	low	low	ADV
gsrj-75	91	3	-	-	PUNCT
gsrj-75	91	4	dose	dose	NOUN
gsrj-75	91	5	mice	mouse	NOUN
gsrj-75	91	6	showed	show	VERB
gsrj-75	91	7	similar	similar	ADJ
gsrj-75	91	8	dermal	dermal	ADJ
gsrj-75	91	9	thickening	thickening	NOUN
gsrj-75	91	10	,	,	PUNCT
gsrj-75	91	11	however	however	ADV
gsrj-75	91	12	changes	change	NOUN
gsrj-75	91	13	to	to	ADP
gsrj-75	91	14	epidermal	epidermal	ADJ
gsrj-75	91	15	thickness	thickness	NOUN
gsrj-75	91	16	and	and	CCONJ
gsrj-75	91	17	hair	hair	NOUN
gsrj-75	91	18	follicle	follicle	NOUN
gsrj-75	91	19	architecture	architecture	NOUN
gsrj-75	91	20	were	be	AUX
gsrj-75	91	21	less	less	ADV
gsrj-75	91	22	prominent	prominent	ADJ
gsrj-75	91	23	than	than	ADP
gsrj-75	91	24	in	in	ADP
gsrj-75	91	25	the	the	DET
gsrj-75	91	26	high	high	ADJ
gsrj-75	91	27	dose	dose	NOUN
gsrj-75	91	28	group	group	NOUN
gsrj-75	91	29	.	.	PUNCT
gsrj-75	92	1	control	control	NOUN
gsrj-75	92	2	mice	mouse	NOUN
gsrj-75	92	3	treated	treat	VERB
gsrj-75	92	4	zone	zone	NOUN
gsrj-75	92	5	skin	skin	NOUN
gsrj-75	92	6	appeared	appear	VERB
gsrj-75	92	7	the	the	DET
gsrj-75	92	8	same	same	ADJ
gsrj-75	92	9	as	as	ADP
gsrj-75	92	10	normal	normal	ADJ
gsrj-75	92	11	skin	skin	NOUN
gsrj-75	92	12	,	,	PUNCT
gsrj-75	92	13	as	as	SCONJ
gsrj-75	92	14	expected	expect	VERB
gsrj-75	92	15	.	.	PUNCT
gsrj-75	93	1	quantitative	quantitative	ADJ
gsrj-75	93	2	assessment	assessment	NOUN
gsrj-75	93	3	of	of	ADP
gsrj-75	93	4	epidermal	epidermal	ADJ
gsrj-75	93	5	thickness	thickness	NOUN
gsrj-75	93	6	(	(	PUNCT
gsrj-75	93	7	figure	figure	NOUN
gsrj-75	93	8	4b	4b	X
gsrj-75	93	9	)	)	PUNCT
gsrj-75	93	10	and	and	CCONJ
gsrj-75	93	11	dermal	dermal	VERB
gsrj-75	93	12	thickness	thickness	NOUN
gsrj-75	93	13	(	(	PUNCT
gsrj-75	93	14	figure	figure	NOUN
gsrj-75	93	15	4c	4c	NOUN
gsrj-75	93	16	)	)	PUNCT
gsrj-75	93	17	confirmed	confirm	VERB
gsrj-75	93	18	thickening	thickening	NOUN
gsrj-75	93	19	of	of	ADP
gsrj-75	93	20	the	the	DET
gsrj-75	93	21	epidermis	epidermis	NOUN
gsrj-75	93	22	(	(	PUNCT
gsrj-75	93	23	14.1±0.19	14.1±0.19	NUM
gsrj-75	93	24	vs	vs	ADP
gsrj-75	93	25	38.8±4.83	38.8±4.83	NUM
gsrj-75	93	26	µm	µm	NOUN
gsrj-75	93	27	)	)	PUNCT
gsrj-75	93	28	and	and	CCONJ
gsrj-75	93	29	dermis	dermis	NOUN
gsrj-75	93	30	(	(	PUNCT
gsrj-75	93	31	104.7±11.1	104.7±11.1	NOUN
gsrj-75	93	32	vs	vs	ADP
gsrj-75	93	33	231±52.5	231±52.5	NUM
gsrj-75	93	34	µm	µm	NOUN
gsrj-75	93	35	)	)	PUNCT
gsrj-75	93	36	in	in	ADP
gsrj-75	93	37	treated	treat	VERB
gsrj-75	93	38	zone	zone	NOUN
gsrj-75	93	39	skin	skin	NOUN
gsrj-75	93	40	compared	compare	VERB
gsrj-75	93	41	to	to	ADP
gsrj-75	93	42	normal	normal	ADJ
gsrj-75	93	43	skin	skin	NOUN
gsrj-75	93	44	for	for	ADP
gsrj-75	93	45	high	high	ADJ
gsrj-75	93	46	-	-	PUNCT
gsrj-75	93	47	dose	dose	NOUN
gsrj-75	93	48	mice	mouse	NOUN
gsrj-75	93	49	,	,	PUNCT
gsrj-75	93	50	however	however	ADV
gsrj-75	93	51	this	this	DET
gsrj-75	93	52	difference	difference	NOUN
gsrj-75	93	53	did	do	AUX
gsrj-75	93	54	not	not	PART
gsrj-75	93	55	reach	reach	VERB
gsrj-75	93	56	significance	significance	NOUN
gsrj-75	93	57	(	(	PUNCT
gsrj-75	93	58	p	p	X
gsrj-75	93	59	>	>	X
gsrj-75	93	60	0.05	0.05	NUM
gsrj-75	93	61	)	)	PUNCT
gsrj-75	93	62	.	.	PUNCT
gsrj-75	94	1	control	control	NOUN
gsrj-75	94	2	,	,	PUNCT
gsrj-75	94	3	low	low	ADJ
gsrj-75	94	4	-	-	PUNCT
gsrj-75	94	5	dose	dose	NOUN
gsrj-75	94	6	,	,	PUNCT
gsrj-75	94	7	and	and	CCONJ
gsrj-75	94	8	mid	mid	ADJ
gsrj-75	94	9	-	-	ADJ
gsrj-75	94	10	dose	dose	ADJ
gsrj-75	94	11	skin	skin	NOUN
gsrj-75	94	12	not	not	PART
gsrj-75	94	13	show	show	VERB
gsrj-75	94	14	any	any	DET
gsrj-75	94	15	significant	significant	ADJ
gsrj-75	94	16	difference	difference	NOUN
gsrj-75	94	17	in	in	ADP
gsrj-75	94	18	epidermal	epidermal	ADJ
gsrj-75	94	19	or	or	CCONJ
gsrj-75	94	20	dermal	dermal	ADJ
gsrj-75	94	21	thickness	thickness	NOUN
gsrj-75	94	22	in	in	ADP
gsrj-75	94	23	the	the	DET
gsrj-75	94	24	treated	treat	VERB
gsrj-75	94	25	zone	zone	NOUN
gsrj-75	94	26	skin	skin	NOUN
gsrj-75	94	27	compared	compare	VERB
gsrj-75	94	28	to	to	ADP
gsrj-75	94	29	normal	normal	ADJ
gsrj-75	94	30	skin	skin	NOUN
gsrj-75	94	31	.	.	PUNCT
gsrj-75	95	1	ffiigguurree	ffiigguurree	NOUN
gsrj-75	95	2	44	44	NUM
gsrj-75	95	3	..	..	PUNCT
gsrj-75	95	4	effects	effect	NOUN
gsrj-75	95	5	of	of	ADP
gsrj-75	95	6	bleomycin	bleomycin	PROPN
gsrj-75	95	7	treatment	treatment	NOUN
gsrj-75	95	8	on	on	ADP
gsrj-75	95	9	dermal	dermal	NOUN
gsrj-75	95	10	and	and	CCONJ
gsrj-75	95	11	epidermal	epidermal	ADJ
gsrj-75	95	12	architecture	architecture	NOUN
gsrj-75	95	13	in	in	ADP
gsrj-75	95	14	a	a	DET
gsrj-75	95	15	mouse	mouse	NOUN
gsrj-75	95	16	model	model	NOUN
gsrj-75	95	17	.	.	PUNCT
gsrj-75	96	1	(	(	PUNCT
gsrj-75	96	2	a	a	X
gsrj-75	96	3	)	)	PUNCT
gsrj-75	96	4	biopsies	biopsy	NOUN
gsrj-75	96	5	of	of	ADP
gsrj-75	96	6	normal	normal	ADJ
gsrj-75	96	7	skin	skin	NOUN
gsrj-75	96	8	and	and	CCONJ
gsrj-75	96	9	treatment	treatment	NOUN
gsrj-75	96	10	zone	zone	NOUN
gsrj-75	96	11	skin	skin	NOUN
gsrj-75	96	12	taken	take	VERB
gsrj-75	96	13	at	at	ADP
gsrj-75	96	14	the	the	DET
gsrj-75	96	15	terminal	terminal	ADJ
gsrj-75	96	16	timepoint	timepoint	NOUN
gsrj-75	96	17	were	be	AUX
gsrj-75	96	18	sectioned	section	VERB
gsrj-75	96	19	and	and	CCONJ
gsrj-75	96	20	h&e	h&e	PROPN
gsrj-75	96	21	stained	stain	VERB
gsrj-75	96	22	to	to	PART
gsrj-75	96	23	be	be	AUX
gsrj-75	96	24	assessed	assess	VERB
gsrj-75	96	25	for	for	ADP
gsrj-75	96	26	dermal	dermal	ADJ
gsrj-75	96	27	thickness	thickness	NOUN
gsrj-75	96	28	(	(	PUNCT
gsrj-75	96	29	red	red	ADJ
gsrj-75	96	30	arrows	arrow	NOUN
gsrj-75	96	31	)	)	PUNCT
gsrj-75	96	32	,	,	PUNCT
gsrj-75	96	33	epidermal	epidermal	ADJ
gsrj-75	96	34	thickness	thickness	NOUN
gsrj-75	96	35	(	(	PUNCT
gsrj-75	96	36	yellow	yellow	ADJ
gsrj-75	96	37	arrow	arrow	NOUN
gsrj-75	96	38	)	)	PUNCT
gsrj-75	96	39	,	,	PUNCT
gsrj-75	96	40	hair	hair	NOUN
gsrj-75	96	41	follicle	follicle	NOUN
gsrj-75	96	42	presence	presence	NOUN
gsrj-75	96	43	(	(	PUNCT
gsrj-75	96	44	blue	blue	ADJ
gsrj-75	96	45	arrow	arrow	NOUN
gsrj-75	96	46	)	)	PUNCT
gsrj-75	96	47	,	,	PUNCT
gsrj-75	96	48	25	25	NUM
gsrj-75	96	49	�	�	PROPN
gsrj-75	96	50	�	�	PROPN
gsrj-75	96	51	�	�	PROPN
gsrj-75	96	52	�	�	PROPN
gsrj-75	96	53	�	�	PROPN
gsrj-75	96	54	�	�	PROPN
gsrj-75	96	55	�	�	PROPN
gsrj-75	96	56	�	�	PROPN
gsrj-75	96	57	�	�	PROPN
gsrj-75	96	58	�	�	PROPN
gsrj-75	96	59	�	�	PROPN
gsrj-75	96	60	�	�	PROPN
gsrj-75	96	61	�	�	PROPN
gsrj-75	96	62	�	�	PROPN
gsrj-75	96	63	�	�	PROPN
gsrj-75	96	64	�	�	PROPN
gsrj-75	96	65	�	�	PROPN
gsrj-75	96	66	�	�	PROPN
gsrj-75	96	67	�	�	PROPN
gsrj-75	96	68	�	�	PROPN
gsrj-75	96	69	�	�	PROPN
gsrj-75	96	70	�	�	PROPN
gsrj-75	96	71	�	�	PROPN
gsrj-75	96	72	�	�	PROPN
gsrj-75	96	73	�	�	PROPN
gsrj-75	96	74	�	�	PROPN
gsrj-75	96	75	�	�	PROPN
gsrj-75	96	76	�	�	PROPN
gsrj-75	96	77	�	�	PROPN
gsrj-75	96	78	�	�	PROPN
gsrj-75	96	79	�	�	PROPN
gsrj-75	96	80	�	�	PROPN
gsrj-75	96	81	�	�	PROPN
gsrj-75	96	82	�	�	PROPN
gsrj-75	96	83	�	�	PROPN
gsrj-75	96	84	�	�	PROPN
gsrj-75	96	85	�	�	PROPN
gsrj-75	96	86	�	�	PROPN
gsrj-75	96	87	and	and	CCONJ
gsrj-75	96	88	other	other	ADJ
gsrj-75	96	89	changes	change	NOUN
gsrj-75	96	90	to	to	PART
gsrj-75	96	91	dermal	dermal	VERB
gsrj-75	96	92	architecture	architecture	NOUN
gsrj-75	96	93	.	.	PUNCT
gsrj-75	97	1	quantitative	quantitative	ADJ
gsrj-75	97	2	measurements	measurement	NOUN
gsrj-75	97	3	of	of	ADP
gsrj-75	97	4	(	(	PUNCT
gsrj-75	97	5	b	b	NOUN
gsrj-75	97	6	)	)	PUNCT
gsrj-75	97	7	epidermal	epidermal	ADJ
gsrj-75	97	8	and	and	CCONJ
gsrj-75	97	9	(	(	PUNCT
gsrj-75	97	10	c	c	NOUN
gsrj-75	97	11	)	)	PUNCT
gsrj-75	97	12	dermal	dermal	NOUN
gsrj-75	97	13	thickness	thickness	NOUN
gsrj-75	97	14	analyzed	analyze	VERB
gsrj-75	97	15	from	from	ADP
gsrj-75	97	16	h&e	h&e	PROPN
gsrj-75	97	17	stained	stain	VERB
gsrj-75	97	18	images	image	NOUN
gsrj-75	97	19	.	.	PUNCT
gsrj-75	98	1	values	value	NOUN
gsrj-75	98	2	presented	present	VERB
gsrj-75	98	3	as	as	ADP
gsrj-75	98	4	mean	mean	PROPN
gsrj-75	98	5	±	±	NUM
gsrj-75	98	6	sem	sem	NOUN
gsrj-75	98	7	.	.	PUNCT
gsrj-75	99	1	33	33	NUM
gsrj-75	99	2	..	..	SYM
gsrj-75	99	3	44	44	NUM
gsrj-75	99	4	ppccrr	ppccrr	NOUN
gsrj-75	99	5	aannaallyyssiiss	aannaallyyssiiss	PROPN
gsrj-75	99	6	ddiidd	ddiidd	PROPN
gsrj-75	99	7	nnoott	nnoott	AUX
gsrj-75	99	8	sshhooww	sshhooww	PROPN
gsrj-75	99	9	ssiiggnniiffiiccaanntt	ssiiggnniiffiiccaanntt	PROPN
gsrj-75	99	10	ddiiffffeerreennttiiaall	ddiiffffeerreennttiiaall	PROPN
gsrj-75	99	11	eexxpprreessssiioonn	eexxpprreessssiioonn	PROPN
gsrj-75	99	12	ooff	ooff	PROPN
gsrj-75	99	13	ggeenneess	ggeenneess	NOUN
gsrj-75	99	14	ooff	ooff	ADP
gsrj-75	100	1	iinntteerreesstt	iinntteerreesstt	NOUN
gsrj-75	100	2	analysis	analysis	NOUN
gsrj-75	100	3	of	of	ADP
gsrj-75	100	4	col1a1	col1a1	NOUN
gsrj-75	100	5	,	,	PUNCT
gsrj-75	100	6	col3a1	col3a1	NOUN
gsrj-75	100	7	,	,	PUNCT
gsrj-75	100	8	and	and	CCONJ
gsrj-75	100	9	tgfb1	tgfb1	VERB
gsrj-75	100	10	qrt	qrt	ADJ
gsrj-75	100	11	-	-	PUNCT
gsrj-75	100	12	pcr	pcr	ADJ
gsrj-75	100	13	data	datum	NOUN
gsrj-75	100	14	between	between	ADP
gsrj-75	100	15	the	the	DET
gsrj-75	100	16	normal	normal	ADJ
gsrj-75	100	17	skin	skin	NOUN
gsrj-75	100	18	and	and	CCONJ
gsrj-75	100	19	treated	treat	VERB
gsrj-75	100	20	zone	zone	NOUN
gsrj-75	100	21	skin	skin	NOUN
gsrj-75	100	22	for	for	ADP
gsrj-75	100	23	each	each	DET
gsrj-75	100	24	group	group	NOUN
gsrj-75	100	25	did	do	AUX
gsrj-75	100	26	not	not	PART
gsrj-75	100	27	show	show	VERB
gsrj-75	100	28	any	any	DET
gsrj-75	100	29	significant	significant	ADJ
gsrj-75	100	30	differential	differential	ADJ
gsrj-75	100	31	expression	expression	NOUN
gsrj-75	100	32	(	(	PUNCT
gsrj-75	100	33	figure	figure	NOUN
gsrj-75	100	34	5a	5a	NUM
gsrj-75	100	35	-	-	PUNCT
gsrj-75	100	36	c	c	NOUN
gsrj-75	100	37	)	)	PUNCT
gsrj-75	100	38	.	.	PUNCT
gsrj-75	101	1	though	though	SCONJ
gsrj-75	101	2	there	there	PRON
gsrj-75	101	3	was	be	VERB
gsrj-75	101	4	an	an	DET
gsrj-75	101	5	increase	increase	NOUN
gsrj-75	101	6	in	in	ADP
gsrj-75	101	7	expression	expression	NOUN
gsrj-75	101	8	of	of	ADP
gsrj-75	101	9	lgals1	lgals1	NOUN
gsrj-75	101	10	in	in	ADP
gsrj-75	101	11	the	the	DET
gsrj-75	101	12	treated	treat	VERB
gsrj-75	101	13	zone	zone	NOUN
gsrj-75	101	14	skin	skin	NOUN
gsrj-75	101	15	compared	compare	VERB
gsrj-75	101	16	to	to	ADP
gsrj-75	101	17	normal	normal	ADJ
gsrj-75	101	18	skin	skin	NOUN
gsrj-75	101	19	in	in	ADP
gsrj-75	101	20	the	the	DET
gsrj-75	101	21	low	low	ADJ
gsrj-75	101	22	-	-	PUNCT
gsrj-75	101	23	dose	dose	NOUN
gsrj-75	101	24	,	,	PUNCT
gsrj-75	101	25	mid	mid	PROPN
gsrj-75	101	26	-	-	NOUN
gsrj-75	101	27	dose	dose	NOUN
gsrj-75	101	28	,	,	PUNCT
gsrj-75	101	29	and	and	CCONJ
gsrj-75	101	30	highdose	highdose	ADJ
gsrj-75	101	31	mice	mouse	NOUN
gsrj-75	101	32	,	,	PUNCT
gsrj-75	101	33	none	none	NOUN
gsrj-75	101	34	of	of	ADP
gsrj-75	101	35	the	the	DET
gsrj-75	101	36	comparisons	comparison	NOUN
gsrj-75	101	37	reached	reach	VERB
gsrj-75	101	38	significance	significance	NOUN
gsrj-75	101	39	(	(	PUNCT
gsrj-75	101	40	figure	figure	NOUN
gsrj-75	101	41	5d	5d	NUM
gsrj-75	101	42	)	)	PUNCT
gsrj-75	101	43	.	.	PUNCT
gsrj-75	102	1	ffiigguurree	ffiigguurree	PROPN
gsrj-75	102	2	55	55	NUM
gsrj-75	102	3	..	..	PUNCT
gsrj-75	102	4	col1a1	col1a1	NOUN
gsrj-75	102	5	(	(	PUNCT
gsrj-75	102	6	a	a	NOUN
gsrj-75	102	7	)	)	PUNCT
gsrj-75	102	8	,	,	PUNCT
gsrj-75	102	9	col3a1	col3a1	NOUN
gsrj-75	102	10	(	(	PUNCT
gsrj-75	102	11	b	b	NOUN
gsrj-75	102	12	)	)	PUNCT
gsrj-75	102	13	,	,	PUNCT
gsrj-75	102	14	tgfb1	tgfb1	NOUN
gsrj-75	102	15	(	(	PUNCT
gsrj-75	102	16	c	c	NOUN
gsrj-75	102	17	)	)	PUNCT
gsrj-75	102	18	,	,	PUNCT
gsrj-75	102	19	and	and	CCONJ
gsrj-75	102	20	lgals1	lgals1	NOUN
gsrj-75	102	21	(	(	PUNCT
gsrj-75	102	22	d	d	NOUN
gsrj-75	102	23	)	)	PUNCT
gsrj-75	102	24	expression	expression	NOUN
gsrj-75	102	25	in	in	ADP
gsrj-75	102	26	normal	normal	ADJ
gsrj-75	102	27	skin	skin	NOUN
gsrj-75	102	28	compared	compare	VERB
gsrj-75	102	29	to	to	ADP
gsrj-75	102	30	treated	treat	VERB
gsrj-75	102	31	zone	zone	NOUN
gsrj-75	102	32	skin	skin	NOUN
gsrj-75	102	33	for	for	ADP
gsrj-75	102	34	each	each	DET
gsrj-75	102	35	group	group	NOUN
gsrj-75	102	36	.	.	PUNCT
gsrj-75	103	1	rna	rna	PROPN
gsrj-75	103	2	was	be	AUX
gsrj-75	103	3	isolated	isolate	VERB
gsrj-75	103	4	and	and	CCONJ
gsrj-75	103	5	purified	purify	VERB
gsrj-75	103	6	from	from	ADP
gsrj-75	103	7	skin	skin	NOUN
gsrj-75	103	8	biopsies	biopsy	NOUN
gsrj-75	103	9	for	for	ADP
gsrj-75	103	10	confirmatory	confirmatory	NOUN
gsrj-75	103	11	qrt	qrt	ADJ
gsrj-75	103	12	-	-	PUNCT
gsrj-75	103	13	pcr	pcr	NOUN
gsrj-75	103	14	analysis	analysis	NOUN
gsrj-75	103	15	.	.	PUNCT
gsrj-75	104	1	fold	fold	ADJ
gsrj-75	104	2	change	change	NOUN
gsrj-75	104	3	was	be	AUX
gsrj-75	104	4	assessed	assess	VERB
gsrj-75	104	5	using	use	VERB
gsrj-75	104	6	!	!	PUNCT
gsrj-75	104	7	!	!	PUNCT
gsrj-75	105	1	ct	ct	NUM
gsrj-75	105	2	analysis	analysis	NOUN
gsrj-75	105	3	.	.	PUNCT
gsrj-75	106	1	p	p	X
gsrj-75	106	2	<	<	X
gsrj-75	106	3	0.05	0.05	NUM
gsrj-75	106	4	is	be	AUX
gsrj-75	106	5	considered	consider	VERB
gsrj-75	106	6	statistically	statistically	ADV
gsrj-75	106	7	significant	significant	ADJ
gsrj-75	106	8	.	.	PUNCT
gsrj-75	107	1	33	33	NUM
gsrj-75	107	2	..	..	SYM
gsrj-75	107	3	55	55	NUM
gsrj-75	107	4	bblleeoommyycciinn	bblleeoommyycciinn	NOUN
gsrj-75	107	5	ttrreeaattmmeenntt	ttrreeaattmmeenntt	PROPN
gsrj-75	107	6	rreessuulltteedd	rreessuulltteedd	PROPN
gsrj-75	107	7	iinn	iinn	ADJ
gsrj-75	107	8	aarreeaass	aarreeaass	PROPN
gsrj-75	107	9	ooff	ooff	PROPN
gsrj-75	107	10	hhaaiirr	hhaaiirr	PROPN
gsrj-75	107	11	lloossss	lloossss	PROPN
gsrj-75	107	12	wwiitthhiinn	wwiitthhiinn	PROPN
gsrj-75	107	13	tthhee	tthhee	PROPN
gsrj-75	107	14	ttrreeaatteedd	ttrreeaatteedd	PROPN
gsrj-75	107	15	zzoonnee	zzoonnee	NOUN
gsrj-75	107	16	images	image	NOUN
gsrj-75	107	17	taken	take	VERB
gsrj-75	107	18	at	at	ADP
gsrj-75	107	19	the	the	DET
gsrj-75	107	20	terminal	terminal	ADJ
gsrj-75	107	21	timepoint	timepoint	NOUN
gsrj-75	107	22	for	for	ADP
gsrj-75	107	23	each	each	DET
gsrj-75	107	24	mouse	mouse	NOUN
gsrj-75	107	25	revealed	reveal	VERB
gsrj-75	107	26	a	a	DET
gsrj-75	107	27	trend	trend	NOUN
gsrj-75	107	28	of	of	ADP
gsrj-75	107	29	hair	hair	NOUN
gsrj-75	107	30	loss	loss	NOUN
gsrj-75	107	31	within	within	ADP
gsrj-75	107	32	the	the	DET
gsrj-75	107	33	demarcated	demarcate	VERB
gsrj-75	107	34	treated	treat	VERB
gsrj-75	107	35	zone	zone	NOUN
gsrj-75	107	36	for	for	ADP
gsrj-75	107	37	the	the	DET
gsrj-75	107	38	high	high	ADJ
gsrj-75	107	39	-	-	PUNCT
gsrj-75	107	40	dose	dose	NOUN
gsrj-75	107	41	mice	mouse	NOUN
gsrj-75	107	42	(	(	PUNCT
gsrj-75	107	43	figure	figure	NOUN
gsrj-75	107	44	6	6	NUM
gsrj-75	107	45	)	)	PUNCT
gsrj-75	107	46	.	.	PUNCT
gsrj-75	108	1	a	a	DET
gsrj-75	108	2	similar	similar	ADJ
gsrj-75	108	3	pattern	pattern	NOUN
gsrj-75	108	4	of	of	ADP
gsrj-75	108	5	hair	hair	NOUN
gsrj-75	108	6	loss	loss	NOUN
gsrj-75	108	7	was	be	AUX
gsrj-75	108	8	also	also	ADV
gsrj-75	108	9	present	present	ADJ
gsrj-75	108	10	in	in	ADP
gsrj-75	108	11	the	the	DET
gsrj-75	108	12	midand	midand	NOUN
gsrj-75	108	13	low	low	ADV
gsrj-75	108	14	-	-	PUNCT
gsrj-75	108	15	dose	dose	NOUN
gsrj-75	108	16	groups	group	NOUN
gsrj-75	108	17	,	,	PUNCT
gsrj-75	108	18	though	though	SCONJ
gsrj-75	108	19	not	not	PART
gsrj-75	108	20	as	as	ADV
gsrj-75	108	21	prominent	prominent	ADJ
gsrj-75	108	22	and	and	CCONJ
gsrj-75	108	23	widespread	widespread	ADJ
gsrj-75	108	24	.	.	PUNCT
gsrj-75	109	1	control	control	NOUN
gsrj-75	109	2	mice	mouse	NOUN
gsrj-75	109	3	did	do	AUX
gsrj-75	109	4	not	not	PART
gsrj-75	109	5	show	show	VERB
gsrj-75	109	6	any	any	DET
gsrj-75	109	7	evidence	evidence	NOUN
gsrj-75	109	8	of	of	ADP
gsrj-75	109	9	hair	hair	NOUN
gsrj-75	109	10	loss	loss	NOUN
gsrj-75	109	11	within	within	ADP
gsrj-75	109	12	the	the	DET
gsrj-75	109	13	treated	treat	VERB
gsrj-75	109	14	zone	zone	NOUN
gsrj-75	109	15	.	.	PUNCT
gsrj-75	110	1	ffiigguurree	ffiigguurree	NOUN
gsrj-75	110	2	66	66	NUM
gsrj-75	110	3	..	..	PUNCT
gsrj-75	110	4	representative	representative	ADJ
gsrj-75	110	5	images	image	NOUN
gsrj-75	110	6	of	of	ADP
gsrj-75	110	7	the	the	DET
gsrj-75	110	8	dorsal	dorsal	NOUN
gsrj-75	110	9	surface	surface	NOUN
gsrj-75	110	10	of	of	ADP
gsrj-75	110	11	high	high	ADJ
gsrj-75	110	12	-	-	PUNCT
gsrj-75	110	13	dose	dose	NOUN
gsrj-75	110	14	,	,	PUNCT
gsrj-75	110	15	mid	mid	PROPN
gsrj-75	110	16	-	-	ADJ
gsrj-75	110	17	dose	dose	ADJ
gsrj-75	110	18	,	,	PUNCT
gsrj-75	110	19	low	low	ADJ
gsrj-75	110	20	-	-	PUNCT
gsrj-75	110	21	dose	dose	NOUN
gsrj-75	110	22	,	,	PUNCT
gsrj-75	110	23	and	and	CCONJ
gsrj-75	110	24	control	control	NOUN
gsrj-75	110	25	mice	mouse	NOUN
gsrj-75	110	26	at	at	ADP
gsrj-75	110	27	the	the	DET
gsrj-75	110	28	terminal	terminal	ADJ
gsrj-75	110	29	timepoint	timepoint	NOUN
gsrj-75	110	30	.	.	PUNCT
gsrj-75	111	1	red	red	ADJ
gsrj-75	111	2	arrows	arrow	NOUN
gsrj-75	111	3	indicate	indicate	VERB
gsrj-75	111	4	areas	area	NOUN
gsrj-75	111	5	of	of	ADP
gsrj-75	111	6	hair	hair	NOUN
gsrj-75	111	7	loss	loss	NOUN
gsrj-75	111	8	within	within	ADP
gsrj-75	111	9	the	the	DET
gsrj-75	111	10	demarcated	demarcate	VERB
gsrj-75	111	11	treated	treat	VERB
gsrj-75	111	12	zone	zone	NOUN
gsrj-75	111	13	.	.	PUNCT
gsrj-75	112	1	33	33	NUM
gsrj-75	112	2	..	..	SYM
gsrj-75	112	3	66	66	NUM
gsrj-75	112	4	hhiigghh	hhiigghh	NOUN
gsrj-75	112	5	--	--	PUNCT
gsrj-75	112	6	ddoossee	ddoossee	NOUN
gsrj-75	112	7	bblleeoommyycciinn	bblleeoommyycciinn	NOUN
gsrj-75	112	8	nneeggaattiivveellyy	nneeggaattiivveellyy	PROPN
gsrj-75	112	9	aaffffeeccttss	aaffffeeccttss	PROPN
gsrj-75	112	10	mmiiccee	mmiiccee	NOUN
gsrj-75	112	11	wweeiigghhttss	wweeiigghhttss	NOUN
gsrj-75	112	12	all	all	DET
gsrj-75	112	13	mice	mouse	NOUN
gsrj-75	112	14	used	use	VERB
gsrj-75	112	15	in	in	ADP
gsrj-75	112	16	groups	group	NOUN
gsrj-75	112	17	1	1	NUM
gsrj-75	112	18	and	and	CCONJ
gsrj-75	112	19	2	2	NUM
gsrj-75	112	20	were	be	AUX
gsrj-75	112	21	weighed	weigh	VERB
gsrj-75	112	22	daily	daily	ADV
gsrj-75	112	23	throughout	throughout	ADP
gsrj-75	112	24	the	the	DET
gsrj-75	112	25	duration	duration	NOUN
gsrj-75	112	26	of	of	ADP
gsrj-75	112	27	the	the	DET
gsrj-75	112	28	study	study	NOUN
gsrj-75	112	29	.	.	PUNCT
gsrj-75	113	1	group	group	NOUN
gsrj-75	113	2	1	1	NUM
gsrj-75	113	3	high	high	ADJ
gsrj-75	113	4	-	-	PUNCT
gsrj-75	113	5	dose	dose	NOUN
gsrj-75	113	6	mice	mouse	NOUN
gsrj-75	113	7	lost	lose	VERB
gsrj-75	113	8	a	a	DET
gsrj-75	113	9	large	large	ADJ
gsrj-75	113	10	amount	amount	NOUN
gsrj-75	113	11	of	of	ADP
gsrj-75	113	12	weight	weight	NOUN
gsrj-75	113	13	throughout	throughout	ADP
gsrj-75	113	14	the	the	DET
gsrj-75	113	15	study	study	NOUN
gsrj-75	113	16	duration	duration	NOUN
gsrj-75	113	17	,	,	PUNCT
gsrj-75	113	18	ending	end	VERB
gsrj-75	113	19	with	with	ADP
gsrj-75	113	20	a	a	DET
gsrj-75	113	21	percent	percent	NOUN
gsrj-75	113	22	difference	difference	NOUN
gsrj-75	113	23	of	of	ADP
gsrj-75	113	24	-23.6	-23.6	NUM
gsrj-75	113	25	%	%	NOUN
gsrj-75	113	26	at	at	ADP
gsrj-75	113	27	the	the	DET
gsrj-75	113	28	terminal	terminal	ADJ
gsrj-75	113	29	timepoint	timepoint	NOUN
gsrj-75	113	30	compared	compare	VERB
gsrj-75	113	31	to	to	ADP
gsrj-75	113	32	baseline	baseline	VERB
gsrj-75	113	33	measurements	measurement	NOUN
gsrj-75	113	34	(	(	PUNCT
gsrj-75	113	35	figure	figure	NOUN
gsrj-75	113	36	7a	7a	NUM
gsrj-75	113	37	)	)	PUNCT
gsrj-75	113	38	.	.	PUNCT
gsrj-75	114	1	group	group	NOUN
gsrj-75	114	2	1	1	NUM
gsrj-75	114	3	control	control	NOUN
gsrj-75	114	4	mice	mouse	NOUN
gsrj-75	114	5	also	also	ADV
gsrj-75	114	6	dropped	drop	VERB
gsrj-75	114	7	weight	weight	NOUN
gsrj-75	114	8	,	,	PUNCT
gsrj-75	114	9	though	though	SCONJ
gsrj-75	114	10	not	not	PART
gsrj-75	114	11	as	as	ADV
gsrj-75	114	12	severely	severely	ADV
gsrj-75	114	13	(	(	PUNCT
gsrj-75	114	14	-13.4	-13.4	NOUN
gsrj-75	114	15	%	%	NOUN
gsrj-75	114	16	)	)	PUNCT
gsrj-75	114	17	at	at	ADP
gsrj-75	114	18	the	the	DET
gsrj-75	114	19	terminal	terminal	ADJ
gsrj-75	114	20	timepoint	timepoint	NOUN
gsrj-75	114	21	)	)	PUNCT
gsrj-75	114	22	.	.	PUNCT
gsrj-75	115	1	low	low	ADJ
gsrj-75	115	2	-	-	PUNCT
gsrj-75	115	3	and	and	CCONJ
gsrj-75	115	4	mid	mid	ADJ
gsrj-75	115	5	-	-	ADJ
gsrj-75	115	6	dose	dose	ADJ
gsrj-75	115	7	mice	mouse	NOUN
gsrj-75	115	8	weights	weight	NOUN
gsrj-75	115	9	stayed	stay	VERB
gsrj-75	115	10	relatively	relatively	ADV
gsrj-75	115	11	consistent	consistent	ADJ
gsrj-75	115	12	.	.	PUNCT
gsrj-75	116	1	group	group	NOUN
gsrj-75	116	2	2	2	NUM
gsrj-75	116	3	control	control	NOUN
gsrj-75	116	4	,	,	PUNCT
gsrj-75	116	5	low-	low-	X
gsrj-75	116	6	,	,	PUNCT
gsrj-75	116	7	and	and	CCONJ
gsrj-75	116	8	mid	mid	ADJ
gsrj-75	116	9	-	-	ADJ
gsrj-75	116	10	dose	dose	ADJ
gsrj-75	116	11	mice	mouse	NOUN
gsrj-75	116	12	weights	weight	NOUN
gsrj-75	116	13	stayed	stay	VERB
gsrj-75	116	14	relatively	relatively	ADV
gsrj-75	116	15	consistent	consistent	ADJ
gsrj-75	116	16	,	,	PUNCT
gsrj-75	116	17	however	however	ADV
gsrj-75	116	18	high	high	ADJ
gsrj-75	116	19	-	-	PUNCT
gsrj-75	116	20	dose	dose	NOUN
gsrj-75	116	21	mice	mouse	NOUN
gsrj-75	116	22	lost	lose	VERB
gsrj-75	116	23	a	a	DET
gsrj-75	116	24	large	large	ADJ
gsrj-75	116	25	amount	amount	NOUN
gsrj-75	116	26	of	of	ADP
gsrj-75	116	27	weight	weight	NOUN
gsrj-75	116	28	(	(	PUNCT
gsrj-75	116	29	-7.8	-7.8	NOUN
gsrj-75	116	30	%	%	NOUN
gsrj-75	116	31	at	at	ADP
gsrj-75	116	32	the	the	DET
gsrj-75	116	33	terminal	terminal	ADJ
gsrj-75	116	34	timepoint	timepoint	NOUN
gsrj-75	116	35	)	)	PUNCT
gsrj-75	116	36	(	(	PUNCT
gsrj-75	116	37	figure	figure	NOUN
gsrj-75	116	38	7b	7b	NOUN
gsrj-75	116	39	)	)	PUNCT
gsrj-75	116	40	.	.	PUNCT
gsrj-75	117	1	26	26	NUM
gsrj-75	117	2	�	�	PROPN
gsrj-75	117	3	�	�	PROPN
gsrj-75	117	4	�	�	PROPN
gsrj-75	117	5	�	�	PROPN
gsrj-75	117	6	�	�	PROPN
gsrj-75	117	7	�	�	PROPN
gsrj-75	117	8	�	�	PROPN
gsrj-75	117	9	�	�	PROPN
gsrj-75	117	10	�	�	PROPN
gsrj-75	117	11	�	�	PROPN
gsrj-75	117	12	�	�	PROPN
gsrj-75	117	13	�	�	PROPN
gsrj-75	117	14	�	�	PROPN
gsrj-75	117	15	�	�	PROPN
gsrj-75	117	16	�	�	PROPN
gsrj-75	117	17	�	�	PROPN
gsrj-75	117	18	�	�	PROPN
gsrj-75	117	19	�	�	PROPN
gsrj-75	117	20	�	�	PROPN
gsrj-75	117	21	�	�	PROPN
gsrj-75	117	22	�	�	PROPN
gsrj-75	117	23	�	�	PROPN
gsrj-75	117	24	�	�	PROPN
gsrj-75	117	25	�	�	PROPN
gsrj-75	117	26	�	�	PROPN
gsrj-75	117	27	�	�	PROPN
gsrj-75	117	28	�	�	PROPN
gsrj-75	117	29	�	�	PROPN
gsrj-75	117	30	�	�	PROPN
gsrj-75	117	31	�	�	PROPN
gsrj-75	117	32	�	�	PROPN
gsrj-75	117	33	�	�	PROPN
gsrj-75	117	34	�	�	PROPN
gsrj-75	117	35	�	�	PROPN
gsrj-75	117	36	�	�	PROPN
gsrj-75	117	37	�	�	PROPN
gsrj-75	117	38	�	�	PROPN
gsrj-75	117	39	�	�	PROPN
gsrj-75	117	40	ffiigguurree	ffiigguurree	PROPN
gsrj-75	117	41	77	77	NUM
gsrj-75	117	42	..	..	PUNCT
gsrj-75	117	43	mice	mouse	NOUN
gsrj-75	117	44	weights	weight	NOUN
gsrj-75	117	45	for	for	ADP
gsrj-75	117	46	each	each	DET
gsrj-75	117	47	group	group	NOUN
gsrj-75	117	48	throughout	throughout	ADP
gsrj-75	117	49	the	the	DET
gsrj-75	117	50	study	study	NOUN
gsrj-75	117	51	duration	duration	NOUN
gsrj-75	117	52	.	.	PUNCT
gsrj-75	118	1	(	(	PUNCT
gsrj-75	118	2	a	a	X
gsrj-75	118	3	)	)	PUNCT
gsrj-75	118	4	group	group	NOUN
gsrj-75	118	5	1	1	NUM
gsrj-75	118	6	mice	mice	NOUN
gsrj-75	118	7	weights	weight	NOUN
gsrj-75	118	8	.	.	PUNCT
gsrj-75	119	1	(	(	PUNCT
gsrj-75	119	2	b	b	X
gsrj-75	119	3	)	)	PUNCT
gsrj-75	119	4	group	group	NOUN
gsrj-75	119	5	2	2	NUM
gsrj-75	119	6	mice	mouse	NOUN
gsrj-75	119	7	weights	weight	NOUN
gsrj-75	119	8	.	.	PUNCT
gsrj-75	120	1	mice	mouse	NOUN
gsrj-75	120	2	weights	weight	NOUN
gsrj-75	120	3	were	be	AUX
gsrj-75	120	4	obtained	obtain	VERB
gsrj-75	120	5	each	each	DET
gsrj-75	120	6	day	day	NOUN
gsrj-75	120	7	.	.	PUNCT
gsrj-75	121	1	percent	percent	NOUN
gsrj-75	121	2	difference	difference	NOUN
gsrj-75	121	3	calculations	calculation	NOUN
gsrj-75	121	4	were	be	AUX
gsrj-75	121	5	obtained	obtain	VERB
gsrj-75	121	6	by	by	ADP
gsrj-75	121	7	comparing	compare	VERB
gsrj-75	121	8	to	to	ADP
gsrj-75	121	9	initial	initial	ADJ
gsrj-75	121	10	mice	mouse	NOUN
gsrj-75	121	11	weights	weight	NOUN
gsrj-75	121	12	on	on	ADP
gsrj-75	121	13	day	day	NOUN
gsrj-75	121	14	1	1	NUM
gsrj-75	121	15	.	.	PUNCT
gsrj-75	122	1	mice	mouse	NOUN
gsrj-75	122	2	with	with	ADP
gsrj-75	122	3	weight	weight	NOUN
gsrj-75	122	4	loss	loss	NOUN
gsrj-75	122	5	of	of	ADP
gsrj-75	122	6	5	5	NUM
gsrj-75	122	7	%	%	NOUN
gsrj-75	122	8	compared	compare	VERB
gsrj-75	122	9	to	to	ADP
gsrj-75	122	10	their	their	PRON
gsrj-75	122	11	initial	initial	ADJ
gsrj-75	122	12	weight	weight	NOUN
gsrj-75	122	13	or	or	CCONJ
gsrj-75	122	14	with	with	ADP
gsrj-75	122	15	obvious	obvious	ADJ
gsrj-75	122	16	signs	sign	NOUN
gsrj-75	122	17	of	of	ADP
gsrj-75	122	18	distress	distress	NOUN
gsrj-75	122	19	were	be	AUX
gsrj-75	122	20	given	give	VERB
gsrj-75	122	21	a	a	DET
gsrj-75	122	22	1	1	NUM
gsrj-75	122	23	ml	ml	NOUN
gsrj-75	122	24	intraperitoneal	intraperitoneal	ADJ
gsrj-75	122	25	injection	injection	NOUN
gsrj-75	122	26	of	of	ADP
gsrj-75	122	27	lactated	lactated	ADJ
gsrj-75	122	28	ringers	ringer	NOUN
gsrj-75	122	29	daily	daily	ADV
gsrj-75	122	30	in	in	ADP
gsrj-75	122	31	addition	addition	NOUN
gsrj-75	122	32	to	to	ADP
gsrj-75	122	33	dietgel	dietgel	NOUN
gsrj-75	122	34	dietary	dietary	ADJ
gsrj-75	122	35	supplements	supplement	NOUN
gsrj-75	122	36	.	.	PUNCT
gsrj-75	123	1	all	all	DET
gsrj-75	123	2	group	group	NOUN
gsrj-75	123	3	2	2	NUM
gsrj-75	123	4	mice	mouse	NOUN
gsrj-75	123	5	were	be	AUX
gsrj-75	123	6	given	give	VERB
gsrj-75	123	7	dietgels	dietgel	NOUN
gsrj-75	123	8	on	on	ADP
gsrj-75	123	9	day	day	NOUN
gsrj-75	123	10	1	1	NUM
gsrj-75	123	11	prophylactically	prophylactically	ADV
gsrj-75	123	12	.	.	PUNCT
gsrj-75	124	1	values	value	NOUN
gsrj-75	124	2	presented	present	VERB
gsrj-75	124	3	as	as	ADP
gsrj-75	124	4	mean	mean	PROPN
gsrj-75	124	5	±	±	NUM
gsrj-75	124	6	sem	sem	NOUN
gsrj-75	124	7	.	.	PROPN
gsrj-75	125	1	44	44	NUM
gsrj-75	125	2	..	..	PUNCT
gsrj-75	125	3	ddiissccuussssiioonn	ddiissccuussssiioonn	NOUN
gsrj-75	125	4	this	this	DET
gsrj-75	125	5	study	study	NOUN
gsrj-75	125	6	aimed	aim	VERB
gsrj-75	125	7	to	to	PART
gsrj-75	125	8	confirm	confirm	VERB
gsrj-75	125	9	the	the	DET
gsrj-75	125	10	experimental	experimental	ADJ
gsrj-75	125	11	methods	method	NOUN
gsrj-75	125	12	of	of	ADP
gsrj-75	125	13	a	a	DET
gsrj-75	125	14	previously	previously	ADV
gsrj-75	125	15	proven	prove	VERB
gsrj-75	125	16	model	model	NOUN
gsrj-75	125	17	of	of	ADP
gsrj-75	125	18	bleomycin	bleomycin	PROPN
gsrj-75	125	19	-	-	PUNCT
gsrj-75	125	20	induced	induce	VERB
gsrj-75	125	21	dermal	dermal	ADJ
gsrj-75	125	22	fibrosis	fibrosis	NOUN
gsrj-75	125	23	in	in	ADP
gsrj-75	125	24	mice	mouse	NOUN
gsrj-75	125	25	within	within	ADP
gsrj-75	125	26	our	our	PRON
gsrj-75	125	27	laboratory	laboratory	NOUN
gsrj-75	125	28	.	.	PUNCT
gsrj-75	126	1	the	the	DET
gsrj-75	126	2	eventual	eventual	ADJ
gsrj-75	126	3	goal	goal	NOUN
gsrj-75	126	4	of	of	ADP
gsrj-75	126	5	being	be	AUX
gsrj-75	126	6	able	able	ADJ
gsrj-75	126	7	to	to	PART
gsrj-75	126	8	synthetically	synthetically	ADV
gsrj-75	126	9	induce	induce	VERB
gsrj-75	126	10	dermal	dermal	NOUN
gsrj-75	126	11	fibrosis	fibrosis	NOUN
gsrj-75	126	12	is	be	AUX
gsrj-75	126	13	to	to	PART
gsrj-75	126	14	ascertain	ascertain	VERB
gsrj-75	126	15	if	if	SCONJ
gsrj-75	126	16	there	there	PRON
gsrj-75	126	17	is	be	VERB
gsrj-75	126	18	a	a	DET
gsrj-75	126	19	causal	causal	ADJ
gsrj-75	126	20	relationship	relationship	NOUN
gsrj-75	126	21	between	between	ADP
gsrj-75	126	22	dermal	dermal	ADJ
gsrj-75	126	23	fibrosis	fibrosis	NOUN
gsrj-75	126	24	and	and	CCONJ
gsrj-75	126	25	epidermal	epidermal	ADJ
gsrj-75	126	26	dyschromia	dyschromia	NOUN
gsrj-75	126	27	.	.	PUNCT
gsrj-75	127	1	following	follow	VERB
gsrj-75	127	2	regular	regular	ADJ
gsrj-75	127	3	injections	injection	NOUN
gsrj-75	127	4	of	of	ADP
gsrj-75	127	5	three	three	NUM
gsrj-75	127	6	different	different	ADJ
gsrj-75	127	7	bleomycin	bleomycin	NOUN
gsrj-75	127	8	doses	dose	NOUN
gsrj-75	127	9	and	and	CCONJ
gsrj-75	127	10	saline	saline	ADJ
gsrj-75	127	11	control	control	NOUN
gsrj-75	127	12	into	into	ADP
gsrj-75	127	13	the	the	DET
gsrj-75	127	14	dorsal	dorsal	NOUN
gsrj-75	127	15	skin	skin	NOUN
gsrj-75	127	16	of	of	ADP
gsrj-75	127	17	c57	c57	NOUN
gsrj-75	127	18	-	-	PUNCT
gsrj-75	127	19	bl/6	bl/6	NOUN
gsrj-75	127	20	mice	mouse	NOUN
gsrj-75	127	21	,	,	PUNCT
gsrj-75	127	22	data	datum	NOUN
gsrj-75	127	23	from	from	ADP
gsrj-75	127	24	non	non	ADJ
gsrj-75	127	25	-	-	ADJ
gsrj-75	127	26	invasive	invasive	ADJ
gsrj-75	127	27	skin	skin	NOUN
gsrj-75	127	28	probes	probe	NOUN
gsrj-75	127	29	,	,	PUNCT
gsrj-75	127	30	histological	histological	ADJ
gsrj-75	127	31	analysis	analysis	NOUN
gsrj-75	127	32	,	,	PUNCT
gsrj-75	127	33	and	and	CCONJ
gsrj-75	127	34	qrt	qrt	ADJ
gsrj-75	127	35	-	-	PUNCT
gsrj-75	127	36	pcr	pcr	ADJ
gsrj-75	127	37	analysis	analysis	NOUN
gsrj-75	127	38	were	be	AUX
gsrj-75	127	39	used	use	VERB
gsrj-75	127	40	to	to	PART
gsrj-75	127	41	determine	determine	VERB
gsrj-75	127	42	if	if	SCONJ
gsrj-75	127	43	bleomycin	bleomycin	PROPN
gsrj-75	127	44	injection	injection	NOUN
gsrj-75	127	45	induced	induce	VERB
gsrj-75	127	46	dermal	dermal	NOUN
gsrj-75	127	47	fibrosis	fibrosis	NOUN
gsrj-75	127	48	.	.	PUNCT
gsrj-75	128	1	one	one	NUM
gsrj-75	128	2	of	of	ADP
gsrj-75	128	3	the	the	DET
gsrj-75	128	4	more	more	ADV
gsrj-75	128	5	promising	promising	ADJ
gsrj-75	128	6	markers	marker	NOUN
gsrj-75	128	7	of	of	ADP
gsrj-75	128	8	skin	skin	NOUN
gsrj-75	128	9	fibrosis	fibrosis	NOUN
gsrj-75	128	10	is	be	AUX
gsrj-75	128	11	known	know	VERB
gsrj-75	128	12	to	to	PART
gsrj-75	128	13	be	be	AUX
gsrj-75	128	14	skin	skin	NOUN
gsrj-75	128	15	elasticity.17	elasticity.17	PROPN
gsrj-75	128	16	elasticity	elasticity	NOUN
gsrj-75	128	17	measurements	measurement	NOUN
gsrj-75	128	18	were	be	AUX
gsrj-75	128	19	collected	collect	VERB
gsrj-75	128	20	by	by	ADP
gsrj-75	128	21	non	non	ADJ
gsrj-75	128	22	-	-	ADJ
gsrj-75	128	23	invasive	invasive	ADJ
gsrj-75	128	24	skin	skin	NOUN
gsrj-75	128	25	probes	probe	NOUN
gsrj-75	128	26	throughout	throughout	ADP
gsrj-75	128	27	the	the	DET
gsrj-75	128	28	duration	duration	NOUN
gsrj-75	128	29	of	of	ADP
gsrj-75	128	30	this	this	DET
gsrj-75	128	31	study	study	NOUN
gsrj-75	128	32	.	.	PUNCT
gsrj-75	129	1	analysis	analysis	NOUN
gsrj-75	129	2	of	of	ADP
gsrj-75	129	3	probe	probe	NOUN
gsrj-75	129	4	data	datum	NOUN
gsrj-75	129	5	showed	show	VERB
gsrj-75	129	6	a	a	DET
gsrj-75	129	7	significant	significant	ADJ
gsrj-75	129	8	decrease	decrease	NOUN
gsrj-75	129	9	in	in	ADP
gsrj-75	129	10	skin	skin	NOUN
gsrj-75	129	11	elasticity	elasticity	NOUN
gsrj-75	129	12	at	at	ADP
gsrj-75	129	13	the	the	DET
gsrj-75	129	14	terminal	terminal	ADJ
gsrj-75	129	15	timepoint	timepoint	NOUN
gsrj-75	129	16	compared	compare	VERB
gsrj-75	129	17	to	to	PART
gsrj-75	129	18	baseline	baseline	VERB
gsrj-75	129	19	measurements	measurement	NOUN
gsrj-75	129	20	for	for	ADP
gsrj-75	129	21	high	high	ADV
gsrj-75	129	22	-	-	PUNCT
gsrj-75	129	23	dose	dose	NOUN
gsrj-75	129	24	and	and	CCONJ
gsrj-75	129	25	low	low	ADJ
gsrj-75	129	26	-	-	PUNCT
gsrj-75	129	27	dose	dose	NOUN
gsrj-75	129	28	groups	group	NOUN
gsrj-75	129	29	,	,	PUNCT
gsrj-75	129	30	suggesting	suggest	VERB
gsrj-75	129	31	an	an	DET
gsrj-75	129	32	increased	increase	VERB
gsrj-75	129	33	skin	skin	NOUN
gsrj-75	129	34	thickness	thickness	NOUN
gsrj-75	129	35	characteristic	characteristic	NOUN
gsrj-75	129	36	of	of	ADP
gsrj-75	129	37	dermal	dermal	ADJ
gsrj-75	129	38	fibrosis	fibrosis	NOUN
gsrj-75	129	39	.	.	PUNCT
gsrj-75	130	1	interestingly	interestingly	ADV
gsrj-75	130	2	,	,	PUNCT
gsrj-75	130	3	the	the	DET
gsrj-75	130	4	mid	mid	ADJ
gsrj-75	130	5	-	-	ADJ
gsrj-75	130	6	dose	dose	ADJ
gsrj-75	130	7	group	group	NOUN
gsrj-75	130	8	did	do	AUX
gsrj-75	130	9	not	not	PART
gsrj-75	130	10	show	show	VERB
gsrj-75	130	11	any	any	DET
gsrj-75	130	12	significant	significant	ADJ
gsrj-75	130	13	difference	difference	NOUN
gsrj-75	130	14	in	in	ADP
gsrj-75	130	15	elasticity	elasticity	NOUN
gsrj-75	130	16	.	.	PUNCT
gsrj-75	131	1	one	one	NUM
gsrj-75	131	2	explanation	explanation	NOUN
gsrj-75	131	3	for	for	ADP
gsrj-75	131	4	this	this	DET
gsrj-75	131	5	finding	finding	NOUN
gsrj-75	131	6	is	be	AUX
gsrj-75	131	7	that	that	SCONJ
gsrj-75	131	8	the	the	DET
gsrj-75	131	9	mid	mid	ADJ
gsrj-75	131	10	-	-	ADJ
gsrj-75	131	11	dose	dose	ADJ
gsrj-75	131	12	mice	mouse	NOUN
gsrj-75	131	13	had	have	VERB
gsrj-75	131	14	an	an	DET
gsrj-75	131	15	increased	increase	VERB
gsrj-75	131	16	presence	presence	NOUN
gsrj-75	131	17	of	of	ADP
gsrj-75	131	18	self	self	NOUN
gsrj-75	131	19	-	-	PUNCT
gsrj-75	131	20	mutilated	mutilate	VERB
gsrj-75	131	21	skin	skin	NOUN
gsrj-75	131	22	(	(	PUNCT
gsrj-75	131	23	caused	cause	VERB
gsrj-75	131	24	by	by	ADP
gsrj-75	131	25	stress	stress	NOUN
gsrj-75	131	26	,	,	PUNCT
gsrj-75	131	27	irritation	irritation	NOUN
gsrj-75	131	28	,	,	PUNCT
gsrj-75	131	29	etc	etc	X
gsrj-75	131	30	.	.	X
gsrj-75	131	31	)	)	PUNCT
gsrj-75	131	32	which	which	PRON
gsrj-75	131	33	could	could	AUX
gsrj-75	131	34	have	have	AUX
gsrj-75	131	35	affected	affect	VERB
gsrj-75	131	36	elasticity	elasticity	NOUN
gsrj-75	131	37	measurements	measurement	NOUN
gsrj-75	131	38	.	.	PUNCT
gsrj-75	132	1	imaging	imaging	NOUN
gsrj-75	132	2	of	of	ADP
gsrj-75	132	3	h&e	h&e	PROPN
gsrj-75	132	4	-	-	PUNCT
gsrj-75	132	5	stained	stain	VERB
gsrj-75	132	6	skin	skin	NOUN
gsrj-75	132	7	biopsies	biopsy	NOUN
gsrj-75	132	8	showed	show	VERB
gsrj-75	132	9	clear	clear	ADJ
gsrj-75	132	10	epidermal	epidermal	ADJ
gsrj-75	132	11	and	and	CCONJ
gsrj-75	132	12	dermal	dermal	VERB
gsrj-75	132	13	thickening	thickening	NOUN
gsrj-75	132	14	indicative	indicative	ADJ
gsrj-75	132	15	of	of	ADP
gsrj-75	132	16	fibrotic	fibrotic	ADJ
gsrj-75	132	17	architecture	architecture	NOUN
gsrj-75	132	18	in	in	ADP
gsrj-75	132	19	the	the	DET
gsrj-75	132	20	high	high	ADJ
gsrj-75	132	21	-	-	PUNCT
gsrj-75	132	22	dose	dose	NOUN
gsrj-75	132	23	,	,	PUNCT
gsrj-75	132	24	mid	mid	PROPN
gsrj-75	132	25	-	-	NOUN
gsrj-75	132	26	dose	dose	ADJ
gsrj-75	132	27	,	,	PUNCT
gsrj-75	132	28	and	and	CCONJ
gsrj-75	132	29	low	low	ADJ
gsrj-75	132	30	-	-	PUNCT
gsrj-75	132	31	dose	dose	NOUN
gsrj-75	132	32	mice	mouse	NOUN
gsrj-75	132	33	,	,	PUNCT
gsrj-75	132	34	though	though	SCONJ
gsrj-75	132	35	less	less	ADV
gsrj-75	132	36	prominent	prominent	ADJ
gsrj-75	132	37	in	in	ADP
gsrj-75	132	38	the	the	DET
gsrj-75	132	39	latter	latter	ADJ
gsrj-75	132	40	two	two	NUM
gsrj-75	132	41	groups	group	NOUN
gsrj-75	132	42	.	.	PUNCT
gsrj-75	133	1	differences	difference	NOUN
gsrj-75	133	2	in	in	ADP
gsrj-75	133	3	treated	treat	VERB
gsrj-75	133	4	zone	zone	NOUN
gsrj-75	133	5	versus	versus	ADP
gsrj-75	133	6	normal	normal	ADJ
gsrj-75	133	7	skin	skin	NOUN
gsrj-75	133	8	thickness	thickness	NOUN
gsrj-75	133	9	might	might	AUX
gsrj-75	133	10	not	not	PART
gsrj-75	133	11	have	have	AUX
gsrj-75	133	12	reached	reach	VERB
gsrj-75	133	13	significance	significance	NOUN
gsrj-75	133	14	due	due	ADP
gsrj-75	133	15	to	to	ADP
gsrj-75	133	16	improper	improper	ADJ
gsrj-75	133	17	collection	collection	NOUN
gsrj-75	133	18	of	of	ADP
gsrj-75	133	19	normal	normal	ADJ
gsrj-75	133	20	skin	skin	NOUN
gsrj-75	133	21	.	.	PUNCT
gsrj-75	134	1	normal	normal	ADJ
gsrj-75	134	2	skin	skin	NOUN
gsrj-75	134	3	was	be	AUX
gsrj-75	134	4	collected	collect	VERB
gsrj-75	134	5	directly	directly	ADV
gsrj-75	134	6	outside	outside	ADV
gsrj-75	134	7	of	of	ADP
gsrj-75	134	8	the	the	DET
gsrj-75	134	9	2	2	NUM
gsrj-75	134	10	cm	cm	NOUN
gsrj-75	134	11	x	x	SYM
gsrj-75	134	12	2	2	NUM
gsrj-75	134	13	cm	cm	NOUN
gsrj-75	134	14	demarcated	demarcate	VERB
gsrj-75	134	15	outer	outer	ADJ
gsrj-75	134	16	square	square	NOUN
gsrj-75	134	17	.	.	PUNCT
gsrj-75	135	1	as	as	ADP
gsrj-75	135	2	a	a	DET
gsrj-75	135	3	result	result	NOUN
gsrj-75	135	4	,	,	PUNCT
gsrj-75	135	5	some	some	PRON
gsrj-75	135	6	of	of	ADP
gsrj-75	135	7	the	the	DET
gsrj-75	135	8	bleomycin	bleomycin	PROPN
gsrj-75	135	9	could	could	AUX
gsrj-75	135	10	have	have	AUX
gsrj-75	135	11	spread	spread	VERB
gsrj-75	135	12	outside	outside	ADV
gsrj-75	135	13	of	of	ADP
gsrj-75	135	14	the	the	DET
gsrj-75	135	15	demarcated	demarcate	VERB
gsrj-75	135	16	injection	injection	NOUN
gsrj-75	135	17	site	site	NOUN
gsrj-75	135	18	and	and	CCONJ
gsrj-75	135	19	caused	cause	VERB
gsrj-75	135	20	changes	change	NOUN
gsrj-75	135	21	to	to	ADP
gsrj-75	135	22	the	the	DET
gsrj-75	135	23	skin	skin	NOUN
gsrj-75	135	24	outside	outside	ADP
gsrj-75	135	25	of	of	ADP
gsrj-75	135	26	the	the	DET
gsrj-75	135	27	treated	treat	VERB
gsrj-75	135	28	zone	zone	NOUN
gsrj-75	135	29	,	,	PUNCT
gsrj-75	135	30	potentially	potentially	ADV
gsrj-75	135	31	influencing	influence	VERB
gsrj-75	135	32	skin	skin	NOUN
gsrj-75	135	33	thickness	thickness	NOUN
gsrj-75	135	34	measurements	measurement	NOUN
gsrj-75	135	35	.	.	PUNCT
gsrj-75	136	1	collection	collection	NOUN
gsrj-75	136	2	of	of	ADP
gsrj-75	136	3	normal	normal	ADJ
gsrj-75	136	4	skin	skin	NOUN
gsrj-75	136	5	further	far	ADV
gsrj-75	136	6	away	away	ADV
gsrj-75	136	7	from	from	ADP
gsrj-75	136	8	the	the	DET
gsrj-75	136	9	treated	treat	VERB
gsrj-75	136	10	zone	zone	NOUN
gsrj-75	136	11	should	should	AUX
gsrj-75	136	12	be	be	AUX
gsrj-75	136	13	performed	perform	VERB
gsrj-75	136	14	in	in	ADP
gsrj-75	136	15	future	future	ADJ
gsrj-75	136	16	studies	study	NOUN
gsrj-75	136	17	to	to	PART
gsrj-75	136	18	account	account	VERB
gsrj-75	136	19	for	for	ADP
gsrj-75	136	20	this	this	DET
gsrj-75	136	21	problem	problem	NOUN
gsrj-75	136	22	.	.	PUNCT
gsrj-75	137	1	highdose	highdose	ADJ
gsrj-75	137	2	skin	skin	NOUN
gsrj-75	137	3	biopsies	biopsy	NOUN
gsrj-75	137	4	showed	show	VERB
gsrj-75	137	5	clear	clear	ADJ
gsrj-75	137	6	obliteration	obliteration	NOUN
gsrj-75	137	7	of	of	ADP
gsrj-75	137	8	hair	hair	NOUN
gsrj-75	137	9	follicles	follicle	NOUN
gsrj-75	137	10	in	in	ADP
gsrj-75	137	11	the	the	DET
gsrj-75	137	12	dermis	dermis	NOUN
gsrj-75	137	13	caused	cause	VERB
gsrj-75	137	14	by	by	ADP
gsrj-75	137	15	the	the	DET
gsrj-75	137	16	bleomycin	bleomycin	PROPN
gsrj-75	137	17	treatment	treatment	NOUN
gsrj-75	137	18	,	,	PUNCT
gsrj-75	137	19	providing	provide	VERB
gsrj-75	137	20	further	further	ADJ
gsrj-75	137	21	evidence	evidence	NOUN
gsrj-75	137	22	supporting	support	VERB
gsrj-75	137	23	the	the	DET
gsrj-75	137	24	efficacy	efficacy	NOUN
gsrj-75	137	25	of	of	ADP
gsrj-75	137	26	the	the	DET
gsrj-75	137	27	drug	drug	NOUN
gsrj-75	137	28	.	.	PUNCT
gsrj-75	138	1	hair	hair	NOUN
gsrj-75	138	2	loss	loss	NOUN
gsrj-75	138	3	within	within	ADP
gsrj-75	138	4	the	the	DET
gsrj-75	138	5	treated	treat	VERB
gsrj-75	138	6	zone	zone	NOUN
gsrj-75	138	7	could	could	AUX
gsrj-75	138	8	also	also	ADV
gsrj-75	138	9	be	be	AUX
gsrj-75	138	10	seen	see	VERB
gsrj-75	138	11	on	on	ADP
gsrj-75	138	12	the	the	DET
gsrj-75	138	13	images	image	NOUN
gsrj-75	138	14	taken	take	VERB
gsrj-75	138	15	of	of	ADP
gsrj-75	138	16	the	the	DET
gsrj-75	138	17	dorsal	dorsal	NOUN
gsrj-75	138	18	surface	surface	NOUN
gsrj-75	138	19	of	of	ADP
gsrj-75	138	20	the	the	DET
gsrj-75	138	21	bleomycin	bleomycin	PROPN
gsrj-75	138	22	-	-	PUNCT
gsrj-75	138	23	treated	treat	VERB
gsrj-75	138	24	groups	group	NOUN
gsrj-75	138	25	.	.	PUNCT
gsrj-75	139	1	collected	collect	VERB
gsrj-75	139	2	qrt	qrt	ADJ
gsrj-75	139	3	-	-	PUNCT
gsrj-75	139	4	pcr	pcr	ADJ
gsrj-75	139	5	data	datum	NOUN
gsrj-75	139	6	did	do	AUX
gsrj-75	139	7	not	not	PART
gsrj-75	139	8	show	show	VERB
gsrj-75	139	9	any	any	DET
gsrj-75	139	10	statistically	statistically	ADV
gsrj-75	139	11	significant	significant	ADJ
gsrj-75	139	12	differences	difference	NOUN
gsrj-75	139	13	in	in	ADP
gsrj-75	139	14	differential	differential	ADJ
gsrj-75	139	15	expression	expression	NOUN
gsrj-75	139	16	in	in	ADP
gsrj-75	139	17	the	the	DET
gsrj-75	139	18	treated	treat	VERB
gsrj-75	139	19	zone	zone	NOUN
gsrj-75	139	20	skin	skin	NOUN
gsrj-75	139	21	compared	compare	VERB
gsrj-75	139	22	to	to	ADP
gsrj-75	139	23	the	the	DET
gsrj-75	139	24	normal	normal	ADJ
gsrj-75	139	25	skin	skin	NOUN
gsrj-75	139	26	for	for	ADP
gsrj-75	139	27	genes	gene	NOUN
gsrj-75	139	28	of	of	ADP
gsrj-75	139	29	interest	interest	NOUN
gsrj-75	139	30	.	.	PUNCT
gsrj-75	140	1	a	a	DET
gsrj-75	140	2	potential	potential	ADJ
gsrj-75	140	3	explanation	explanation	NOUN
gsrj-75	140	4	for	for	ADP
gsrj-75	140	5	this	this	DET
gsrj-75	140	6	lack	lack	NOUN
gsrj-75	140	7	of	of	ADP
gsrj-75	140	8	significance	significance	NOUN
gsrj-75	140	9	is	be	AUX
gsrj-75	140	10	that	that	SCONJ
gsrj-75	140	11	the	the	DET
gsrj-75	140	12	bleomycin	bleomycin	NOUN
gsrj-75	140	13	destroyed	destroy	VERB
gsrj-75	140	14	tissue	tissue	NOUN
gsrj-75	140	15	architecture	architecture	NOUN
gsrj-75	140	16	and	and	CCONJ
gsrj-75	140	17	cellular	cellular	ADJ
gsrj-75	140	18	function	function	NOUN
gsrj-75	140	19	to	to	ADP
gsrj-75	140	20	such	such	DET
gsrj-75	140	21	an	an	DET
gsrj-75	140	22	extent	extent	NOUN
gsrj-75	140	23	that	that	SCONJ
gsrj-75	140	24	cells	cell	NOUN
gsrj-75	140	25	were	be	AUX
gsrj-75	140	26	unable	unable	ADJ
gsrj-75	140	27	to	to	PART
gsrj-75	140	28	undergo	undergo	VERB
gsrj-75	140	29	gene	gene	NOUN
gsrj-75	140	30	transcription	transcription	NOUN
gsrj-75	140	31	.	.	PUNCT
gsrj-75	141	1	however	however	ADV
gsrj-75	141	2	,	,	PUNCT
gsrj-75	141	3	an	an	DET
gsrj-75	141	4	increase	increase	NOUN
gsrj-75	141	5	in	in	ADP
gsrj-75	141	6	expression	expression	NOUN
gsrj-75	141	7	of	of	ADP
gsrj-75	141	8	lgals1	lgals1	NOUN
gsrj-75	141	9	in	in	ADP
gsrj-75	141	10	the	the	DET
gsrj-75	141	11	low-	low-	NOUN
gsrj-75	141	12	,	,	PUNCT
gsrj-75	141	13	mid-	mid-	ADJ
gsrj-75	141	14	,	,	PUNCT
gsrj-75	141	15	and	and	CCONJ
gsrj-75	141	16	high	high	ADJ
gsrj-75	141	17	-	-	PUNCT
gsrj-75	141	18	dose	dose	NOUN
gsrj-75	141	19	mice	mouse	NOUN
gsrj-75	141	20	was	be	AUX
gsrj-75	141	21	observed	observe	VERB
gsrj-75	141	22	.	.	PUNCT
gsrj-75	142	1	increased	increase	VERB
gsrj-75	142	2	presence	presence	NOUN
gsrj-75	142	3	of	of	ADP
gsrj-75	142	4	lgals1	lgals1	NOUN
gsrj-75	142	5	provided	provide	VERB
gsrj-75	142	6	some	some	DET
gsrj-75	142	7	molecular	molecular	ADJ
gsrj-75	142	8	evidence	evidence	NOUN
gsrj-75	142	9	of	of	ADP
gsrj-75	142	10	fibrotic	fibrotic	ADJ
gsrj-75	142	11	development	development	NOUN
gsrj-75	142	12	within	within	ADP
gsrj-75	142	13	the	the	DET
gsrj-75	142	14	treated	treat	VERB
gsrj-75	142	15	zone	zone	NOUN
gsrj-75	142	16	,	,	PUNCT
gsrj-75	142	17	though	though	SCONJ
gsrj-75	142	18	perhaps	perhaps	ADV
gsrj-75	142	19	other	other	ADJ
gsrj-75	142	20	genes	gene	NOUN
gsrj-75	142	21	should	should	AUX
gsrj-75	142	22	be	be	AUX
gsrj-75	142	23	assessed	assess	VERB
gsrj-75	142	24	for	for	ADP
gsrj-75	142	25	further	further	ADJ
gsrj-75	142	26	confirmation	confirmation	NOUN
gsrj-75	142	27	of	of	ADP
gsrj-75	142	28	fibrosis.18	fibrosis.18	NOUN
gsrj-75	142	29	in	in	ADP
gsrj-75	142	30	future	future	ADJ
gsrj-75	142	31	work	work	NOUN
gsrj-75	142	32	,	,	PUNCT
gsrj-75	142	33	immunofluorescence	immunofluorescence	NOUN
gsrj-75	142	34	visualization	visualization	NOUN
gsrj-75	142	35	of	of	ADP
gsrj-75	142	36	�	�	NOUN
gsrj-75	142	37	-sma	-sma	ADJ
gsrj-75	142	38	-	-	PUNCT
gsrj-75	142	39	positive	positive	ADJ
gsrj-75	142	40	myofibroblasts	myofibroblast	NOUN
gsrj-75	142	41	should	should	AUX
gsrj-75	142	42	be	be	AUX
gsrj-75	142	43	conducted	conduct	VERB
gsrj-75	142	44	and	and	CCONJ
gsrj-75	142	45	assessed	assess	VERB
gsrj-75	142	46	for	for	ADP
gsrj-75	142	47	further	further	ADJ
gsrj-75	142	48	molecular	molecular	ADJ
gsrj-75	142	49	confirmation.19	confirmation.19	NOUN
gsrj-75	142	50	in	in	ADP
gsrj-75	142	51	addition	addition	NOUN
gsrj-75	142	52	to	to	ADP
gsrj-75	142	53	affecting	affect	VERB
gsrj-75	142	54	the	the	DET
gsrj-75	142	55	dermal	dermal	NOUN
gsrj-75	142	56	and	and	CCONJ
gsrj-75	142	57	epidermal	epidermal	ADJ
gsrj-75	142	58	histoarchitecture	histoarchitecture	NOUN
gsrj-75	142	59	of	of	ADP
gsrj-75	142	60	the	the	DET
gsrj-75	142	61	mice	mouse	NOUN
gsrj-75	142	62	,	,	PUNCT
gsrj-75	142	63	bleomycin	bleomycin	PROPN
gsrj-75	142	64	also	also	ADV
gsrj-75	142	65	seemed	seem	VERB
gsrj-75	142	66	to	to	PART
gsrj-75	142	67	have	have	VERB
gsrj-75	142	68	systemic	systemic	ADJ
gsrj-75	142	69	effects	effect	NOUN
gsrj-75	142	70	on	on	ADP
gsrj-75	142	71	the	the	DET
gsrj-75	142	72	mice	mouse	NOUN
gsrj-75	142	73	as	as	SCONJ
gsrj-75	142	74	observed	observe	VERB
gsrj-75	142	75	by	by	ADP
gsrj-75	142	76	changes	change	NOUN
gsrj-75	142	77	in	in	ADP
gsrj-75	142	78	their	their	PRON
gsrj-75	142	79	weights	weight	NOUN
gsrj-75	142	80	.	.	PUNCT
gsrj-75	143	1	group	group	NOUN
gsrj-75	143	2	1	1	NUM
gsrj-75	143	3	high	high	ADJ
gsrj-75	143	4	-	-	PUNCT
gsrj-75	143	5	dose	dose	NOUN
gsrj-75	143	6	mice	mouse	NOUN
gsrj-75	143	7	were	be	AUX
gsrj-75	143	8	injected	inject	VERB
gsrj-75	143	9	with	with	ADP
gsrj-75	143	10	a	a	DET
gsrj-75	143	11	5	5	NUM
gsrj-75	143	12	u	u	NOUN
gsrj-75	143	13	/	/	SYM
gsrj-75	143	14	ml	ml	NOUN
gsrj-75	143	15	concentration	concentration	NOUN
gsrj-75	143	16	of	of	ADP
gsrj-75	143	17	bleomycin	bleomycin	PROPN
gsrj-75	143	18	,	,	PUNCT
gsrj-75	143	19	whereas	whereas	SCONJ
gsrj-75	143	20	group	group	NOUN
gsrj-75	143	21	2	2	NUM
gsrj-75	143	22	high	high	ADJ
gsrj-75	143	23	-	-	PUNCT
gsrj-75	143	24	dose	dose	NOUN
gsrj-75	143	25	mice	mouse	NOUN
gsrj-75	143	26	were	be	AUX
gsrj-75	143	27	injected	inject	VERB
gsrj-75	143	28	with	with	ADP
gsrj-75	143	29	a	a	DET
gsrj-75	143	30	2.5	2.5	NUM
gsrj-75	143	31	u	u	NOUN
gsrj-75	143	32	/	/	SYM
gsrj-75	143	33	ml	ml	NOUN
gsrj-75	143	34	concentration	concentration	NOUN
gsrj-75	143	35	.	.	PUNCT
gsrj-75	144	1	these	these	DET
gsrj-75	144	2	dosages	dosage	NOUN
gsrj-75	144	3	were	be	AUX
gsrj-75	144	4	arbitrarily	arbitrarily	ADV
gsrj-75	144	5	chosen	choose	VERB
gsrj-75	144	6	and	and	CCONJ
gsrj-75	144	7	were	be	AUX
gsrj-75	144	8	not	not	PART
gsrj-75	144	9	based	base	VERB
gsrj-75	144	10	on	on	ADP
gsrj-75	144	11	previously	previously	ADV
gsrj-75	144	12	proven	prove	VERB
gsrj-75	144	13	models	model	NOUN
gsrj-75	144	14	as	as	SCONJ
gsrj-75	144	15	the	the	DET
gsrj-75	144	16	literature	literature	NOUN
gsrj-75	144	17	did	do	AUX
gsrj-75	144	18	not	not	PART
gsrj-75	144	19	report	report	VERB
gsrj-75	144	20	specific	specific	ADJ
gsrj-75	144	21	dosage	dosage	NOUN
gsrj-75	144	22	values	value	NOUN
gsrj-75	144	23	for	for	ADP
gsrj-75	144	24	study	study	NOUN
gsrj-75	144	25	replication	replication	NOUN
gsrj-75	144	26	.	.	PUNCT
gsrj-75	145	1	this	this	DET
gsrj-75	145	2	problem	problem	NOUN
gsrj-75	145	3	was	be	AUX
gsrj-75	145	4	the	the	DET
gsrj-75	145	5	main	main	ADJ
gsrj-75	145	6	issue	issue	NOUN
gsrj-75	145	7	we	we	PRON
gsrj-75	145	8	faced	face	VERB
gsrj-75	145	9	when	when	SCONJ
gsrj-75	145	10	attempting	attempt	VERB
gsrj-75	145	11	to	to	ADP
gsrj-75	145	12	27	27	NUM
gsrj-75	145	13	�	�	PROPN
gsrj-75	145	14	�	�	PROPN
gsrj-75	145	15	�	�	PROPN
gsrj-75	145	16	�	�	PROPN
gsrj-75	145	17	�	�	PROPN
gsrj-75	145	18	�	�	PROPN
gsrj-75	145	19	�	�	PROPN
gsrj-75	145	20	�	�	PROPN
gsrj-75	145	21	�	�	PROPN
gsrj-75	145	22	�	�	PROPN
gsrj-75	145	23	�	�	PROPN
gsrj-75	145	24	�	�	PROPN
gsrj-75	145	25	�	�	PROPN
gsrj-75	145	26	�	�	PROPN
gsrj-75	145	27	�	�	PROPN
gsrj-75	145	28	�	�	PROPN
gsrj-75	145	29	�	�	PROPN
gsrj-75	145	30	�	�	PROPN
gsrj-75	145	31	�	�	PROPN
gsrj-75	145	32	�	�	PROPN
gsrj-75	145	33	�	�	PROPN
gsrj-75	145	34	�	�	PROPN
gsrj-75	145	35	�	�	PROPN
gsrj-75	145	36	�	�	PROPN
gsrj-75	145	37	�	�	PROPN
gsrj-75	145	38	�	�	PROPN
gsrj-75	145	39	�	�	PROPN
gsrj-75	145	40	�	�	PROPN
gsrj-75	145	41	�	�	PROPN
gsrj-75	145	42	�	�	PROPN
gsrj-75	145	43	�	�	PROPN
gsrj-75	145	44	�	�	PROPN
gsrj-75	145	45	�	�	PROPN
gsrj-75	145	46	�	�	PROPN
gsrj-75	145	47	�	�	PROPN
gsrj-75	145	48	�	�	PROPN
gsrj-75	145	49	�	�	PROPN
gsrj-75	145	50	�	�	PROPN
gsrj-75	145	51	replicate	replicate	VERB
gsrj-75	145	52	the	the	DET
gsrj-75	145	53	previously	previously	ADV
gsrj-75	145	54	proven	prove	VERB
gsrj-75	145	55	model	model	NOUN
gsrj-75	145	56	.	.	PUNCT
gsrj-75	146	1	the	the	DET
gsrj-75	146	2	dosage	dosage	NOUN
gsrj-75	146	3	of	of	ADP
gsrj-75	146	4	bleomycin	bleomycin	PROPN
gsrj-75	146	5	was	be	AUX
gsrj-75	146	6	adjusted	adjust	VERB
gsrj-75	146	7	for	for	ADP
gsrj-75	146	8	group	group	NOUN
gsrj-75	146	9	2	2	NUM
gsrj-75	146	10	due	due	ADP
gsrj-75	146	11	to	to	ADP
gsrj-75	146	12	the	the	DET
gsrj-75	146	13	significant	significant	ADJ
gsrj-75	146	14	weight	weight	NOUN
gsrj-75	146	15	loss	loss	NOUN
gsrj-75	146	16	that	that	PRON
gsrj-75	146	17	was	be	AUX
gsrj-75	146	18	observed	observe	VERB
gsrj-75	146	19	in	in	ADP
gsrj-75	146	20	group	group	NOUN
gsrj-75	146	21	1	1	NUM
gsrj-75	146	22	mice	mouse	NOUN
gsrj-75	146	23	.	.	PUNCT
gsrj-75	147	1	group	group	NOUN
gsrj-75	147	2	1	1	NUM
gsrj-75	147	3	high	high	ADJ
gsrj-75	147	4	-	-	PUNCT
gsrj-75	147	5	dose	dose	NOUN
gsrj-75	147	6	mice	mouse	NOUN
gsrj-75	147	7	lost	lose	VERB
gsrj-75	147	8	more	more	ADJ
gsrj-75	147	9	weight	weight	NOUN
gsrj-75	147	10	overall	overall	ADJ
gsrj-75	147	11	than	than	ADP
gsrj-75	147	12	group	group	NOUN
gsrj-75	147	13	2	2	NUM
gsrj-75	147	14	high	high	ADJ
gsrj-75	147	15	-	-	PUNCT
gsrj-75	147	16	dose	dose	NOUN
gsrj-75	147	17	mice	mouse	NOUN
gsrj-75	147	18	.	.	PUNCT
gsrj-75	148	1	however	however	ADV
gsrj-75	148	2	,	,	PUNCT
gsrj-75	148	3	in	in	ADP
gsrj-75	148	4	addition	addition	NOUN
gsrj-75	148	5	to	to	ADP
gsrj-75	148	6	receiving	receive	VERB
gsrj-75	148	7	a	a	DET
gsrj-75	148	8	lower	low	ADJ
gsrj-75	148	9	dosage	dosage	NOUN
gsrj-75	148	10	of	of	ADP
gsrj-75	148	11	bleomycin	bleomycin	PROPN
gsrj-75	148	12	,	,	PUNCT
gsrj-75	148	13	group	group	NOUN
gsrj-75	148	14	2	2	NUM
gsrj-75	148	15	mice	mouse	NOUN
gsrj-75	148	16	were	be	AUX
gsrj-75	148	17	also	also	ADV
gsrj-75	148	18	prophylactically	prophylactically	ADV
gsrj-75	148	19	given	give	VERB
gsrj-75	148	20	dietgels	dietgel	NOUN
gsrj-75	148	21	at	at	ADP
gsrj-75	148	22	the	the	DET
gsrj-75	148	23	beginning	beginning	NOUN
gsrj-75	148	24	of	of	ADP
gsrj-75	148	25	the	the	DET
gsrj-75	148	26	study	study	NOUN
gsrj-75	148	27	in	in	ADP
gsrj-75	148	28	an	an	DET
gsrj-75	148	29	effort	effort	NOUN
gsrj-75	148	30	to	to	PART
gsrj-75	148	31	mitigate	mitigate	VERB
gsrj-75	148	32	weight	weight	NOUN
gsrj-75	148	33	loss	loss	NOUN
gsrj-75	148	34	.	.	PUNCT
gsrj-75	149	1	these	these	DET
gsrj-75	149	2	two	two	NUM
gsrj-75	149	3	changes	change	NOUN
gsrj-75	149	4	to	to	ADP
gsrj-75	149	5	the	the	DET
gsrj-75	149	6	study	study	NOUN
gsrj-75	149	7	protocol	protocol	NOUN
gsrj-75	149	8	clearly	clearly	ADV
gsrj-75	149	9	helped	help	VERB
gsrj-75	149	10	reduce	reduce	VERB
gsrj-75	149	11	the	the	DET
gsrj-75	149	12	amount	amount	NOUN
gsrj-75	149	13	of	of	ADP
gsrj-75	149	14	weight	weight	NOUN
gsrj-75	149	15	the	the	DET
gsrj-75	149	16	mice	mouse	NOUN
gsrj-75	149	17	lost	lose	VERB
gsrj-75	149	18	throughout	throughout	ADP
gsrj-75	149	19	the	the	DET
gsrj-75	149	20	study	study	NOUN
gsrj-75	149	21	.	.	PUNCT
gsrj-75	150	1	in	in	ADP
gsrj-75	150	2	future	future	ADJ
gsrj-75	150	3	work	work	NOUN
gsrj-75	150	4	,	,	PUNCT
gsrj-75	150	5	rna	rna	NOUN
gsrj-75	150	6	from	from	ADP
gsrj-75	150	7	lung	lung	NOUN
gsrj-75	150	8	biopsies	biopsy	NOUN
gsrj-75	150	9	and	and	CCONJ
gsrj-75	150	10	blood	blood	NOUN
gsrj-75	150	11	samples	sample	NOUN
gsrj-75	150	12	should	should	AUX
gsrj-75	150	13	be	be	AUX
gsrj-75	150	14	isolated	isolate	VERB
gsrj-75	150	15	and	and	CCONJ
gsrj-75	150	16	analyzed	analyze	VERB
gsrj-75	150	17	via	via	ADP
gsrj-75	150	18	qrtpcr	qrtpcr	ADV
gsrj-75	150	19	to	to	PART
gsrj-75	150	20	look	look	VERB
gsrj-75	150	21	for	for	ADP
gsrj-75	150	22	evidence	evidence	NOUN
gsrj-75	150	23	of	of	ADP
gsrj-75	150	24	systemic	systemic	ADJ
gsrj-75	150	25	impacts	impact	NOUN
gsrj-75	150	26	of	of	ADP
gsrj-75	150	27	bleomycin	bleomycin	PROPN
gsrj-75	150	28	.	.	PUNCT
gsrj-75	151	1	the	the	DET
gsrj-75	151	2	c57	c57	PROPN
gsrj-75	151	3	-	-	PUNCT
gsrj-75	151	4	bl/6	bl/6	NOUN
gsrj-75	151	5	mice	mouse	NOUN
gsrj-75	151	6	used	use	VERB
gsrj-75	151	7	in	in	ADP
gsrj-75	151	8	this	this	DET
gsrj-75	151	9	study	study	NOUN
gsrj-75	151	10	lack	lack	NOUN
gsrj-75	151	11	melanocytes	melanocyte	NOUN
gsrj-75	151	12	within	within	ADP
gsrj-75	151	13	the	the	DET
gsrj-75	151	14	skin	skin	NOUN
gsrj-75	151	15	,	,	PUNCT
gsrj-75	151	16	however	however	ADV
gsrj-75	151	17	melanin	melanin	NOUN
gsrj-75	151	18	index	index	NOUN
gsrj-75	151	19	significantly	significantly	ADV
gsrj-75	151	20	increased	increase	VERB
gsrj-75	151	21	in	in	ADP
gsrj-75	151	22	control	control	NOUN
gsrj-75	151	23	,	,	PUNCT
gsrj-75	151	24	low	low	ADJ
gsrj-75	151	25	-	-	PUNCT
gsrj-75	151	26	dose	dose	NOUN
gsrj-75	151	27	,	,	PUNCT
gsrj-75	151	28	and	and	CCONJ
gsrj-75	151	29	mid	mid	ADJ
gsrj-75	151	30	-	-	ADJ
gsrj-75	151	31	dose	dose	ADJ
gsrj-75	151	32	mice	mouse	NOUN
gsrj-75	151	33	throughout	throughout	ADP
gsrj-75	151	34	the	the	DET
gsrj-75	151	35	study	study	NOUN
gsrj-75	151	36	duration	duration	NOUN
gsrj-75	151	37	.	.	PUNCT
gsrj-75	152	1	an	an	DET
gsrj-75	152	2	explanation	explanation	NOUN
gsrj-75	152	3	for	for	ADP
gsrj-75	152	4	this	this	DET
gsrj-75	152	5	finding	finding	NOUN
gsrj-75	152	6	is	be	AUX
gsrj-75	152	7	that	that	SCONJ
gsrj-75	152	8	hair	hair	NOUN
gsrj-75	152	9	regrowth	regrowth	NOUN
gsrj-75	152	10	influenced	influence	VERB
gsrj-75	152	11	melanin	melanin	NOUN
gsrj-75	152	12	measurements	measurement	NOUN
gsrj-75	152	13	in	in	ADP
gsrj-75	152	14	the	the	DET
gsrj-75	152	15	mice	mouse	NOUN
gsrj-75	152	16	.	.	PUNCT
gsrj-75	153	1	this	this	PRON
gsrj-75	153	2	would	would	AUX
gsrj-75	153	3	also	also	ADV
gsrj-75	153	4	explain	explain	VERB
gsrj-75	153	5	why	why	SCONJ
gsrj-75	153	6	the	the	DET
gsrj-75	153	7	high	high	ADJ
gsrj-75	153	8	-	-	PUNCT
gsrj-75	153	9	dose	dose	NOUN
gsrj-75	153	10	mice	mouse	NOUN
gsrj-75	153	11	did	do	AUX
gsrj-75	153	12	not	not	PART
gsrj-75	153	13	show	show	VERB
gsrj-75	153	14	a	a	DET
gsrj-75	153	15	significant	significant	ADJ
gsrj-75	153	16	difference	difference	NOUN
gsrj-75	153	17	in	in	ADP
gsrj-75	153	18	melanin	melanin	NOUN
gsrj-75	153	19	index	index	NOUN
gsrj-75	153	20	because	because	SCONJ
gsrj-75	153	21	the	the	DET
gsrj-75	153	22	high	high	ADJ
gsrj-75	153	23	-	-	PUNCT
gsrj-75	153	24	dose	dose	NOUN
gsrj-75	153	25	mice	mouse	NOUN
gsrj-75	153	26	experienced	experience	VERB
gsrj-75	153	27	hair	hair	NOUN
gsrj-75	153	28	loss	loss	NOUN
gsrj-75	153	29	as	as	ADP
gsrj-75	153	30	a	a	DET
gsrj-75	153	31	result	result	NOUN
gsrj-75	153	32	of	of	ADP
gsrj-75	153	33	bleomycin	bleomycin	PROPN
gsrj-75	153	34	,	,	PUNCT
gsrj-75	153	35	limiting	limit	VERB
gsrj-75	153	36	the	the	DET
gsrj-75	153	37	extent	extent	NOUN
gsrj-75	153	38	to	to	PART
gsrj-75	153	39	which	which	PRON
gsrj-75	153	40	melanin	melanin	NOUN
gsrj-75	153	41	measurements	measurement	NOUN
gsrj-75	153	42	were	be	AUX
gsrj-75	153	43	falsely	falsely	ADV
gsrj-75	153	44	influenced	influence	VERB
gsrj-75	153	45	.	.	PUNCT
gsrj-75	154	1	the	the	DET
gsrj-75	154	2	application	application	NOUN
gsrj-75	154	3	of	of	ADP
gsrj-75	154	4	nair	nair	NOUN
gsrj-75	154	5	during	during	ADP
gsrj-75	154	6	depilation	depilation	NOUN
gsrj-75	154	7	seemed	seem	VERB
gsrj-75	154	8	to	to	PART
gsrj-75	154	9	induce	induce	VERB
gsrj-75	154	10	hair	hair	NOUN
gsrj-75	154	11	follicle	follicle	NOUN
gsrj-75	154	12	neogenesis	neogenesis	NOUN
gsrj-75	154	13	or	or	CCONJ
gsrj-75	154	14	induction	induction	NOUN
gsrj-75	154	15	of	of	ADP
gsrj-75	154	16	the	the	DET
gsrj-75	154	17	hair	hair	NOUN
gsrj-75	154	18	cycling	cycling	NOUN
gsrj-75	154	19	pathway	pathway	NOUN
gsrj-75	154	20	,	,	PUNCT
gsrj-75	154	21	which	which	PRON
gsrj-75	154	22	further	far	ADV
gsrj-75	154	23	affected	affect	VERB
gsrj-75	154	24	melanin	melanin	NOUN
gsrj-75	154	25	measurements	measurement	NOUN
gsrj-75	154	26	.	.	PUNCT
gsrj-75	155	1	further	further	ADJ
gsrj-75	155	2	investigation	investigation	NOUN
gsrj-75	155	3	needs	need	VERB
gsrj-75	155	4	to	to	PART
gsrj-75	155	5	be	be	AUX
gsrj-75	155	6	conducted	conduct	VERB
gsrj-75	155	7	on	on	ADP
gsrj-75	155	8	the	the	DET
gsrj-75	155	9	influence	influence	NOUN
gsrj-75	155	10	on	on	ADP
gsrj-75	155	11	depilating	depilate	VERB
gsrj-75	155	12	agents	agent	NOUN
gsrj-75	155	13	on	on	ADP
gsrj-75	155	14	hair	hair	NOUN
gsrj-75	155	15	follicle	follicle	NOUN
gsrj-75	155	16	neogenesis	neogenesis	NOUN
gsrj-75	155	17	and	and	CCONJ
gsrj-75	155	18	induction	induction	NOUN
gsrj-75	155	19	of	of	ADP
gsrj-75	155	20	cycling	cycle	VERB
gsrj-75	155	21	to	to	PART
gsrj-75	155	22	better	well	ADV
gsrj-75	155	23	understand	understand	VERB
gsrj-75	155	24	how	how	SCONJ
gsrj-75	155	25	to	to	PART
gsrj-75	155	26	account	account	VERB
gsrj-75	155	27	for	for	ADP
gsrj-75	155	28	this	this	DET
gsrj-75	155	29	problem	problem	NOUN
gsrj-75	155	30	in	in	ADP
gsrj-75	155	31	future	future	ADJ
gsrj-75	155	32	work	work	NOUN
gsrj-75	155	33	.	.	PUNCT
gsrj-75	156	1	additionally	additionally	ADV
gsrj-75	156	2	,	,	PUNCT
gsrj-75	156	3	melanin	melanin	NOUN
gsrj-75	156	4	content	content	NOUN
gsrj-75	156	5	can	can	AUX
gsrj-75	156	6	be	be	AUX
gsrj-75	156	7	assessed	assess	VERB
gsrj-75	156	8	via	via	ADP
gsrj-75	156	9	fontana	fontana	PROPN
gsrj-75	156	10	masson	masson	PROPN
gsrj-75	156	11	staining	stain	VERB
gsrj-75	156	12	techniques	technique	NOUN
gsrj-75	156	13	instead	instead	ADV
gsrj-75	156	14	of	of	ADP
gsrj-75	156	15	non	non	ADJ
gsrj-75	156	16	-	-	ADJ
gsrj-75	156	17	invasive	invasive	ADJ
gsrj-75	156	18	probes	probe	NOUN
gsrj-75	156	19	measurements	measurement	NOUN
gsrj-75	156	20	for	for	ADP
gsrj-75	156	21	more	more	ADV
gsrj-75	156	22	accurate	accurate	ADJ
gsrj-75	156	23	results	result	NOUN
gsrj-75	156	24	.	.	PUNCT
gsrj-75	157	1	fontana	fontana	PROPN
gsrj-75	157	2	-	-	PUNCT
gsrj-75	157	3	masson	masson	PROPN
gsrj-75	157	4	staining	stain	VERB
gsrj-75	157	5	allows	allow	VERB
gsrj-75	157	6	for	for	ADP
gsrj-75	157	7	visual	visual	ADJ
gsrj-75	157	8	-	-	PUNCT
gsrj-75	157	9	ization	ization	NOUN
gsrj-75	157	10	of	of	ADP
gsrj-75	157	11	melanin	melanin	NOUN
gsrj-75	157	12	within	within	ADP
gsrj-75	157	13	the	the	DET
gsrj-75	157	14	epidermis	epidermis	NOUN
gsrj-75	157	15	of	of	ADP
gsrj-75	157	16	the	the	DET
gsrj-75	157	17	skin	skin	NOUN
gsrj-75	157	18	.	.	PUNCT
gsrj-75	158	1	elasticity	elasticity	NOUN
gsrj-75	158	2	measurements	measurement	NOUN
gsrj-75	158	3	and	and	CCONJ
gsrj-75	158	4	h&e	h&e	PROPN
gsrj-75	158	5	-	-	PUNCT
gsrj-75	158	6	stained	stain	VERB
gsrj-75	158	7	skin	skin	NOUN
gsrj-75	158	8	biopsies	biopsy	NOUN
gsrj-75	158	9	showed	show	VERB
gsrj-75	158	10	evidence	evidence	NOUN
gsrj-75	158	11	of	of	ADP
gsrj-75	158	12	bleomycininduced	bleomycininduced	ADJ
gsrj-75	158	13	dermal	dermal	ADJ
gsrj-75	158	14	fibrosis	fibrosis	NOUN
gsrj-75	158	15	in	in	ADP
gsrj-75	158	16	all	all	DET
gsrj-75	158	17	three	three	NUM
gsrj-75	158	18	drug	drug	NOUN
gsrj-75	158	19	treatment	treatment	NOUN
gsrj-75	158	20	groups	group	NOUN
gsrj-75	158	21	,	,	PUNCT
gsrj-75	158	22	but	but	CCONJ
gsrj-75	158	23	most	most	ADV
gsrj-75	158	24	profoundly	profoundly	ADV
gsrj-75	158	25	in	in	ADP
gsrj-75	158	26	the	the	DET
gsrj-75	158	27	high	high	ADJ
gsrj-75	158	28	-	-	PUNCT
gsrj-75	158	29	dose	dose	NOUN
gsrj-75	158	30	group	group	NOUN
gsrj-75	158	31	.	.	PUNCT
gsrj-75	159	1	however	however	ADV
gsrj-75	159	2	,	,	PUNCT
gsrj-75	159	3	additional	additional	ADJ
gsrj-75	159	4	qrt	qrt	ADJ
gsrj-75	159	5	-	-	PUNCT
gsrj-75	159	6	pcr	pcr	NOUN
gsrj-75	159	7	analysis	analysis	NOUN
gsrj-75	159	8	,	,	PUNCT
gsrj-75	159	9	immuno	immuno	ADJ
gsrj-75	159	10	-	-	PUNCT
gsrj-75	159	11	fluorescence	fluorescence	NOUN
gsrj-75	159	12	visualization	visualization	NOUN
gsrj-75	159	13	,	,	PUNCT
gsrj-75	159	14	and	and	CCONJ
gsrj-75	159	15	other	other	ADJ
gsrj-75	159	16	molecular	molecular	ADJ
gsrj-75	159	17	assays	assay	NOUN
gsrj-75	159	18	should	should	AUX
gsrj-75	159	19	be	be	AUX
gsrj-75	159	20	conducted	conduct	VERB
gsrj-75	159	21	to	to	PART
gsrj-75	159	22	obtain	obtain	VERB
gsrj-75	159	23	significant	significant	ADJ
gsrj-75	159	24	molecular	molecular	ADJ
gsrj-75	159	25	confirmation	confirmation	NOUN
gsrj-75	159	26	of	of	ADP
gsrj-75	159	27	fibrosis	fibrosis	NOUN
gsrj-75	159	28	.	.	PUNCT
gsrj-75	160	1	further	further	ADJ
gsrj-75	160	2	evidence	evidence	NOUN
gsrj-75	160	3	is	be	AUX
gsrj-75	160	4	needed	need	VERB
gsrj-75	160	5	to	to	PART
gsrj-75	160	6	confirm	confirm	VERB
gsrj-75	160	7	the	the	DET
gsrj-75	160	8	efficacy	efficacy	NOUN
gsrj-75	160	9	of	of	ADP
gsrj-75	160	10	bleomycin	bleomycin	PROPN
gsrj-75	160	11	-	-	PUNCT
gsrj-75	160	12	induced	induce	VERB
gsrj-75	160	13	dermal	dermal	NOUN
gsrj-75	160	14	fibrosis	fibrosis	NOUN
gsrj-75	160	15	before	before	ADP
gsrj-75	160	16	attempting	attempt	VERB
gsrj-75	160	17	to	to	PART
gsrj-75	160	18	understand	understand	VERB
gsrj-75	160	19	the	the	DET
gsrj-75	160	20	mechanistic	mechanistic	ADJ
gsrj-75	160	21	relationship	relationship	NOUN
gsrj-75	160	22	between	between	ADP
gsrj-75	160	23	dermal	dermal	ADJ
gsrj-75	160	24	fibrosis	fibrosis	NOUN
gsrj-75	160	25	and	and	CCONJ
gsrj-75	160	26	epidermal	epidermal	ADJ
gsrj-75	160	27	dyschromia	dyschromia	NOUN
gsrj-75	160	28	.	.	PUNCT
gsrj-75	161	1	rreeffeerreenncceess	rreeffeerreenncceess	PROPN
gsrj-75	161	2	1.	1.	SYM
gsrj-75	161	3	�	�	PROPN
gsrj-75	161	4	aarabi	aarabi	PROPN
gsrj-75	161	5	,	,	PUNCT
gsrj-75	161	6	s.	s.	PROPN
gsrj-75	161	7	,	,	PUNCT
gsrj-75	161	8	longaker	longaker	PROPN
gsrj-75	161	9	,	,	PUNCT
gsrj-75	161	10	m.t	m.t	PROPN
gsrj-75	161	11	.	.	PROPN
gsrj-75	161	12	,	,	PUNCT
gsrj-75	161	13	&	&	CCONJ
gsrj-75	161	14	gurtner	gurtner	NOUN
gsrj-75	161	15	,	,	PUNCT
gsrj-75	161	16	g.c	g.c	PROPN
gsrj-75	161	17	.	.	PROPN
gsrj-75	161	18	(	(	PUNCT
gsrj-75	161	19	2007	2007	NUM
gsrj-75	161	20	)	)	PUNCT
gsrj-75	161	21	.	.	PUNCT
gsrj-75	162	1	hypertrophic	hypertrophic	ADJ
gsrj-75	162	2	scar	scar	ADJ
gsrj-75	162	3	formation	formation	NOUN
gsrj-75	162	4	following	follow	VERB
gsrj-75	162	5	burns	burn	NOUN
gsrj-75	162	6	and	and	CCONJ
gsrj-75	162	7	trauma	trauma	NOUN
gsrj-75	162	8	:	:	PUNCT
gsrj-75	162	9	new	new	ADJ
gsrj-75	162	10	approaches	approach	NOUN
gsrj-75	162	11	to	to	ADP
gsrj-75	162	12	treatment	treatment	NOUN
gsrj-75	162	13	.	.	PUNCT
gsrj-75	163	1	plos	plos	PROPN
gsrj-75	163	2	med	med	PROPN
gsrj-75	163	3	.	.	PUNCT
gsrj-75	164	1	4(9	4(9	NUM
gsrj-75	164	2	)	)	PUNCT
gsrj-75	164	3	,	,	PUNCT
gsrj-75	164	4	1464	1464	NUM
gsrj-75	164	5	-	-	SYM
gsrj-75	164	6	70	70	NUM
gsrj-75	164	7	.	.	PUNCT
gsrj-75	165	1	https://doi.org/10.1371/journal.pmed.0040234	https://doi.org/10.1371/journal.pmed.0040234	ADJ
gsrj-75	165	2	2.	2.	NOUN
gsrj-75	165	3	�	�	NOUN
gsrj-75	165	4	finnerty	finnerty	NOUN
gsrj-75	165	5	,	,	PUNCT
gsrj-75	165	6	c.c	c.c	PROPN
gsrj-75	165	7	.	.	PROPN
gsrj-75	165	8	,	,	PUNCT
gsrj-75	165	9	jeschke	jeschke	PROPN
gsrj-75	165	10	,	,	PUNCT
gsrj-75	165	11	m.g	m.g	PROPN
gsrj-75	165	12	.	.	PROPN
gsrj-75	165	13	,	,	PUNCT
gsrj-75	165	14	branski	branski	PROPN
gsrj-75	165	15	,	,	PUNCT
gsrj-75	165	16	l.k	l.k	PROPN
gsrj-75	165	17	.	.	PROPN
gsrj-75	165	18	,	,	PUNCT
gsrj-75	165	19	barret	barret	PROPN
gsrj-75	165	20	,	,	PUNCT
gsrj-75	165	21	j.p	j.p	PROPN
gsrj-75	165	22	.	.	PROPN
gsrj-75	165	23	,	,	PUNCT
gsrj-75	165	24	dziewulski	dziewulski	PROPN
gsrj-75	165	25	,	,	PUNCT
gsrj-75	165	26	p.	p.	PROPN
gsrj-75	165	27	,	,	PUNCT
gsrj-75	165	28	&	&	CCONJ
gsrj-75	165	29	herndon	herndon	PROPN
gsrj-75	165	30	,	,	PUNCT
gsrj-75	165	31	d.n	d.n	PROPN
gsrj-75	165	32	.	.	PROPN
gsrj-75	165	33	2016	2016	NUM
gsrj-75	165	34	.	.	PUNCT
gsrj-75	166	1	hypertrophic	hypertrophic	ADJ
gsrj-75	166	2	scarring	scarring	NOUN
gsrj-75	166	3	:	:	PUNCT
gsrj-75	166	4	the	the	DET
gsrj-75	166	5	greatest	great	ADJ
gsrj-75	166	6	unmet	unmet	NOUN
gsrj-75	166	7	challenge	challenge	NOUN
gsrj-75	166	8	after	after	ADP
gsrj-75	166	9	burn	burn	NOUN
gsrj-75	166	10	injury	injury	NOUN
gsrj-75	166	11	.	.	PUNCT
gsrj-75	167	1	lancet	lancet	NOUN
gsrj-75	167	2	.	.	PUNCT
gsrj-75	168	1	388(10052	388(10052	X
gsrj-75	168	2	)	)	PUNCT
gsrj-75	168	3	,	,	PUNCT
gsrj-75	168	4	1427	1427	NUM
gsrj-75	168	5	-	-	SYM
gsrj-75	168	6	36	36	NUM
gsrj-75	168	7	.	.	PUNCT
gsrj-75	169	1	https://doi.org/10.1016/s0140-6736(16)31406-4	https://doi.org/10.1016/s0140-6736(16)31406-4	PROPN
gsrj-75	169	2	3.	3.	NUM
gsrj-75	169	3	�	�	PROPN
gsrj-75	169	4	chiang	chiang	PROPN
gsrj-75	169	5	,	,	PUNCT
gsrj-75	169	6	r.s	r.s	PROPN
gsrj-75	169	7	.	.	PROPN
gsrj-75	169	8	,	,	PUNCT
gsrj-75	169	9	borovikova	borovikova	PROPN
gsrj-75	169	10	,	,	PUNCT
gsrj-75	169	11	a.a	a.a	PROPN
gsrj-75	169	12	.	.	PROPN
gsrj-75	169	13	,	,	PUNCT
gsrj-75	169	14	king	king	PROPN
gsrj-75	169	15	,	,	PUNCT
gsrj-75	169	16	k.	k.	PROPN
gsrj-75	169	17	,	,	PUNCT
gsrj-75	169	18	banyard	banyard	ADV
gsrj-75	169	19	,	,	PUNCT
gsrj-75	169	20	d.a	d.a	PROPN
gsrj-75	169	21	.	.	PROPN
gsrj-75	169	22	,	,	PUNCT
gsrj-75	169	23	lalezari	lalezari	PROPN
gsrj-75	169	24	,	,	PUNCT
gsrj-75	169	25	s.	s.	PROPN
gsrj-75	169	26	,	,	PUNCT
gsrj-75	169	27	toranto	toranto	PROPN
gsrj-75	169	28	,	,	PUNCT
gsrj-75	169	29	j.d	j.d	PROPN
gsrj-75	169	30	.	.	PROPN
gsrj-75	169	31	,	,	PUNCT
gsrj-75	169	32	paydar	paydar	PROPN
gsrj-75	169	33	,	,	PUNCT
gsrj-75	169	34	k.z	k.z	PROPN
gsrj-75	169	35	.	.	PROPN
gsrj-75	169	36	,	,	PUNCT
gsrj-75	169	37	wirth	wirth	PROPN
gsrj-75	169	38	,	,	PUNCT
gsrj-75	169	39	g.a	g.a	PROPN
gsrj-75	169	40	.	.	PROPN
gsrj-75	169	41	,	,	PUNCT
gsrj-75	169	42	evans	evans	PROPN
gsrj-75	169	43	,	,	PUNCT
gsrj-75	169	44	g.r	g.r	PROPN
gsrj-75	169	45	.	.	PROPN
gsrj-75	169	46	,	,	PUNCT
gsrj-75	169	47	&	&	CCONJ
gsrj-75	169	48	widgerow	widgerow	PROPN
gsrj-75	169	49	,	,	PUNCT
gsrj-75	169	50	a.d	a.d	PROPN
gsrj-75	169	51	.	.	PROPN
gsrj-75	169	52	(	(	PUNCT
gsrj-75	169	53	2016	2016	NUM
gsrj-75	169	54	)	)	PUNCT
gsrj-75	169	55	.	.	PUNCT
gsrj-75	170	1	current	current	ADJ
gsrj-75	170	2	concepts	concept	NOUN
gsrj-75	170	3	related	relate	VERB
gsrj-75	170	4	to	to	ADP
gsrj-75	170	5	hypertrophic	hypertrophic	ADJ
gsrj-75	170	6	scarring	scarring	NOUN
gsrj-75	170	7	in	in	ADP
gsrj-75	170	8	burn	burn	NOUN
gsrj-75	170	9	injuries	injury	NOUN
gsrj-75	170	10	.	.	PUNCT
gsrj-75	171	1	wound	wound	PROPN
gsrj-75	171	2	repair	repair	PROPN
gsrj-75	171	3	regen	regen	PROPN
gsrj-75	171	4	.	.	PUNCT
gsrj-75	172	1	24(3	24(3	NUM
gsrj-75	172	2	)	)	PUNCT
gsrj-75	172	3	,	,	PUNCT
gsrj-75	172	4	466	466	NUM
gsrj-75	172	5	-	-	SYM
gsrj-75	172	6	77	77	NUM
gsrj-75	172	7	.	.	PUNCT
gsrj-75	173	1	https://doi.org/10.1111/wrr.12432	https://doi.org/10.1111/wrr.12432	PROPN
gsrj-75	173	2	4.	4.	NUM
gsrj-75	173	3	�	�	PROPN
gsrj-75	173	4	van	van	ADJ
gsrj-75	173	5	der	der	NOUN
gsrj-75	173	6	veer	veer	NOUN
gsrj-75	173	7	,	,	PUNCT
gsrj-75	173	8	w.m	w.m	PROPN
gsrj-75	173	9	.	.	PROPN
gsrj-75	173	10	,	,	PUNCT
gsrj-75	173	11	bloemen	bloemen	PROPN
gsrj-75	173	12	,	,	PUNCT
gsrj-75	173	13	m.c	m.c	PROPN
gsrj-75	173	14	.	.	PROPN
gsrj-75	173	15	,	,	PUNCT
gsrj-75	173	16	ulrich	ulrich	PROPN
gsrj-75	173	17	,	,	PUNCT
gsrj-75	173	18	m.m	m.m	PROPN
gsrj-75	173	19	.	.	PROPN
gsrj-75	173	20	,	,	PUNCT
gsrj-75	173	21	molema	molema	PROPN
gsrj-75	173	22	,	,	PUNCT
gsrj-75	173	23	g.	g.	PROPN
gsrj-75	173	24	,	,	PUNCT
gsrj-75	173	25	van	van	PROPN
gsrj-75	173	26	zuijlen	zuijlen	PROPN
gsrj-75	173	27	,	,	PUNCT
gsrj-75	173	28	p.p	p.p	PROPN
gsrj-75	173	29	.	.	PROPN
gsrj-75	173	30	,	,	PUNCT
gsrj-75	173	31	middelkoop	middelkoop	NOUN
gsrj-75	173	32	,	,	PUNCT
gsrj-75	173	33	e.	e.	PROPN
gsrj-75	173	34	,	,	PUNCT
gsrj-75	173	35	&	&	CCONJ
gsrj-75	173	36	niessen	niessen	PROPN
gsrj-75	173	37	,	,	PUNCT
gsrj-75	173	38	f.b	f.b	PROPN
gsrj-75	173	39	,	,	PUNCT
gsrj-75	173	40	.	.	PUNCT
gsrj-75	174	1	(	(	PUNCT
gsrj-75	174	2	2009	2009	NUM
gsrj-75	174	3	)	)	PUNCT
gsrj-75	174	4	.	.	PUNCT
gsrj-75	175	1	potential	potential	ADJ
gsrj-75	175	2	cellular	cellular	ADJ
gsrj-75	175	3	and	and	CCONJ
gsrj-75	175	4	molecular	molecular	ADJ
gsrj-75	175	5	causes	cause	NOUN
gsrj-75	175	6	of	of	ADP
gsrj-75	175	7	hypertrophic	hypertrophic	ADJ
gsrj-75	175	8	scar	scar	ADJ
gsrj-75	175	9	formation	formation	NOUN
gsrj-75	175	10	.	.	PUNCT
gsrj-75	176	1	burns	burn	NOUN
gsrj-75	176	2	.	.	PUNCT
gsrj-75	177	1	35(1	35(1	NUM
gsrj-75	177	2	)	)	PUNCT
gsrj-75	177	3	,	,	PUNCT
gsrj-75	177	4	1529	1529	NUM
gsrj-75	177	5	.	.	PUNCT
gsrj-75	178	1	https://doi.org/10.1016/j.burns.2008.06.020	https://doi.org/10.1016/j.burns.2008.06.020	PROPN
gsrj-75	178	2	5.	5.	NUM
gsrj-75	178	3	�	�	PROPN
gsrj-75	178	4	huang	huang	PROPN
gsrj-75	178	5	,	,	PUNCT
gsrj-75	178	6	c.	c.	PROPN
gsrj-75	178	7	,	,	PUNCT
gsrj-75	178	8	murphy	murphy	PROPN
gsrj-75	178	9	,	,	PUNCT
gsrj-75	178	10	g.f	g.f	PROPN
gsrj-75	178	11	.	.	PROPN
gsrj-75	178	12	,	,	PUNCT
gsrj-75	178	13	akaishi	akaishi	PROPN
gsrj-75	178	14	,	,	PUNCT
gsrj-75	178	15	s.	s.	PROPN
gsrj-75	178	16	,	,	PUNCT
gsrj-75	178	17	&	&	CCONJ
gsrj-75	178	18	ogawa	ogawa	PROPN
gsrj-75	178	19	,	,	PUNCT
gsrj-75	178	20	r.	r.	PROPN
gsrj-75	178	21	(	(	PUNCT
gsrj-75	178	22	2013	2013	NUM
gsrj-75	178	23	)	)	PUNCT
gsrj-75	178	24	.	.	PUNCT
gsrj-75	179	1	keloids	keloid	NOUN
gsrj-75	179	2	and	and	CCONJ
gsrj-75	179	3	hypertrophic	hypertrophic	ADJ
gsrj-75	179	4	scars	scar	NOUN
gsrj-75	179	5	:	:	PUNCT
gsrj-75	179	6	update	update	NOUN
gsrj-75	179	7	and	and	CCONJ
gsrj-75	179	8	future	future	ADJ
gsrj-75	179	9	directions	direction	NOUN
gsrj-75	179	10	.	.	PUNCT
gsrj-75	180	1	plastic	plastic	NOUN
gsrj-75	180	2	and	and	CCONJ
gsrj-75	180	3	reconstructive	reconstructive	ADJ
gsrj-75	180	4	surfery	surfery	NOUN
gsrj-75	180	5	.	.	PUNCT
gsrj-75	181	1	1(4	1(4	NUM
gsrj-75	181	2	)	)	PUNCT
gsrj-75	181	3	,	,	PUNCT
gsrj-75	181	4	e25	e25	PROPN
gsrj-75	181	5	.	.	PUNCT
gsrj-75	182	1	https://doi.org/10.1097/gox.0b013e31829c4597	https://doi.org/10.1097/gox.0b013e31829c4597	PROPN
gsrj-75	183	1	6.	6.	X
gsrj-75	183	2	�	�	PROPN
gsrj-75	183	3	limandjaja	limandjaja	PROPN
gsrj-75	183	4	,	,	PUNCT
gsrj-75	183	5	g.c	g.c	PROPN
gsrj-75	183	6	.	.	PROPN
gsrj-75	183	7	,	,	PUNCT
gsrj-75	183	8	van	van	PROPN
gsrj-75	183	9	den	den	PROPN
gsrj-75	183	10	broek	broek	PROPN
gsrj-75	183	11	,	,	PUNCT
gsrj-75	183	12	l.j	l.j	PROPN
gsrj-75	183	13	.	.	PROPN
gsrj-75	183	14	,	,	PUNCT
gsrj-75	183	15	waaijman	waaijman	NOUN
gsrj-75	183	16	,	,	PUNCT
gsrj-75	183	17	t.	t.	PROPN
gsrj-75	183	18	,	,	PUNCT
gsrj-75	183	19	van	van	PROPN
gsrj-75	183	20	veen	veen	PROPN
gsrj-75	183	21	,	,	PUNCT
gsrj-75	183	22	h.a	h.a	PROPN
gsrj-75	183	23	.	.	PROPN
gsrj-75	183	24	,	,	PUNCT
gsrj-75	183	25	everts	everts	PROPN
gsrj-75	183	26	,	,	PUNCT
gsrj-75	183	27	v.	v.	ADV
gsrj-75	183	28	,	,	PUNCT
gsrj-75	183	29	monstrey	monstrey	PROPN
gsrj-75	183	30	,	,	PUNCT
gsrj-75	183	31	s.	s.	PROPN
gsrj-75	183	32	,	,	PUNCT
gsrj-75	183	33	scheper	scheper	PROPN
gsrj-75	183	34	,	,	PUNCT
gsrj-75	183	35	r.j	r.j	PROPN
gsrj-75	183	36	.	.	PROPN
gsrj-75	183	37	,	,	PUNCT
gsrj-75	183	38	niessen	niessen	PROPN
gsrj-75	183	39	,	,	PUNCT
gsrj-75	183	40	f.b	f.b	PROPN
gsrj-75	183	41	.	.	PROPN
gsrj-75	183	42	,	,	PUNCT
gsrj-75	183	43	&	&	CCONJ
gsrj-75	183	44	gibbs	gibbs	PROPN
gsrj-75	183	45	,	,	PUNCT
gsrj-75	183	46	s.	s.	PROPN
gsrj-75	183	47	(	(	PUNCT
gsrj-75	183	48	2020	2020	NUM
gsrj-75	183	49	)	)	PUNCT
gsrj-75	183	50	.	.	PUNCT
gsrj-75	184	1	increased	increase	VERB
gsrj-75	184	2	epidermal	epidermal	ADJ
gsrj-75	184	3	thickness	thickness	NOUN
gsrj-75	184	4	and	and	CCONJ
gsrj-75	184	5	abnormal	abnormal	ADJ
gsrj-75	184	6	epidermal	epidermal	ADJ
gsrj-75	184	7	differentiation	differentiation	NOUN
gsrj-75	184	8	in	in	ADP
gsrj-75	184	9	keloid	keloid	ADJ
gsrj-75	184	10	scars	scar	NOUN
gsrj-75	184	11	.	.	PUNCT
gsrj-75	185	1	dermatologic	dermatologic	ADJ
gsrj-75	185	2	surgery	surgery	NOUN
gsrj-75	185	3	.	.	PUNCT
gsrj-75	186	1	176(1	176(1	NUM
gsrj-75	186	2	)	)	PUNCT
gsrj-75	186	3	,	,	PUNCT
gsrj-75	186	4	116	116	NUM
gsrj-75	186	5	-	-	SYM
gsrj-75	186	6	126	126	NUM
gsrj-75	186	7	.	.	PUNCT
gsrj-75	187	1	https://doi.org/10.1111/bjd.14844	https://doi.org/10.1111/bjd.14844	PROPN
gsrj-75	187	2	7.	7.	NUM
gsrj-75	187	3	�	�	PROPN
gsrj-75	187	4	ni!escu	ni!escu	NOUN
gsrj-75	187	5	,	,	PUNCT
gsrj-75	187	6	c.	c.	NOUN
gsrj-75	187	7	,	,	PUNCT
gsrj-75	187	8	calot	calot	NOUN
gsrj-75	187	9	"	"	PUNCT
gsrj-75	187	10	,	,	PUNCT
gsrj-75	187	11	d.r	d.r	PROPN
gsrj-75	187	12	.	.	PROPN
gsrj-75	187	13	,	,	PUNCT
gsrj-75	187	14	st"ncioiu	st"ncioiu	PROPN
gsrj-75	187	15	,	,	PUNCT
gsrj-75	187	16	t.a	t.a	PROPN
gsrj-75	187	17	.	.	PROPN
gsrj-75	187	18	,	,	PUNCT
gsrj-75	187	19	marinescu	marinescu	PROPN
gsrj-75	187	20	,	,	PUNCT
gsrj-75	187	21	s.a	s.a	PROPN
gsrj-75	187	22	.	.	PROPN
gsrj-75	187	23	,	,	PUNCT
gsrj-75	187	24	florescu	florescu	PROPN
gsrj-75	187	25	,	,	PUNCT
gsrj-75	187	26	i.p	i.p	PROPN
gsrj-75	187	27	.	.	PROPN
gsrj-75	187	28	,	,	PUNCT
gsrj-75	187	29	&	&	CCONJ
gsrj-75	187	30	lasc"r	lasc"r	PROPN
gsrj-75	187	31	,	,	PUNCT
gsrj-75	187	32	i.	i.	PROPN
gsrj-75	187	33	28	28	NUM
gsrj-75	187	34	�	�	PROPN
gsrj-75	187	35	�	�	PROPN
gsrj-75	187	36	�	�	PROPN
gsrj-75	187	37	�	�	PROPN
gsrj-75	187	38	�	�	PROPN
gsrj-75	187	39	�	�	PROPN
gsrj-75	187	40	�	�	PROPN
gsrj-75	187	41	�	�	PROPN
gsrj-75	187	42	�	�	PROPN
gsrj-75	187	43	�	�	PROPN
gsrj-75	187	44	�	�	PROPN
gsrj-75	187	45	�	�	PROPN
gsrj-75	187	46	�	�	PROPN
gsrj-75	187	47	�	�	PROPN
gsrj-75	187	48	�	�	PROPN
gsrj-75	187	49	�	�	PROPN
gsrj-75	187	50	�	�	PROPN
gsrj-75	187	51	�	�	PROPN
gsrj-75	187	52	�	�	PROPN
gsrj-75	187	53	�	�	PROPN
gsrj-75	187	54	�	�	PROPN
gsrj-75	187	55	�	�	PROPN
gsrj-75	187	56	�	�	PROPN
gsrj-75	187	57	�	�	PROPN
gsrj-75	187	58	�	�	PROPN
gsrj-75	187	59	�	�	PROPN
gsrj-75	187	60	�	�	PROPN
gsrj-75	187	61	�	�	PROPN
gsrj-75	187	62	�	�	PROPN
gsrj-75	187	63	�	�	PROPN
gsrj-75	187	64	�	�	PROPN
gsrj-75	187	65	�	�	PROPN
gsrj-75	187	66	�	�	PROPN
gsrj-75	187	67	�	�	PROPN
gsrj-75	187	68	�	�	PROPN
gsrj-75	187	69	�	�	PROPN
gsrj-75	187	70	�	�	PROPN
gsrj-75	187	71	�	�	PROPN
gsrj-75	187	72	(	(	PUNCT
gsrj-75	187	73	2012	2012	NUM
gsrj-75	187	74	)	)	PUNCT
gsrj-75	187	75	.	.	PUNCT
gsrj-75	188	1	psychological	psychological	ADJ
gsrj-75	188	2	impact	impact	NOUN
gsrj-75	188	3	of	of	ADP
gsrj-75	188	4	burn	burn	VERB
gsrj-75	188	5	scars	scar	NOUN
gsrj-75	188	6	on	on	ADP
gsrj-75	188	7	quality	quality	NOUN
gsrj-75	188	8	of	of	ADP
gsrj-75	188	9	life	life	NOUN
gsrj-75	188	10	in	in	ADP
gsrj-75	188	11	patients	patient	NOUN
gsrj-75	188	12	with	with	ADP
gsrj-75	188	13	extensive	extensive	ADJ
gsrj-75	188	14	burns	burn	NOUN
gsrj-75	188	15	who	who	PRON
gsrj-75	188	16	received	receive	VERB
gsrj-75	188	17	allotransplant	allotransplant	NOUN
gsrj-75	188	18	.	.	PUNCT
gsrj-75	189	1	romanian	romanian	ADJ
gsrj-75	189	2	journal	journal	PROPN
gsrj-75	189	3	of	of	ADP
gsrj-75	189	4	morphology	morphology	PROPN
gsrj-75	189	5	&	&	CCONJ
gsrj-75	189	6	embryology	embryology	PROPN
gsrj-75	189	7	.	.	PUNCT
gsrj-75	190	1	53(3	53(3	NUM
gsrj-75	190	2	)	)	PUNCT
gsrj-75	190	3	,	,	PUNCT
gsrj-75	190	4	577	577	NUM
gsrj-75	190	5	-	-	SYM
gsrj-75	190	6	83	83	NUM
gsrj-75	190	7	.	.	PUNCT
gsrj-75	191	1	8.	8.	X
gsrj-75	191	2	�	�	PROPN
gsrj-75	191	3	zeitlin	zeitlin	PROPN
gsrj-75	191	4	,	,	PUNCT
gsrj-75	191	5	r.e	r.e	PROPN
gsrj-75	191	6	.	.	PROPN
gsrj-75	191	7	(	(	PUNCT
gsrj-75	191	8	1997	1997	NUM
gsrj-75	191	9	)	)	PUNCT
gsrj-75	191	10	.	.	PUNCT
gsrj-75	192	1	long	long	ADJ
gsrj-75	192	2	-	-	PUNCT
gsrj-75	192	3	term	term	NOUN
gsrj-75	192	4	psychosocial	psychosocial	ADJ
gsrj-75	192	5	sequelae	sequelae	NOUN
gsrj-75	192	6	of	of	ADP
gsrj-75	192	7	paediatric	paediatric	ADJ
gsrj-75	192	8	burns	burn	NOUN
gsrj-75	192	9	.	.	PUNCT
gsrj-75	193	1	burns	burn	NOUN
gsrj-75	193	2	.	.	PUNCT
gsrj-75	194	1	23(6	23(6	NUM
gsrj-75	194	2	)	)	PUNCT
gsrj-75	194	3	,	,	PUNCT
gsrj-75	195	1	467472	467472	NUM
gsrj-75	195	2	.	.	PUNCT
gsrj-75	196	1	https://doi.org/10.1016/s0305-4179(97)00045-4	https://doi.org/10.1016/s0305-4179(97)00045-4	VERB
gsrj-75	196	2	9.	9.	NUM
gsrj-75	196	3	�	�	PROPN
gsrj-75	196	4	ross	ross	PROPN
gsrj-75	196	5	,	,	PUNCT
gsrj-75	196	6	e.	e.	PROPN
gsrj-75	196	7	,	,	PUNCT
gsrj-75	196	8	crijns	crijns	PROPN
gsrj-75	196	9	,	,	PUNCT
gsrj-75	196	10	t.j	t.j	PROPN
gsrj-75	196	11	.	.	PROPN
gsrj-75	196	12	,	,	PUNCT
gsrj-75	196	13	ring	ring	NOUN
gsrj-75	196	14	,	,	PUNCT
gsrj-75	196	15	d.	d.	PROPN
gsrj-75	196	16	,	,	PUNCT
gsrj-75	196	17	&	&	CCONJ
gsrj-75	196	18	coopwood	coopwood	PROPN
gsrj-75	196	19	,	,	PUNCT
gsrj-75	196	20	b.	b.	PROPN
gsrj-75	196	21	(	(	PUNCT
gsrj-75	196	22	2021	2021	NUM
gsrj-75	196	23	)	)	PUNCT
gsrj-75	196	24	.	.	PUNCT
gsrj-75	197	1	social	social	ADJ
gsrj-75	197	2	factors	factor	NOUN
gsrj-75	197	3	and	and	CCONJ
gsrj-75	197	4	injury	injury	NOUN
gsrj-75	197	5	characteristics	characteristic	NOUN
gsrj-75	197	6	associated	associate	VERB
gsrj-75	197	7	with	with	ADP
gsrj-75	197	8	the	the	DET
gsrj-75	197	9	development	development	NOUN
gsrj-75	197	10	of	of	ADP
gsrj-75	197	11	perceived	perceive	VERB
gsrj-75	197	12	injury	injury	NOUN
gsrj-75	197	13	stigma	stigma	NOUN
gsrj-75	197	14	among	among	ADP
gsrj-75	197	15	burn	burn	NOUN
gsrj-75	197	16	survivors	survivor	NOUN
gsrj-75	197	17	.	.	PUNCT
gsrj-75	198	1	burns	burn	NOUN
gsrj-75	198	2	.	.	PUNCT
gsrj-75	199	1	47(3	47(3	NOUN
gsrj-75	199	2	)	)	PUNCT
gsrj-75	199	3	,	,	PUNCT
gsrj-75	199	4	692	692	NUM
gsrj-75	199	5	-	-	SYM
gsrj-75	199	6	697	697	NUM
gsrj-75	199	7	.	.	PUNCT
gsrj-75	200	1	https://doi.org/10.1016/j.burns.2020.07.022	https://doi.org/10.1016/j.burns.2020.07.022	PROPN
gsrj-75	200	2	10.	10.	PROPN
gsrj-75	200	3	�	�	PROPN
gsrj-75	200	4	stoddard	stoddard	NOUN
gsrj-75	200	5	,	,	PUNCT
gsrj-75	200	6	f.j	f.j	PROPN
gsrj-75	200	7	.	.	PROPN
gsrj-75	200	8	jr	jr	PROPN
gsrj-75	200	9	.	.	PROPN
gsrj-75	200	10	,	,	PUNCT
gsrj-75	200	11	ryan	ryan	PROPN
gsrj-75	200	12	,	,	PUNCT
gsrj-75	200	13	c.m	c.m	PROPN
gsrj-75	200	14	.	.	PROPN
gsrj-75	200	15	,	,	PUNCT
gsrj-75	200	16	&	&	CCONJ
gsrj-75	200	17	schneider	schneider	PROPN
gsrj-75	200	18	,	,	PUNCT
gsrj-75	200	19	j.c	j.c	PROPN
gsrj-75	200	20	.	.	PROPN
gsrj-75	200	21	(	(	PUNCT
gsrj-75	200	22	2014	2014	NUM
gsrj-75	200	23	)	)	PUNCT
gsrj-75	200	24	.	.	PUNCT
gsrj-75	201	1	physical	physical	ADJ
gsrj-75	201	2	and	and	CCONJ
gsrj-75	201	3	psychiatric	psychiatric	ADJ
gsrj-75	201	4	recovery	recovery	NOUN
gsrj-75	201	5	from	from	ADP
gsrj-75	201	6	burns	burn	NOUN
gsrj-75	201	7	.	.	PUNCT
gsrj-75	202	1	surgical	surgical	ADJ
gsrj-75	202	2	clinics	clinic	NOUN
gsrj-75	202	3	of	of	ADP
gsrj-75	202	4	north	north	PROPN
gsrj-75	202	5	america	america	PROPN
gsrj-75	202	6	.	.	PUNCT
gsrj-75	203	1	94(4	94(4	NUM
gsrj-75	203	2	)	)	PUNCT
gsrj-75	203	3	,	,	PUNCT
gsrj-75	203	4	863	863	NUM
gsrj-75	203	5	-	-	SYM
gsrj-75	203	6	78	78	NUM
gsrj-75	203	7	.	.	PUNCT
gsrj-75	204	1	https://doi.org/10.1016/j.suc.2014.05.007	https://doi.org/10.1016/j.suc.2014.05.007	PROPN
gsrj-75	204	2	11.	11.	PROPN
gsrj-75	204	3	�	�	PROPN
gsrj-75	204	4	taal	taal	NOUN
gsrj-75	204	5	,	,	PUNCT
gsrj-75	204	6	l.	l.	PROPN
gsrj-75	204	7	,	,	PUNCT
gsrj-75	204	8	&	&	CCONJ
gsrj-75	204	9	faber	faber	PROPN
gsrj-75	204	10	,	,	PUNCT
gsrj-75	204	11	a.w	a.w	PROPN
gsrj-75	204	12	.	.	PROPN
gsrj-75	204	13	(	(	PUNCT
gsrj-75	204	14	1998	1998	NUM
gsrj-75	204	15	)	)	PUNCT
gsrj-75	204	16	.	.	PUNCT
gsrj-75	205	1	posttraumatic	posttraumatic	ADJ
gsrj-75	205	2	stress	stress	NOUN
gsrj-75	205	3	and	and	CCONJ
gsrj-75	205	4	maladjustment	maladjustment	NOUN
gsrj-75	205	5	among	among	ADP
gsrj-75	205	6	adult	adult	NOUN
gsrj-75	205	7	burn	burn	NOUN
gsrj-75	205	8	survivors	survivor	NOUN
gsrj-75	205	9	1	1	NUM
gsrj-75	205	10	to	to	PART
gsrj-75	205	11	2	2	NUM
gsrj-75	205	12	years	year	NOUN
gsrj-75	205	13	postburn	postburn	NOUN
gsrj-75	205	14	.	.	PUNCT
gsrj-75	206	1	part	part	PROPN
gsrj-75	206	2	ii	ii	PROPN
gsrj-75	206	3	:	:	PUNCT
gsrj-75	206	4	the	the	DET
gsrj-75	206	5	interview	interview	NOUN
gsrj-75	206	6	data	datum	NOUN
gsrj-75	206	7	.	.	PUNCT
gsrj-75	207	1	burns	burn	NOUN
gsrj-75	207	2	.	.	PUNCT
gsrj-75	208	1	24(5	24(5	NUM
gsrj-75	208	2	)	)	PUNCT
gsrj-75	208	3	,	,	PUNCT
gsrj-75	208	4	399	399	NUM
gsrj-75	208	5	-	-	SYM
gsrj-75	208	6	405	405	NUM
gsrj-75	208	7	.	.	PUNCT
gsrj-75	209	1	https://doi.org/10.1016/s0305-4179(98)00053-9	https://doi.org/10.1016/s0305-4179(98)00053-9	PROPN
gsrj-75	209	2	12.	12.	NUM
gsrj-75	209	3	�	�	NOUN
gsrj-75	209	4	wisely	wisely	ADV
gsrj-75	209	5	,	,	PUNCT
gsrj-75	209	6	j.a	j.a	PROPN
gsrj-75	209	7	.	.	PROPN
gsrj-75	209	8	,	,	PUNCT
gsrj-75	209	9	hoyle	hoyle	PROPN
gsrj-75	209	10	,	,	PUNCT
gsrj-75	209	11	e.	e.	PROPN
gsrj-75	209	12	,	,	PUNCT
gsrj-75	209	13	tarrier	tarrier	NOUN
gsrj-75	209	14	,	,	PUNCT
gsrj-75	209	15	n.	n.	NOUN
gsrj-75	209	16	,	,	PUNCT
gsrj-75	209	17	&	&	CCONJ
gsrj-75	209	18	edwards	edwards	PROPN
gsrj-75	209	19	,	,	PUNCT
gsrj-75	209	20	j.	j.	PROPN
gsrj-75	209	21	(	(	PUNCT
gsrj-75	209	22	2007	2007	NUM
gsrj-75	209	23	)	)	PUNCT
gsrj-75	209	24	.	.	PUNCT
gsrj-75	210	1	where	where	SCONJ
gsrj-75	210	2	to	to	PART
gsrj-75	210	3	start	start	VERB
gsrj-75	210	4	?	?	PUNCT
gsrj-75	211	1	attempting	attempt	VERB
gsrj-75	211	2	to	to	PART
gsrj-75	211	3	meet	meet	VERB
gsrj-75	211	4	the	the	DET
gsrj-75	211	5	psychological	psychological	ADJ
gsrj-75	211	6	needs	need	NOUN
gsrj-75	211	7	of	of	ADP
gsrj-75	211	8	burned	burn	VERB
gsrj-75	211	9	patients	patient	NOUN
gsrj-75	211	10	.	.	PUNCT
gsrj-75	212	1	burns	burn	NOUN
gsrj-75	212	2	.	.	PUNCT
gsrj-75	213	1	33(6	33(6	NUM
gsrj-75	213	2	)	)	PUNCT
gsrj-75	213	3	,	,	PUNCT
gsrj-75	213	4	736	736	NUM
gsrj-75	213	5	-	-	SYM
gsrj-75	213	6	46	46	NUM
gsrj-75	213	7	.	.	PUNCT
gsrj-75	214	1	https://doi.org/10.1016/j.burns.2006.10.379	https://doi.org/10.1016/j.burns.2006.10.379	PROPN
gsrj-75	214	2	13.	13.	PROPN
gsrj-75	214	3	�	�	PROPN
gsrj-75	214	4	baugh	baugh	NOUN
gsrj-75	214	5	,	,	PUNCT
gsrj-75	214	6	e.g.	e.g.	ADV
gsrj-75	214	7	,	,	PUNCT
gsrj-75	214	8	anagu	anagu	ADJ
gsrj-75	214	9	,	,	PUNCT
gsrj-75	214	10	o.	o.	PROPN
gsrj-75	214	11	,	,	PUNCT
gsrj-75	214	12	&	&	CCONJ
gsrj-75	214	13	kelly	kelly	PROPN
gsrj-75	214	14	,	,	PUNCT
gsrj-75	214	15	k.m	k.m	PROPN
gsrj-75	214	16	.	.	PROPN
gsrj-75	214	17	(	(	PUNCT
gsrj-75	214	18	2022	2022	NUM
gsrj-75	214	19	)	)	PUNCT
gsrj-75	214	20	.	.	PUNCT
gsrj-75	215	1	laser	laser	NOUN
gsrj-75	215	2	treatment	treatment	NOUN
gsrj-75	215	3	of	of	ADP
gsrj-75	215	4	hypopigmentation	hypopigmentation	NOUN
gsrj-75	215	5	in	in	ADP
gsrj-75	215	6	scars	scar	NOUN
gsrj-75	215	7	:	:	PUNCT
gsrj-75	215	8	a	a	DET
gsrj-75	215	9	review	review	NOUN
gsrj-75	215	10	.	.	PUNCT
gsrj-75	216	1	dermatologic	dermatologic	ADJ
gsrj-75	216	2	surgery	surgery	NOUN
gsrj-75	216	3	.	.	PUNCT
gsrj-75	217	1	48(2	48(2	NUM
gsrj-75	217	2	)	)	PUNCT
gsrj-75	217	3	,	,	PUNCT
gsrj-75	217	4	201	201	NUM
gsrj-75	217	5	-	-	SYM
gsrj-75	217	6	206	206	NUM
gsrj-75	217	7	.	.	PUNCT
gsrj-75	218	1	https://doi.org/10.1097/dss.0000000000003330	https://doi.org/10.1097/dss.0000000000003330	PROPN
gsrj-75	218	2	14.	14.	PROPN
gsrj-75	218	3	�	�	PROPN
gsrj-75	218	4	b!yszczuk	b!yszczuk	NOUN
gsrj-75	218	5	,	,	PUNCT
gsrj-75	218	6	p.	p.	PROPN
gsrj-75	218	7	,	,	PUNCT
gsrj-75	218	8	kozlova	kozlova	PROPN
gsrj-75	218	9	,	,	PUNCT
gsrj-75	218	10	a.	a.	PROPN
gsrj-75	218	11	,	,	PUNCT
gsrj-75	218	12	guo	guo	PROPN
gsrj-75	218	13	,	,	PUNCT
gsrj-75	218	14	z.	z.	PROPN
gsrj-75	218	15	,	,	PUNCT
gsrj-75	218	16	kania	kania	PROPN
gsrj-75	218	17	,	,	PUNCT
gsrj-75	218	18	g.	g.	PROPN
gsrj-75	218	19	,	,	PUNCT
gsrj-75	218	20	&	&	CCONJ
gsrj-75	218	21	distler	distler	NOUN
gsrj-75	218	22	,	,	PUNCT
gsrj-75	218	23	o.	o.	NOUN
gsrj-75	218	24	(	(	PUNCT
gsrj-75	218	25	2019	2019	NUM
gsrj-75	218	26	)	)	PUNCT
gsrj-75	218	27	.	.	PUNCT
gsrj-75	219	1	experimental	experimental	ADJ
gsrj-75	219	2	mouse	mouse	PROPN
gsrj-75	219	3	model	model	NOUN
gsrj-75	219	4	of	of	ADP
gsrj-75	219	5	bleomycin	bleomycin	PROPN
gsrj-75	219	6	-	-	PUNCT
gsrj-75	219	7	induced	induce	VERB
gsrj-75	219	8	skin	skin	NOUN
gsrj-75	219	9	fibrosis	fibrosis	NOUN
gsrj-75	219	10	.	.	PUNCT
gsrj-75	220	1	current	current	ADJ
gsrj-75	220	2	protocols	protocol	NOUN
gsrj-75	220	3	in	in	ADP
gsrj-75	220	4	immunology	immunology	NOUN
gsrj-75	220	5	.	.	PUNCT
gsrj-75	221	1	126(1	126(1	NUM
gsrj-75	221	2	)	)	PUNCT
gsrj-75	221	3	,	,	PUNCT
gsrj-75	221	4	e88	e88	PROPN
gsrj-75	221	5	.	.	PUNCT
gsrj-75	222	1	https://doi.org/10.1002/cpim.88	https://doi.org/10.1002/cpim.88	PUNCT
gsrj-75	222	2	15.	15.	NUM
gsrj-75	222	3	�	�	NOUN
gsrj-75	222	4	jawitz	jawitz	PROPN
gsrj-75	222	5	,	,	PUNCT
gsrj-75	222	6	j.c	j.c	PROPN
gsrj-75	222	7	.	.	PROPN
gsrj-75	222	8	,	,	PUNCT
gsrj-75	222	9	albert	albert	PROPN
gsrj-75	222	10	,	,	PUNCT
gsrj-75	222	11	m.k	m.k	PROPN
gsrj-75	222	12	.	.	PROPN
gsrj-75	222	13	,	,	PUNCT
gsrj-75	222	14	nigra	nigra	PROPN
gsrj-75	222	15	,	,	PUNCT
gsrj-75	222	16	t.p	t.p	PROPN
gsrj-75	222	17	.	.	PROPN
gsrj-75	222	18	,	,	PUNCT
gsrj-75	222	19	&	&	CCONJ
gsrj-75	222	20	bunning	bunning	PROPN
gsrj-75	222	21	,	,	PUNCT
gsrj-75	222	22	r.d	r.d	PROPN
gsrj-75	222	23	.	.	PROPN
gsrj-75	222	24	(	(	PUNCT
gsrj-75	222	25	1984	1984	NUM
gsrj-75	222	26	)	)	PUNCT
gsrj-75	222	27	.	.	PUNCT
gsrj-75	223	1	a	a	DET
gsrj-75	223	2	new	new	ADJ
gsrj-75	223	3	skin	skin	NOUN
gsrj-75	223	4	manifestation	manifestation	NOUN
gsrj-75	223	5	of	of	ADP
gsrj-75	223	6	progressive	progressive	ADJ
gsrj-75	223	7	systemic	systemic	ADJ
gsrj-75	223	8	sclerosis	sclerosis	NOUN
gsrj-75	223	9	.	.	PUNCT
gsrj-75	224	1	journal	journal	PROPN
gsrj-75	224	2	of	of	ADP
gsrj-75	224	3	the	the	DET
gsrj-75	224	4	american	american	PROPN
gsrj-75	224	5	academy	academy	PROPN
gsrj-75	224	6	of	of	ADP
gsrj-75	224	7	dermatology	dermatology	NOUN
gsrj-75	224	8	.	.	PUNCT
gsrj-75	225	1	11(2	11(2	X
gsrj-75	225	2	)	)	PUNCT
gsrj-75	225	3	,	,	PUNCT
gsrj-75	225	4	265	265	NUM
gsrj-75	225	5	.	.	PUNCT
gsrj-75	225	6	https://doi.org/10.1016/s0190-9622(84)70163-0	https://doi.org/10.1016/s0190-9622(84)70163-0	PROPN
gsrj-75	225	7	16.	16.	NUM
gsrj-75	225	8	�	�	NOUN
gsrj-75	225	9	sakamoto	sakamoto	NOUN
gsrj-75	225	10	,	,	PUNCT
gsrj-75	225	11	t.	t.	PROPN
gsrj-75	225	12	,	,	PUNCT
gsrj-75	225	13	kaburaki	kaburaki	PROPN
gsrj-75	225	14	,	,	PUNCT
gsrj-75	225	15	m.	m.	NOUN
gsrj-75	225	16	,	,	PUNCT
gsrj-75	225	17	&	&	CCONJ
gsrj-75	225	18	shimizu	shimizu	PROPN
gsrj-75	225	19	,	,	PUNCT
gsrj-75	225	20	t.	t.	PROPN
gsrj-75	225	21	(	(	PUNCT
gsrj-75	225	22	2021	2021	NUM
gsrj-75	225	23	)	)	PUNCT
gsrj-75	225	24	.	.	PUNCT
gsrj-75	226	1	salt	salt	NOUN
gsrj-75	226	2	-	-	PUNCT
gsrj-75	226	3	and	and	CCONJ
gsrj-75	226	4	-	-	PUNCT
gsrj-75	226	5	pepper	pepper	NOUN
gsrj-75	226	6	skin	skin	NOUN
gsrj-75	226	7	appearance	appearance	NOUN
gsrj-75	226	8	and	and	CCONJ
gsrj-75	226	9	systemic	systemic	ADJ
gsrj-75	226	10	sclerosis	sclerosis	NOUN
gsrj-75	226	11	.	.	PUNCT
gsrj-75	227	1	qjm	qjm	INTJ
gsrj-75	227	2	.	.	PUNCT
gsrj-75	228	1	114(8	114(8	NUM
gsrj-75	228	2	)	)	PUNCT
gsrj-75	228	3	,	,	PUNCT
gsrj-75	228	4	599	599	NUM
gsrj-75	228	5	-	-	SYM
gsrj-75	228	6	600	600	NUM
gsrj-75	228	7	.	.	PUNCT
gsrj-75	229	1	https://doi.org/10.1093/qjmed/hcab070	https://doi.org/10.1093/qjmed/hcab070	NOUN
gsrj-75	229	2	17.	17.	NUM
gsrj-75	229	3	�	�	SYM
gsrj-75	229	4	carney	carney	PROPN
gsrj-75	229	5	,	,	PUNCT
gsrj-75	229	6	b.c	b.c	PROPN
gsrj-75	229	7	.	.	PROPN
gsrj-75	229	8	,	,	PUNCT
gsrj-75	229	9	chen	chen	PROPN
gsrj-75	229	10	,	,	PUNCT
gsrj-75	229	11	j.h	j.h	PROPN
gsrj-75	229	12	.	.	PROPN
gsrj-75	229	13	,	,	PUNCT
gsrj-75	229	14	luker	luker	PROPN
gsrj-75	229	15	,	,	PUNCT
gsrj-75	229	16	j.n	j.n	PROPN
gsrj-75	229	17	.	.	PROPN
gsrj-75	229	18	,	,	PUNCT
gsrj-75	229	19	alkhalil	alkhalil	PROPN
gsrj-75	229	20	,	,	PUNCT
gsrj-75	229	21	a.	a.	PROPN
gsrj-75	229	22	,	,	PUNCT
gsrj-75	229	23	jo	jo	PROPN
gsrj-75	229	24	,	,	PUNCT
gsrj-75	229	25	d.y	d.y	PROPN
gsrj-75	229	26	.	.	PROPN
gsrj-75	229	27	,	,	PUNCT
gsrj-75	229	28	travis	travis	PROPN
gsrj-75	229	29	,	,	PUNCT
gsrj-75	229	30	t.e	t.e	PROPN
gsrj-75	229	31	.	.	PROPN
gsrj-75	229	32	,	,	PUNCT
gsrj-75	229	33	moffatt	moffatt	PROPN
gsrj-75	229	34	,	,	PUNCT
gsrj-75	229	35	l.t	l.t	PROPN
gsrj-75	229	36	.	.	PROPN
gsrj-75	229	37	,	,	PUNCT
gsrj-75	229	38	simbulan	simbulan	NOUN
gsrj-75	229	39	-	-	PUNCT
gsrj-75	229	40	rosenthal	rosenthal	NOUN
gsrj-75	229	41	,	,	PUNCT
gsrj-75	229	42	c.m	c.m	PROPN
gsrj-75	229	43	.	.	PROPN
gsrj-75	229	44	,	,	PUNCT
gsrj-75	229	45	rosenthal	rosenthal	PROPN
gsrj-75	229	46	,	,	PUNCT
gsrj-75	229	47	d.s	d.s	PROPN
gsrj-75	229	48	.	.	PROPN
gsrj-75	229	49	,	,	PUNCT
gsrj-75	229	50	&	&	CCONJ
gsrj-75	229	51	shupp	shupp	PROPN
gsrj-75	229	52	,	,	PUNCT
gsrj-75	229	53	j.w	j.w	PROPN
gsrj-75	229	54	.	.	PROPN
gsrj-75	229	55	(	(	PUNCT
gsrj-75	229	56	2019	2019	NUM
gsrj-75	229	57	)	)	PUNCT
gsrj-75	229	58	.	.	PUNCT
gsrj-75	230	1	pigmentation	pigmentation	NOUN
gsrj-75	230	2	diathesis	diathesis	NOUN
gsrj-75	230	3	of	of	ADP
gsrj-75	230	4	hypertrophic	hypertrophic	ADJ
gsrj-75	230	5	scar	scar	NOUN
gsrj-75	230	6	:	:	PUNCT
gsrj-75	230	7	an	an	DET
gsrj-75	230	8	examination	examination	NOUN
gsrj-75	230	9	of	of	ADP
gsrj-75	230	10	known	know	VERB
gsrj-75	230	11	signaling	signal	VERB
gsrj-75	230	12	pathways	pathway	NOUN
gsrj-75	230	13	to	to	PART
gsrj-75	230	14	elucidate	elucidate	VERB
gsrj-75	230	15	the	the	DET
gsrj-75	230	16	molecular	molecular	ADJ
gsrj-75	230	17	pathophysiology	pathophysiology	NOUN
gsrj-75	230	18	of	of	ADP
gsrj-75	230	19	injury	injury	NOUN
gsrj-75	230	20	-	-	PUNCT
gsrj-75	230	21	related	relate	VERB
gsrj-75	230	22	dyschromia	dyschromia	NOUN
gsrj-75	230	23	.	.	PUNCT
gsrj-75	231	1	journal	journal	PROPN
gsrj-75	231	2	of	of	ADP
gsrj-75	231	3	burn	burn	NOUN
gsrj-75	231	4	care	care	NOUN
gsrj-75	231	5	&	&	CCONJ
gsrj-75	231	6	research	research	NOUN
gsrj-75	231	7	.	.	PUNCT
gsrj-75	232	1	40(1	40(1	NUM
gsrj-75	232	2	)	)	PUNCT
gsrj-75	232	3	,	,	PUNCT
gsrj-75	232	4	58	58	NUM
gsrj-75	232	5	-	-	SYM
gsrj-75	232	6	71	71	NUM
gsrj-75	232	7	.	.	PUNCT
gsrj-75	233	1	https://doi.org/10.1093/jbcr/iry045	https://doi.org/10.1093/jbcr/iry045	PROPN
gsrj-75	233	2	18.	18.	NUM
gsrj-75	233	3	�	�	PROPN
gsrj-75	233	4	kirkpatrick	kirkpatrick	PROPN
gsrj-75	233	5	,	,	PUNCT
gsrj-75	233	6	l.d	l.d	PROPN
gsrj-75	233	7	.	.	PROPN
gsrj-75	233	8	,	,	PUNCT
gsrj-75	233	9	shupp	shupp	PROPN
gsrj-75	233	10	,	,	PUNCT
gsrj-75	233	11	j.w	j.w	PROPN
gsrj-75	233	12	.	.	PROPN
gsrj-75	233	13	,	,	PUNCT
gsrj-75	233	14	smith	smith	PROPN
gsrj-75	233	15	,	,	PUNCT
gsrj-75	233	16	r.d	r.d	PROPN
gsrj-75	233	17	.	.	PROPN
gsrj-75	233	18	,	,	PUNCT
gsrj-75	233	19	alkhalil	alkhalil	PROPN
gsrj-75	233	20	,	,	PUNCT
gsrj-75	233	21	a.	a.	PROPN
gsrj-75	233	22	,	,	PUNCT
gsrj-75	233	23	moffatt	moffatt	PROPN
gsrj-75	233	24	,	,	PUNCT
gsrj-75	233	25	l.t	l.t	PROPN
gsrj-75	233	26	.	.	PROPN
gsrj-75	233	27	,	,	PUNCT
gsrj-75	233	28	&	&	CCONJ
gsrj-75	233	29	carney	carney	PROPN
gsrj-75	233	30	,	,	PUNCT
gsrj-75	233	31	bc	bc	PROPN
gsrj-75	233	32	.	.	PROPN
gsrj-75	233	33	(	(	PUNCT
gsrj-75	233	34	2021	2021	NUM
gsrj-75	233	35	)	)	PUNCT
gsrj-75	233	36	.	.	PUNCT
gsrj-75	234	1	galectin-1	galectin-1	NUM
gsrj-75	234	2	production	production	NOUN
gsrj-75	234	3	is	be	AUX
gsrj-75	234	4	elevated	elevate	VERB
gsrj-75	234	5	in	in	ADP
gsrj-75	234	6	hypertrophic	hypertrophic	ADJ
gsrj-75	234	7	scar	scar	NOUN
gsrj-75	234	8	.	.	PUNCT
gsrj-75	235	1	wound	wound	PROPN
gsrj-75	235	2	repair	repair	NOUN
gsrj-75	235	3	&	&	CCONJ
gsrj-75	235	4	regeneration	regeneration	NOUN
gsrj-75	235	5	.	.	PUNCT
gsrj-75	236	1	29(1	29(1	NUM
gsrj-75	236	2	)	)	PUNCT
gsrj-75	236	3	,	,	PUNCT
gsrj-75	236	4	117	117	NUM
gsrj-75	236	5	-	-	SYM
gsrj-75	236	6	128	128	NUM
gsrj-75	236	7	.	.	PUNCT
gsrj-75	237	1	https://doi.org/10.1111/wrr.12869	https://doi.org/10.1111/wrr.12869	PROPN
gsrj-75	237	2	19.	19.	PROPN
gsrj-75	237	3	�	�	PROPN
gsrj-75	237	4	tejiram	tejiram	PROPN
gsrj-75	237	5	,	,	PUNCT
gsrj-75	237	6	s.	s.	PROPN
gsrj-75	237	7	,	,	PUNCT
gsrj-75	237	8	zhang	zhang	PROPN
gsrj-75	237	9	,	,	PUNCT
gsrj-75	237	10	j.	j.	PROPN
gsrj-75	237	11	,	,	PUNCT
gsrj-75	237	12	travis	travis	PROPN
gsrj-75	237	13	,	,	PUNCT
gsrj-75	237	14	t.e	t.e	PROPN
gsrj-75	237	15	.	.	PROPN
gsrj-75	237	16	,	,	PUNCT
gsrj-75	237	17	carney	carney	PROPN
gsrj-75	237	18	,	,	PUNCT
gsrj-75	237	19	b.c	b.c	PROPN
gsrj-75	237	20	.	.	PROPN
gsrj-75	237	21	,	,	PUNCT
gsrj-75	237	22	alkhalil	alkhalil	PROPN
gsrj-75	237	23	,	,	PUNCT
gsrj-75	237	24	a.	a.	PROPN
gsrj-75	237	25	,	,	PUNCT
gsrj-75	237	26	moffatt	moffatt	PROPN
gsrj-75	237	27	,	,	PUNCT
gsrj-75	237	28	l.t	l.t	PROPN
gsrj-75	237	29	.	.	PROPN
gsrj-75	237	30	,	,	PUNCT
gsrj-75	237	31	johnson	johnson	PROPN
gsrj-75	237	32	,	,	PUNCT
gsrj-75	237	33	l.s	l.s	PROPN
gsrj-75	237	34	.	.	PROPN
gsrj-75	237	35	,	,	PUNCT
gsrj-75	237	36	&	&	CCONJ
gsrj-75	237	37	shupp	shupp	PROPN
gsrj-75	237	38	,	,	PUNCT
gsrj-75	237	39	j.w	j.w	PROPN
gsrj-75	237	40	.	.	PROPN
gsrj-75	237	41	(	(	PUNCT
gsrj-75	237	42	2016	2016	NUM
gsrj-75	237	43	)	)	PUNCT
gsrj-75	237	44	.	.	PUNCT
gsrj-75	238	1	compression	compression	NOUN
gsrj-75	238	2	therapy	therapy	NOUN
gsrj-75	238	3	affects	affect	VERB
gsrj-75	238	4	collagen	collagen	NOUN
gsrj-75	238	5	type	type	NOUN
gsrj-75	238	6	balance	balance	NOUN
gsrj-75	238	7	in	in	ADP
gsrj-75	238	8	hypertrophic	hypertrophic	ADJ
gsrj-75	238	9	scar	scar	NOUN
gsrj-75	238	10	.	.	PUNCT
gsrj-75	239	1	journal	journal	PROPN
gsrj-75	239	2	of	of	ADP
gsrj-75	239	3	surgical	surgical	ADJ
gsrj-75	239	4	research	research	NOUN
gsrj-75	239	5	.	.	PUNCT
gsrj-75	240	1	201(2	201(2	NUM
gsrj-75	240	2	)	)	PUNCT
gsrj-75	240	3	,	,	PUNCT
gsrj-75	240	4	299	299	NUM
gsrj-75	240	5	-	-	SYM
gsrj-75	240	6	305	305	NUM
gsrj-75	240	7	.	.	PUNCT
gsrj-75	241	1	https://doi.org/10.1016/j.jss.2015.10.040	https://doi.org/10.1016/j.jss.2015.10.040	ADJ
gsrj-75	241	2	29	29	NUM
gsrj-75	241	3	30	30	NUM